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Myocardial infarction is the necrosis of heart tissue due to isch-
emia which is the obstruction of circulation to the heart. There are 
two serious consequences to this occlusion of coronary arteries and the 
resulting infarction. 71 One is the development of life-threatening 
arrhythmias and the other is the failure of the heart as a pump. The 
latter may also be the direct result of the arrhythmias. 
The purpose of this study is to develop a novel class of anti-
arrhythmic agents with characteristics of being both potent and non-
toxic. In addition, it would be of value to be able to label the agent 
with a radionuclide which would permit imaging of the heart in a non-
invasive manner, thus giving indication of the extent of damage caused 
by a myocardial infarction and also to provide insight into the mecha-
nism of its biological activity. 
Arrhythmias and Heart Disease 
Coronary heart disease culminating in myocardial infarction accounts 
for 650,000 deaths each year making this the leading cause of death in 
this country. 71 Cardiac arrest, initiated without warning, occurs over 
300,000 times each year. These deaths, in most cases, are caused by 
ventricular fibrillation which may be preceded and precipitated by 
t . ul h th . 100 ven r~c ar arr y m~as. 
1 
Of myocardial infarction related deaths, 60-70% occur in the first 
hour after onset of symptoms. This is before many victims even reach 
the hospital. Most of these succumb as a result of ventricular tachy-
cardias71 which are rapid or accelerated heart rhythms originating 
within the ventricles. In fact, half of the deaths from myocardial 
infarction are the result of cardiac arrhythmias41 with ventricular 
tachycardias being the most serious and life threatening. 24, 100 
Following a myocardial infarction, nearly all patients exhibit 
ventricular tachycardia. 24 Of these, 70-80% require pharmacological 
therapy71 since the mortality rate for myocardial infarction is two to 
three times higher when complicated with ventricular tachycardia. 24 
There is also a link between ventricular tachycardia and coronary heart 
disease indicated by the fact that these arrhythmias are nearly always 
found in patients with advanced coronary heart disease. 24 
In addition to myocardial infarction, there are a number of other 
potential causes of cardiac arrhythmias. For example, all healthy 
adults have at one time or another experienced ventricular premature 
contractions which are the first signs of an arrhythmia. These most 
2 
often occur after excessive ingestion of coffee or tea, heavy smoking, 
or emotional excitement. 24 Other causes of arrhythmias include hypo-
kalemia, hypocalcemia, hyperthyroidism, hyperactivity of the sympathetic 
system, and hypoxia. The latter includes local ischemia in the heart 
tissue due to atherosclerosis in the coronary system. 116 Even one of 
the main drugs presently being used for the suppression of atrial ar-
rhythmias, namely digitalis, can produce severe arrhythmias in an over-
dose. 
3 
Dog Models for the Study of Arrhythmias and Antiarrhythmics 
For practical and ethical reasons, experimentation required in the 
study of arrhythmias and antiarrhythmic agents is not always feasible on 
human subjects. Consequently, this experimentation must be performed on 
animal subjects such as the dog. The dog is the model of choice since 
the ligation of the anterior descending coronary artery in this animal 
produces arrhythmias which have similar etiologies to certain types of 
ventricular arrhythmias which are found in man. 25 Moreover, the persis-
tence of these arrhythmias makes repeated testing possible as well as 
simultaneous evaluation of drug activity and toxicity in some cases. 25 
Following the design and synthesis of the potential antiarrhythmic 
agents to be discussed later, the evaluation for biological activity was 
performed in the laboratory of Dr. Benjamin Scherlag of the Veterans 
Administration Medical Center in Oklahoma City. Under his supervision, 
the dogs were prepared according to standardized procedures. 52 , 101 , 102 
The method begins with anesthetizing the dog with sodium pento-
barbital (30 mg/kg, iv). 101 ' 102 The dog is then connected to an artifi-
cial breathing apparatus and a thoracotomy is performed at the fourth 
intercostal space. The left atrium is pulled back to expose the left 
anterior descending coronary artery. This artery is then closed off in 
two stages by a double ligature. The first ligature is drawn around the 
artery and a 20-gauge hypodermic needle. Once this is tied, the needle 
is removed, thus leaving the artery constricted but not completely 
occluded. After thirty minutes, the second ligature is tightened. This 
ligature completely and permanently closes the artery. 
The resulting myocardial infarction gives rise to arrhythmias which 
occur in two distinct phases. 56 , 101 There is an initial arrhythmic 
period immediately following the coronary occlusion which lasts for 20-
30 minutes. This is a very serious and often fatal phase since these 
arrhythmias, which are attributed to re-entry mechanisms, 24, 29 , 56 may 
degenerate into ventricular fibrillation leading to cardiac arrest and 
death. 35 This phase has its clinical counterpart in the pre-hospital 
phase of acute myocardial infarction. 57 The frequency of sudden death 
caused by ventricular fibrillation in this phase is greater than 50%. 56 
Assuming the dog survives this phase of arrhythmias, there is a 
4 
quiescent period of up to several hours. This is followed by a second 
phase of arrhythmic activity which lasts from 24 to 48 hours 56 , 101 which 
corresponds to the coronary care, hospitalization phase in the clinical 
setting. The arrhythmias in this phase are attributed to increased 
automaticity of ventricular pacemakers. 56 , 102 
During this phase, reentrant ventricular arrhythmias may be induced 
by electrically pacing the dog heart with a low voltage DC current. 102 
In this way, the arrhythmia may be studied as well as the response of 
the heart to antiarrhythmic agents. 
Antiarrhythmic Agents 
There are large number of antiarrhythmic agents in clinical use. 
However, all of these exhibit a variety of undesirable side effects, 
some even critical in certain instances. The most common side effects 
are cardiotoxicity, gastrointestinal complications, and adverse effects 
111 on the central nervous system. 
The treatments of arrhythmias are as varied as the causes. One 
simple treatment employed to terminate ventricular arrhythmia is a sharp 
5 
thump or blow to the pericardium. Since this treatment only succeeds 
occasionally, other, more harsh remedies must be used. 
Cardioversion or the administration of a DC shock is effective in 
terminating a paroxysm of ventricular tachycardia in greater than 90% of 
all cases. However, it should not be used indiscriminately. The use of 
electric shock in the case of arrhythmias caused by digitalis intoxica-
tipn may provoke fatal ventricular fibrillation. Other measures should 
also be used when the tachycardia is repetitive. 24,41 
There are a wide variety of drugs in use at the present time for 
the suppression and prevention of arrhythmias of different types. The 
earliest reported drug therapy for cardiac arrhythmias occurred in 1914 
when an arrhythmia in a malarial patient, being treated with cinchona 
alkaloids (Figure 1), was converted to a normal sinus rhythm. 80 Later, 
it was found that each of these alkaloids had the ability to convert 
atrial fibrillation to normal sinus rhythm. Of the alkaloids in this 
group, quinidine (3) was the most potent and is still in wide usage in 
the treatment of atrial fibrillation41 , 80 and also in the treatment of 
atrial and ventricular premature depolarization. 14 As mentioned ear-
lier, all antiarrhythmic agents currently available exhibit undesired 
side effects. Quinidine and related compounds can promote nausea or 
vomiting, diarrhea, cramping abdominal pain, and headaches. This drug 
has also been known to produce ventricular tachycardia and fibrillation 
even at therapeutic doses.41 
Another antiarrhythmic agent used in the treatment of atrial ar-
rhythmias is atropine (5). This drug is used in the treatment and 
abolishment of sinus bradycardia. 14 , 41 Adverse side effects of atropine 
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Figure 1. Selected Cinchona Alkaloids 
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disturbances, and minor aberrations of mental function.41 
A very important family of antiarrhythmics is a group of glycosides 
which are extracts of the plant Digitalis Purpurea. The most common 
preparation is referred to as digoxin (6) and is used to control and 
Convert . t h d . d f. b . 11 t . 1 4 ' 41 ' 11 5 Slnus ac year la an l rl a lon. Digoxin (6) and 
related systems 7-9 are shown in Figure 2. Of the side effects atten-
dant to digitalis glycosides, the most common are headaches, gastrointes-
tinal upset, and visual disturbances. Ironically, digitalis glycoides 
may even produce cardiac arrhythmias of virtually all types including 
the most dangerous ones such as ventricular tachycardia and ventricular 
fibrillation. 
10 
For the treatment of arrhythmias induced by digitalis intoxication, 
the drug of choice is diphenylhydantoin (10, dilantin). It also has 
more than its share of side effects of which the most common are giddi-
ness, ataxia, nystagmus, dysarthria, fatigue, gastrointestinal upset, 
hirsutism, hyperplasia of the gums, morbilliform rashes, hemorrhagic 















Figure 2. Selected Digitalis Glycosides 
8 
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One very potent and much prescribed antiarrhythmic drug is procain-
amide (11, pronestyl). It is used in the suppression of premature 
ventricular contractions and ventricular tachycardia. The side effects 
related to this drug include anorexia, nausea, vomiting, diarrhea, 
weakness, giddiness. Also reported are occasional hallucinations, 
fevers, rashes, and hypotension.41 
11 12 
Of all of the antiarrhythmic agents in clinical use at this time, 
lidocaine (12, xylocaine) may be the most important. It is usually the 
first drug administered to patients with acute myocardial infarction 
when serious arrhythmias are recognized. 41 Lidocaine is the preferred 
agent for the treatment of ventricular tachycardia arising from nearly 
any cause with the exception of digitalis intoxication. 24 It is for 
these reasons that the activities of the new potential antiarrhythmic 
agents to be discussed later are compared to that of lidocaine which is 
used as a standard. 
Lidocaine (12), which is given intravenously, begins to act within 




serum halflife of lidocaine is only 20 to 30 minutes. Lidocaine also 
has the disadvantage of being capable of producing sinus arrest due to 
depressed automaticity of the sinoatrial node tissue. The most alarming 
toxic reactions to lidocaine involve the central nervous system. These 
include muscular twitching, visual disturbances, tinnitus, paresthesias, 
dizziness, drowsiness, dysarthria, confusion, coma, convulsions, arte-
rial hypotension, bradycardia, and respiratory arrest. There have also 
been complaints of intense feelings of apprehension and also intense 
euphoria. 41 Although these are substantial side effects, most are due 
to excessive doses or advanced liver disease.41 
The group of antiarrhythmic drugs described is by no means all 
inclusive. There are many new potential antiarrhythmic agents exhib-
iting novel structures and mechanism of biological activity which are 
tl . t. th 1 t. f 1. . 1 t . 1 6' 80' 84' 111 '116 curren y awa~ ~ng e comp e ~on o c ~n~ca r~a s. 
Radionuclides for Myocardial Imaging Studies 
Although much is known about the etiology of cardiac arrhythmias, 
much remains undiscovered. After myocardial infarction, it is of inter-
est to be able to determine the extent of damage. One method of assess-
ing the damage is to perform exploratory open-heart surgery. It is of 
considerable importance to be able to make this determination via a less 
traumatic, nonsurgical technique. This may be done through the use of 
radionuclide tracer studies, or imaging, of the heart tissue. A large 
volume of work has been done in the area of designing and testing 
d . · t · 11 1 b 11 d d f use ;n th;s fash;on. 27b,90 ra ~o~so op~ca y a e e compoun s or ~ ~ ~ 
Many of these compounds are also of potential use in the detection of 
coronary artery disease. 
There are two radiopharmaceutical methods which are used in the 
identification and quantitation of ischemic regions due to myocardial 
infarction. 90 One technique, referred to as cold spot imaging, employs 
labelled compounds which show greater uptake in normal tissue than in 
infarcted and ischemic regions, thus leading to indirect information 
11 
about the type and extent of damage. The other approach, referred to as 
hot spot imaging, utilizes those labels which localize in the infarcted 
or damaged regions. Representatives of each group of myocardial imaging 
agents are found in Tables I and II. 
Although each of the radioisotopes currently in use has character-
istics of value to imaging studies, many also possess intrinsic traits 
which hinder their general utility. For example, many of the nuclides, 
such as 14c and 3H are beta particle emitters. Since these particles 
will not penetrate tissues of the body, these are limited mainly to in 
vitro studies. 27 , 90 Other nuclides, such as 13N, 11 c, and 15o are 
ultra-short lived positron emitters which require a nearby cyclotron. 
This greatly restricts general use since equipment of this type is not 
widely available. 
Gamma emitting radioisotopes are the best suited for imaging stud-
ies since this nonparticle radiation will readily penetrate tissues. 
However, just being a gamma emitter is not enough to make a radioisotope 
a good candidate for imaging studies. The emission energy must be of 
sufficient power so as to be detectable (20 keV), and it must also be 
within an upper limit (510 keV) to obtain good quality images and also 
t · d · t · t d · t · 27a o avo1 excess1ve pa 1en ra 1a 1on. It is for the latter reason 
that the use of 43K on a routine basis is limited. 
12 
TABLE I 
COLD-SPOT IMAGING AGENTS90 
Radionuclide Major Half-life Emissions 
Inorganic Salts 
43KC1 y s- 22.4 h 
81 RbCl y s+ 4-7 h 
131 csCl x-ray 9.7 d 
201 T1Cl y 72h 
13NH 
3 
s+ 10 m 
99mTc Complexes y 6.1 h 
Macroaggregated Albumin 
Human Serum Albumin 
Metabolites 
1-[14c]Palmitic Acid s- 5730 y 
1-[ 14c]Oleic Acid 
131 s- 8.05 d 16- [ I] Iodo-9- y 
Hexadecenoic Acid 
123m 119 d 18-Iodo-13-[ Te]Tellura- 11 64 y 
17-octadecenoic Acid ' a 
82 - 35.7 h 18-[ Br]Bromo-5-tellura- 64b 8 
17-octadecenoic Acid 
[13N]1-Asparagine s+ 10 m 
Inert Gases 
133xe y s- 5.3 d 
81~r y 13 s 
TABLE II 
HOT-SPOT IMAGING AGENTs90 
13 
Major Half-life Emissions Radio nuclide 

























y 10.3 h 
(3 - 49.6 d 
(3 - 49.6 d 
s - 49.6 d 
A short half-life is desirable so as to minimize the patient's 
radiation exposure. However, there are time requirements for synthesis 
and administration of the agent as well as for its in vivo accumulation 
and the collection of data. It is also preferable that the observed 
radioactivity does not drastically decrease during the imaging proce-
dure.27a For this reason, some of the isotopes, which have short half-
. 81 m.. ) 1 23 ) 99m l~ves, such as Kr (13 s , I (13.3 h , and Tc (6.1 h), must be 
produced immediately before use by the decay of other radioactive 
species. The precursors of these three are 81 Rb, 123xe, and 99Mo, 
respectively. 2?a, 90 
In addition to having desirable physical characteristics, the ra-
14 
dioisotope must also possess certain chemical traits. One such trait is 
that the nuclide must be able to be incorporated into an organic carrier 
molecule or be amenable to use in an inorganic form. Because of one 
restriction or another, of the 600 gamma-emitting nuclides, nine of them 
(131I 132I 125I 51C 99mT 22N 85K 197H d 203H ) . , , , r, c, a, r, g, an g compr~se 
greater than 70% of the radionuclides used as diagnostic radiotrac-
27a ers. 
One very productive technique used in the development of novel 
compounds for use in radioactive tracing studies utilizes the concept of 
bioisosterism in the design of these compounds. The concept of isoste-
rism, first proposed by Langmuir69 in 1919, dealt with the similarities 
and substitution of atoms or groups of atoms with respect to electron 
20 number and arrangement. Substitutions of this type should give new 
compounds which have properties similar to the parent compound. This 
idea was extended by Erlenmeyer37 and Grimm20b to include atoms or 
groups of atoms which were similar in size or shape. For example, -NH-, 
-CH2-, and -0- are close enough in group size and bond angles that 
compounds 13, 14, and 15 each exhibit similar antigen activity. 20c This 
is a useful concept in the formation of radionuclide-containing mole-
cules for use as imaging agents which should have similar biological 
functions as the parent compound. For example, 18F may be incorporated 
into a molecule as a bioisosteric replacement of hydrogen. 27a The 
16 
13 X = 
14 X = 
15 X = 
17 
isotope 82Br may bioisosterically replace a methyl group. 20 , 27a 
One pair of bioisosteres which is currently receiving considerable 
attention is that of sulfur and selenium. 27a, 63 , 122 These elements, 
being in the same chemical family, have the same valence electron con-
figuration and are also similar in size and electronegativities, thus 
making them excellent bioisosteres. This is supported by the fact that 
15 
compounds 16 and 17 share almost identical abilities to block axial 
transmission of nerve impulses. 23 Findings of this nature have led to 
the incorporation of the gamma emitting 75se in place of sulfur23 ,96 (as 
96 97 99 well as -CH2-, -NH-, and other isosteric groups ). 
Selenium-75 possesses some characteristics which make it favorable 
for radionuclide studies. It has a half-life of 120 days which allows 
time for synthesis and handling. Selenium-75 is a gamma emitting iso-
tope which gives 1.74 gamma rays per disintegration between 100 and 400 
16 
keV. Iodine-131, the most common of the foreign labels, gives only 0.91 
gamma rays per disintegration. This, plus the fact that the beta parti-
cle absorbed dose is only about 7% of that for 131r, indicates that 
smaller administered doses are required for imaging. 10 Selenium forms 
stable covalent bonds with carbon, giving organoselenium compounds 
greater stability in vivo than corresponding halogenated derivatives.97 
The 75se containing compounds may be synthesized directly from their 
nonradioactive counterparts by use of a neutron beam in a graphite reac-
tor.73 However, recent synthetic developments have led to more simple 
and cost-effective methods for introducing this radioisotope.10,98 
Elemental selenium-75 may be reduced directly to the very useful 
nucleophile, NaH75se, by sodium borohydride according to the following 
equation. 10 The NaH75se thus formed may then be treated with alkyl 
halides, tosylates, or epoxides to form other useful nucleophiles of the 
type R75seH. 
An improvement on this method involves the reduction of [75se]-
selenous acid, instead of elemental selenium-75, with sodium hydride in 
the production of NaH75se.98 Elemental selenium-75 is commercially 




is available with a much greater specific activity of 0.1-2.3 
Ci/mg Se. [75se]Selenous acid may be obtained for as little as 
$2.00/mCi while the price of 75se metal is closer to $30.00/mCi.98 This 
makes the use of H275seo3 much more cost effective than 75se metal in 
the total synthesis of potential radionuclide imaging agents. 
Bicyclo[J.J.1]nonanes and the Treatment of Arrhythmias 
By 1949, sparteine (18), one of the lupine alkaloids, was known to 
17 
have properties as a local anesthetic and also was able to cause a 
depression in heart action as well as circulation. 53 It was later found 
to have useful antiarrhythmic characteristics32 , 93 , 107 and has actually 
been used in the management of various cardiac arrhythmias. 86 In one 
study, sparteine was found to be more potent as an antiarrhythmic agent 
than quinidine (3), diphenylhydantoin (10), procainamide (11), or lido-
caine (12). 112 However, animals intoxicated with plants which produce 
sparteine showed symptoms of nervousness, difficulty in breathing, loss 
of muscular control, salivation, convulsions, and coma in extreme 
86 cases. 
The two central rings in sparteine (18) form the structural back-
bone of 3,7-diheterabicyclo[J.J.1 ]nonanes (19) •59 Several compounds of 
this type have been synthesized and were found to have antiarrhythmic 
activity. 6,9J, 94 These bicyclic systems are potentially an equilibrium 
mixture involving four different conformers as attested to by numerous 
18 
18 
y y X 
B-C C-C C-B B-B 
19 
publications in the area of conformational analysis. 121 The variety of 
choices for atoms X andY, as well as ring substituents, gives rise to 
very diverse methods of syntheses. 
Several reaction types are utilized in the syntheses of many types 
of bicyclo[3.3.1]nonanes. A double Michael addition of dimethyl acetone-
dicarboxylate to the dienone 20 gave the bicyclononane 21 in a yield 
of 86%. 59c The a,a-annelation of the enamine 22 produced the phosphorus 
containing bicyclononane 23 (59%). 77 
1\ 
0 0 





Other means of producing bicyclo[3.3.1]nonanes include several 
methods for bridging certain functionalized cyclooctanes. Bromination 
of 1,5-dimethylenecyclooctane (24) gave the bicyclononane dibromide 25 




alcohol 26 (88%).24 The intermediate 9-borabicyclononane (27), gener-

















THF, EtOH, H2o 
28 
Of the various method of producing bicyclo[3.3.1]nonanes, the most 
versatile and widely used is the double Mannich reaction involving 
substituted cyclohexanones, an amine, and two or more equivalents of an 
aldehyde. One early paper in the area reports a yield of 80% for 3-
methyl-3-azabicyclo[J.J.1]nonan-9-one dicarboxylate (29) from diethyl 




[3.3.1]nonanes have been synthesized with different combinations of 
heteroatoms in the 3- and 7- positions, such as nitrogen-nitrogen sys-
tems,95 oxygen-nitrogen systems, 3' 7 as well as sulfur-nitrogen sys-
tems.5'8'34 The syntheses of the first reported bicyclo(3.3.1]nonanes 
21 
with selenium incorporated into the ring at the 3-position are discussed 
in the next chapter. 
Current Organoselenium Chemistry 
Although extensive organoselenium work was reported in the compre-
·hensive reviews published by Bradt and co-workers18 (1929-1933) before 
about 1973, there were only two selenium reagents which were in common 
usage by organic chemists.104 These were elemental selenium and seleni-
um dioxide. Elemental selenium was used mainly in the dehydrogenation 
of cyclic and acyclic hydrocarbons91 such as in the dehydrogenation of 
cholesterol (30} to Diel 1s hydrocarbon (31}.39 Selenium dioxide was and 
is still used as an oxidizing agent for ketones and olefins.92•119 





c6H5CcH3 dioxane 0 II 
or + Se02 c6H5












Since 1973, there have been major advances in the usefulness of 
selenium reagents which affect a variety of functional groups. 26•104 
22 
One of the most important functional group transformations is the intro-
duction of unsaturation into saturated systems. These reaction se~uenc-
es begin with the formation of an aryl alkyl selenoether primarily via 
attack of a selenophenylate anion on an alkyl halide, or the attack of 



















selenoether thus ~ormed is oxidized to a selenoxide which then fragments 
to the unsaturated system as shown. 26a,105a 
In addition to the use of selenium reagents to modify substrate 
molecules, methods for using selenium reagents for the purpose of incor-
porating selenium into target molecules have been known for well over 50 
years. 18, 91 Although techniques and the availability of certain rea-
gents have changed, the basic starting material for these reactions is 
still elemental selenium. Elemental selenium may be used in its metal-
lie form or it may be reduced to neutral and anionic nucleophilic rea-
gents. 
Elemental selenium undergoes an insertion reaction with phospha-
zines (32) to give sterically hindered selenoketones (33) in fair to 
good yields. 50•105b Selenium will also insert into carbon-metal bonds 
in cases such as Grignard40 and alkyl lithium reagents.48 These organa-
metallic selenides are very nucleophilic reagents and are generally 


























SeH + MgClBr 
(71%) 
24 
One very useful reagent employed in the synthesis of organoselenium 
compounds is hydrogen selenide which may be prepared in several ways as 
shown below.JB,46,65,85, 117 Because H
2
Se is very air sensitive and 
extremely toxic, it is usually generated in situ. In order to circum-
vent the handling problems associated with handling H2Se, a number of 
very useful synthons may be produced by the reduction of elemental 
selenium under various and quite convenient conditions.19 , 62 These 
alkali selenides are extremely aggressive nucleophiles which may partie-
ipate in most types of displacement reactions leading to target organa-
selenium molecules. 
Al2se3 + 6 H20 3 H2Se + 2 Al(OH)J 
(85%) 
paraffin wax + Se .380°C ) H
2
Se + ole fins (90%) 
Se + co + H20 
Etl 
H2Se + co2 
4 NaBH4 + 2 Se + 7 H20 ) 2 NaHSe + Na2B4o7 + 14 H2 
NaBH4 + Se + 3 EtOH ) NaHSe + B(OEt) 3 + 3 H2 
2 Na + Se 
NH3 
Na2se 
Na + Se 
NH3 
) Na2se2 
2 NaBH4 + 2 Se + 6 H2o ~ Na2se2 + 2 H3Bo3 + 7 H2 
In comparison to sulfur analogs, H2Se and the selenols, RSeH and ArSeH, 
are more acidic81 and also more nucleophilic89 than their sulfur coun-
terparts. 
Toxicity of Selenium Compounds 
Selenium is one of the essential trace elements which is required 
for optimum health. Dietary deficiency of selenium has been indicated 
to increase the potential for developing cardiovascular disease and 
certain types of cancer. 43 It also appears that a deficiency of sele-
nium may increase incidences of chronic arthritis. 43 Although benefi-
cial in trace amounts, larger quantities of selenium and some of its 
compounds have been found to be quite toxic. 63 , 122 Little is actually 
25 
known about the toxicity of these compounds, however, since no systematic 
study has been made. 
Elemental selenium is relatively non-toxic. Although it appears 
from animal studies that some inorganic selenium compounds are metabo-
lized,72,87 elemental selenium has been found to pass unchanged through 
26 
dog intestine without observable effect on the dog. 63 Fine selenium 
122 dust and fumes have been found to be "irritating" to exposed workers. 
In one particular case, some workers were exposed to dense selenium 
fumes which reportedly had an unpleasant, garlic-like odor and caused an 
intense irritation of the eyes, nose, and throat. The more severely 
exposed workers experienced immediate sneezing, coughing, nasal conges-
tion, dizziness, inflammation of the eyes, and headaches. However, no 
selenium was detected in the urine. All workers were entirely well in 
three days with no persisting ill effects. 122 
Although elemental selenium appears to exhibit little systemic 
toxicity, hydrogen selenide is one of the most toxic substances known. 63 
This gas has an extremely offensive odor (that of rotting radishes), but 
causes olfactory fatigue at a concentration of 0.0001 mg/1 which makes 
it all the more hazardous. 63 The threshold limit for exposure has been 
set at 0.05 ppm Se by the American Conference of Governmental Industrial 
Hygienists. 63 
Selenium dioxide has been found to cause intense local irritation 
and inflammation as well as cause the developement of dermatitis. Some 
people can develop an allergy to selenium dioxide resulting in the 
11. f th . h d t d" t 122 swe ~ng o e~r eyes w en expose even a a ~s ance. Sodium 
selenite and selenate have been shown to have a marked toxicity in 
. 1 t d" 122 
an~ma s u ~es. 
Few organoselenium compounds have been tested for toxicity and thus 
general trends and conclusion that can be drawn are also few. To date, 
no organoselenium compound has been found to be more toxic than the 
inorganic forms of the element. 122 Representative samples of toxicity 
data may be found in Table III. 
TABLE III 





















aintraperitoneal administration of a minimum fatal dose to a rat. 
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CHAPTER II 
RESULTS AND DISCUSSION 
3,7-Diheterabicyclo[3.3.1]nonane systems 19 have intriguing ste-
reochemical properties34 , 59 , 88 , 95c, 121 and, in some cases, valuable 
antiarrhythmic properties. 6 ' 93 We have developed methods of prepara-
tion of selenium-containg derivatives, several of which also display 
antiarrhythmic action in dog models.35,56 ,57, 101 , 102 
X y X 
19 
The principle objective of this research was to develop synthetic 
methodology to obtain substituted 3-selena-7-azabicyclo[3.3.1]nonanones 
34, the corresponding nonanes 35, and the salts 36 and 37. Moreover, it 
was also an objective to screen these heterocycles for potential antiar-
rhythmic activity in dog models and to evaluate selected members of the 
above families for use as imaging agents for mapping infarcted areas of 
the heart in the animal models. For imaging purposes, the cold selenium 




R" 34 R' 
a, R = c6H5cH2-; R' 
b, R = 2-C4H3SCH2-; 
c, R = c6H5cH2CH2-; 
R' R" 
\ 
R" 35 R' 
= R" = H 
R' = R" = 
R' = R" = 
d, R = 4-CH3oc6H4cH2cH2-; R' = 
e, R = 3,4-(CH3o) 2c6H3cH2CH2-; 
f, R' = C6H5-; R = R11 = H 
g, R' = 2-C4H3S-; R = R" = H 
h, R' = 4-ClC6H4-; R = R" = H 






R" = H 
R' = R" = H 
activity was evaluated in anesthetized dogs by Dr. Benjamin J. Scherlag 
of the Veterans Administration Medical Center in Oklahoma City. The 
29 
development of the imaging agent utilizing our synthetic techniques is 
currently in progress under the direction of Dr. G. Basmadjian of the 
University of Oklahoma College of Pharmacy in Oklahoma City. 
Initially, it seemed logical that 4-selenanone (38) would be a key 
synthon for the preparation of the ketones 34 which, in turn, could be 
converted to the amines 35 and the salts 36 and 37. It was surprising 
to find that 4-selenanone had never been reported, although it is a 
parent six-membered ketone in the group VIa elements. Consequently, a 
de novo synthesis was completed for 4-selenanone (38) and a paper is in 
k 114a press on the wor • In addition, the preparation has been submitted 
for possible inclusion in Inorganic Syntheses. 114b One additional spin 
off from the work has been the recording of 77se NMR shifts for a 
variety of selenanones and related six-membered, selenium-containing 
. t 115 
r~ng sys ems. These kinds of data appear to be of potential value 





During the course of this investigation, the screening for antiar-
rhythmic activity in dogs by Dr. Scherlag required a standard agent with 
which to compare the action of the selenium compounds. Since lidocaine 
(12) is the most common clinical agent for the treatment of arrhythmias 
for victims of sudden heart attacks, we elected to synthesize a selenium-
containing mimic of lidocaine. This was achieved with the complete 
structure characterization of 39. 
Chemistry 
Because of the favorable biological properties of several of the 
3,7-diheterobicyclo[3.3.1]nonanes, and most notably 7-benzyl-3-thia-7-
azabicyclo[3.3.1]nonane hydroperchlorate (40), 6 we wished to synthesize 
selenium-containing analogs of 40, namely 36 and 37, which, with 75se 









Frequently, the synthetic routes leading to most of the 3,7-dihet-
erabicyclo[3.3.1]nonanes begin with heterocyclic analogs of cyclo-
hexanone. Therefore, 4-selenanone (38) was chosen as the selenium-
containing synthon. Although a few substituted selenanones have been 
31 51 66 78 82 . reported, ' ' ' ' this parent compound was heretofore unknown and 
32 
constituted a new member in the family of 4-heteracyclohexanones. 54, 67 , 68 
The synthesis of 4-selenanone (38, Figure 3) was accomplished in a 
manner which bears a remote similarity to that for 4-thianone. 61 Elemen 
tal selenium was reduced in situ with an equivalent of sodium borohy-
dride62 to give sodium hydrogen selenide which attacked 1,1-dimethyl-4-
piperidonium iodide (41) in a double SN2 displacement of dimethylamine. 
The reduction was performed in ethanol at room temperature and produced 
a colorless solution to which the amine salt 41 was added. After 5 h at 
reflux, followed by partial evaporation of ethanol, an aqueous work-up 
gave a yellow-brown solid which was sublimed to give 4-selenanone (38) 
as a white crystalline solid (63%) which melted at 55.0-55.5°C. Other 
attempted syntheses met with varying degrees of success (Figure 3). 
Efforts to cyclize dicyanoethylselenide under Thorpe condensation 
conditions failed. In situ generation of H2Se by reaction of aluminum 
selenide with water and sodium acetate followed by reaction with 1,1-
dimethyl-4-piperidonium iodide (41) produced 4-selenanone in a yield of 
only 5%. Similarly, reaction of the iodide 41 with sodium selenide also 
resulted in a low yield of 4-selenanone (38, 5%). Better success was 
achieved by the generation of H2Se via reaction of elemental selenium 
with paraffin wax at 400°C. The H2se thus formed was bubbled into 
methanolic sodium methoxide. Reaction of this solution with the iodide 

























this compound, a single crystal X-ray diffraction analysis was performed 
which will be discussed later. For characterization purposes , the 2,4-
DNP derivative 42 was prepared and melted at 167 . 0- 16? . 5°C . 
42 
4-Selenanone (38) was then condensed in a double Mannich reaction 
with an excess of paraformaldehyde and one of several members of a 
series of primary amines which contained an aromatic ring (Figure 4). 
The amines chosen for this study were benzylamine, 2-aminomethylthio-
phene, phenethylamine, 4-methoxyphenethylamine, and 3,4-dimethoxyphen-






a, R "" c6n5cH2-
b, R = 2-C4H3ScH2-
c, R = c6n5cn2cH2-
d, R = 4-CH3oc6a4cH2cH2-










Figur~ 4· Synthesis of ?-Alkyl-3-selena-
7-azabicyclo[J.3.1]nonanes 
34 
These 7-alkyl-3-selena-7-azabicyclo[J.J.1]nonan-9-ones 34a-e were 
subjected to Huang-Minlon modifications79 of the Wolff-Kischner reduc-
tion. A typical reduction consisted of dissolving a bicyclic ketone 34 
in triethylene glycol along with an excess of hydrazine and potassium 
hydroxide (Figure 4). Under a stream of nitrogen, the reaction mixture 
was heated to 140-145°C for 1.5-4 hours. During this time a small 
amount of water and excess hydrazine was distilled from the reaction 
mixture. After cooling the glycol solution, it was poured into cool 
water. The resulting mixture was extracted with ether. The ether 
35 
extracts were dried and 60% perchloric acid was added very slowly. This 
precipitated an orange solid, which was recrystallized from methanol, 





Ketone 34a was treated with 60% perchloric acid in ether to give 
the diol hydroperchlorate salt 37. This is reminiscent of other diols 
of 3,7-diheterabicyclo[J.J.1]nonan-9-one systems. 3 ' 5a In addition, 
36 
ketone 34a was subjected to a single crystal X-ray diffraction analysis. 
The synthesis and X-ray diffraction analysis of ketone 43, the sulfur 
. . 6 
analog of 34a, was reported by Bailey and co-workers as a precursor to 
compound 40. In that study, it was determined that solid ketone 43 
existed in a chair-boat conformation with the sulfur atom in the boat 
ring. Due to the isosterism of selenium and sulfur and the very close 
similarities of the 13c NMR data for all corresponding carbons (except 
those alpha to Se and S) of 34a and 43, a chair-boat conformation for 
34a (selenium in the boat ring) was assumed. This assumption was veri-
fied by a single crystal X-ray diffraction analysis performed on 34a. 
Because of the close similarities in all the spectral data of compounds 
34a-e, we feel that a chair-boat conformation is present in these 
systems with the selenium atom in a boat ring. Salt 36a, a representa-
tive member of family 36, was also subjected to a single crystal X-ray 
diffraction analysis which revealed a chair-chair conformation similar 
6 to that found by Bailey and co-workers for the sulfur analog 40 and 






The biological activity of compounds 36a, 36c, and 37 were assayed 
in the laboratory of Dr. B. J. Scherlag of the Veterans Administration 
Medical Center, Oklahoma City. The results of these tests will be 
discussed below. 
37 
As previously indicated, these bicyclic heterocycles have the same 
structural backbone as the two internal rings of sparteine (18) and also 
in many cases share antiarrhythmic properties. 6 ' 93 Sparteine (18) has 
been found to be metabolized in vitro, through postulated intermediates 




lism of 3,7-diheterabicyclo[3.3.1]nonanes may proceed in a similar man-
ner, it was decided to synthesize several bicyclononanes 36f-i (page 29) 
which had aromatic rings substituted at C(6) and C(8) (flanking the 
nitrogen atom). These aromatic rings would stabilize a radical gener-
ated alpha to nitrogen (and benzylic). The aromatic groups were chosen 
so as to enhance the stability of this radical. 
The synthetic scheme for the 6,8-diaryl-3-selena-7-azabicy-
clo[3.3.1]nonanes in Figure 5 involve a double Mannich condensation of 
an aryl aldehyde and ammonium acetate with 4-selenanone (.38). An etha.-
nolic solution of 4-selenanone (38) was added to a warm solution of 
2 
3As 






f, R = C6H5-
g, R = 2-C
4
H3s-
h, R = 4-ClC6H4-
2 
2 








benzaldehyde and ammonium acetate in ethanol. After one hour, a small 
amount of ether was added and the resulting solution was refrigerated 
overnight. Work-up of the solid which formed gave 6,8-diphenyl-3-
selena-7-azabicyclo[3.3.1]nonan-9-one (34g, 17%). 
In the cases using 2-thiophenecarboxaldehyde and 4-chlorobenzalde-
hyde, a simpler, more crude method appeared to be advantageous. In these 
cases, a boiling solution of the aromatic aldehyde and 4-selenanone (38) 
in ethanol was poured into a boiling solution of ammonium acetate in 
ethanol. This was accomplished in open Erlenmeyer flasks on a hot 
plate. Unaccountably, in these cases, this procedure gave comparable 
yields (18% and 13%, respectively) of the bicyclic ketones (34g and 34h) 











Evaporation of the mother liquor in the run using 2-thiophenecarbox-
aldehyde gave a dark orange-red oil which crystallized from absolute 
ethanol to give a small amount of an orange solid which was determined 
to be enone 47 based on NMR and elemental analyses. Addition of water 
to the mother liquor in the run using 4-chlorobenzaldehyde caused the 
formation of a precipitate which was determined to be ketone 34i, an 
isomer of J4h. The conformational analysis of 34h and 34i will be 
discussed in the NMR analysis section. 
These bicyclic ketones (J4f-i) were then subjected to reduction 
under Wolff-Kishner conditions. For example, ketone 34f was dissolved 
in triethylene glycol and allowed to react with an excess of hydrazine 
and potassium hydroxide at a temperature of about 200°C for four hours 
(Figure 5). A precipitate formed upon pouring the reaction mixture into 
cold water. Recrystallization of the crude product gave a good yield 
(74%) of 35f. The reductions of 34g, 34h, and 34i were accomplished in 
a similar manner (67%, 47%, 59%, respectively). Hydroperchlorate salts 
36f-i of these amines were formed by treatment with 60% hydrochloric 
acid in either benzene or ether in the usual manner. 
Since lidocaine (12) is the drug of choice in the treatment of 
ventricular tachycardia and also because it is the standard to which the 
CHJ 
Cl 0 0 I II II 







compounds above are compared in their assay of biological activity, we 
elected to synthesize the selenium-containing lidocaine analogue 39. 
The preparation of 39 (Figure 6) began with preparation of the synthon, 
diethyl diselenide (48). This was accomplished by a dissolving metal 



















Figure 6. Synthesis of Selenalidocaine (39) 
41 
42 
reduction of elemental selenium to disodium diselenide followed by 
addition of ethyl bromide to produce, after distillation, diethyl dise-
lenide (48, 48%). Sodium borohydride reduction of diethyl diselenide 
(48) followed by addition of an aqueous solution of sodium chloroacetate 
gave, after acidification, 3-selenavaleric acid (49) in a yield of 
76%.13 
The acid chloride 50 could not be formed by reaction of acid 49 
with thionyl chloride. Instead, this tranformation was accomplished 
with oxalyl chloride as the chlorinating agent to give 3-selenavaleryl 
chloride (50, 76%). Two equivalents of 2,6-dimethylaniline were added 
dropwise to an ether solution of 50 precipitating 2,6-dimethylaniline 
hydrochloride. Filtration of this solid and evaporation of the ether 
gave the amide 51 (71% after recrystallization). 
In order to increase the water-solubility of the amide 51 and also 
more closely mimic lidocaine (12), attempts were made to ethylate sele-
nium in 51 with ethyl bromide, ethyl iodide, and diethyl sulfate. How-
ever, each of these methods failed, and thus the dichloride derivative 
39 was synthesized (Figure 6). Amide 51 was dissolved in ether and 
chlorine gas was bubbled through the solution with the immediate precipi-
tation of dichloroselenide 39 (78%). A single crystal X-ray diffraction 
analysis was performed on 39. 
NMR Analyses 
In the characterization and structure elucidation of the compounds 
discussed above, NMR spectral analysis was indispensable. The elements 
examined were 1H, 13c, 15N as well as 77se NMR. 
The proton spectra of 4-selenanone (38) exhibited an A2x2 splitting 
pattern appearing as two triplets, one at o 2.82 for H(3,5) and one at 
0 3.00 for H(2,6). Each of the triplets had a coupling constant of 6.1 
Hz. The assignments were made by noting the reduction in the intensity 
of the triplet at o 3.00 when the NMR sample was treated with D2o and 
K2co3 , indicating the exchange of the protons adjacent to the carbonyl 
~o~. 
Carbon-13 resonances for 4-selenanone (38) appeared at 19.29, 
43.68, and 209.28 ppm and were assigned to C(2,4), C(3,5), and C(4), 
respectively. Assignments were made by comparison with model compounds 
such as 4-thianone. 54 Resonances for 4-thianone are shown in Table IV 
along with those of other heteracyclohexan-4-ones. 54 Comparison of the 
shifts for the carbons alpha to the heteroatom seem to indicate that 
43 
selenium is more electropositive than carbon as well as the other hetero-
atoms shown in the table. 
Also recorded was the 77se NMR spectrum of 4-selenanone (38; this 
was done as well for the other compounds synthesized in this project). 
Selenium-77, one of the six stable isotopes of selenium, has a spin of 
one-half, and, although it has a sensitivity somewhat less than that of 
carbon (6.93 X 10-3 for selenium; 1.59 X 10-2 for carbon) 83 , 77se has a 
natural abundance of 7.58% which allows for convenient observation. 
Since 77se NMR is still a relatively new technique, there has not 
been complete agreement on a universal standard. Some of the suggested 
standards have been liquid Se0Cl2, 15 selenophene,42,47 and dimethyl 
selenide. 83 All of the 77se shifts reported herein will be referenced 
downfield from dimethyl selenide. However, for routine use, diphenyl 
diselenide (481.0 ppm downfield from dimethyl selenide83 ) has been used 




13c NMR DATA FOR SELECTED HETERACYCLOHEXAN-4-0NESa,b 
X C(2,6) 





Spectra taken in CDC13 ; 
internal Me4si. 
13c shifts except those 
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shifts (ppm) are downfield from 






Table V is a collection of 77se shifts for a selection of organoselenium 
compounds which includes that of 4-selenanone (38). It is of interest 
77 to note that H2Se gives a Se resonance at a very high field in view of 
the fact that CH4, PH3, NH3, and H2o give very high field resonances in 
13C 31p 15N d 170 NMR t• l 15 , , , an , respec lve y. 
TABLE V 
SELENIUM-77 SHIFTS OF SELECTED ORGANOSELENIUM COMPOUNDSa 
Compound Shift (ppm) 




(C6H5Se) 2 481 
H2Se -288b 
0 
6 (38) 176.6 
a. See reference 83. 
b. Spectra taken in D2o. All others taken in CDC13• 
Proton resonances for the 7-alkyl-3-selena-7-azabicyclo[3.3.1]-
nonan-9-ones (34a-e) were assigned by comparison with model compounds 
such as 436 and 52. 3 There was also heavy reliance upon integrations, 
45 
splitting patterns, and coupling constants. The highest field resonance 
1 in the H spectra of 34a was a multiplet at 8 2.64-2.78 which integrated 
to four protons. This was assigned to H(2,4) due to the indication men-
tioned earlier that selenium appears to be electropositive relative to 
carbon. A two-proton singlet corresponding to H(10) (benzylic CH2) was 
46 
0 a, R = c6H5cH2-
b, R = 2-C4H3scH2-
8 c, R = c6H5cH2CH2-
d, R = 4-CH3oc6H4cH2CH2-




found at o 3.59. This is in comparison with the corresponding protons 
in 436 and 523 which appear at 0 3.50 and 3.52, respectively. The ring 
protons next to the nitrogen atom in 34a appeared as a four-proton 
multiplet at o 3.14-3.25. The corresponding resonance in 52 appears as 
peaks at o 2.9-3.1. 3 A two-proton multiplet (or broad singlet) for 
H(1,5) was found at o 3.02-3.14. The aromatic protons appeared as a 
five-proton multiplet at 8 7.24-7.50. Similar shifts were found for 
34b. In 34c, 34d, and 34e, the resonances for H(1,5), H(2,4), and H(11) 
all appear under the same eight proton multiplet. These are centered at 
o 2.72 , 8 2.65, and o 2.70 for 34c, 34d, and 34e, respectively. Reso-
nances for H(6,8) and H(10) also appear together as multiplets which are 
centered at o 3.11, o 3.05, and 8 3.10 for 34c, 34d, and 34e, respec-
47 
tively. Other resonances are found in the experimental section. 
Carbon-13 resonances of the bicyclic ketones 34a-e were assigned by 
comparison with the model ketone 43 and also with respect to the multi-
plicities found in the off-resonance spectra. In each case the most 
upfield carbon was determined to be C(2,4). Aliphatic carbon resonances 
for the model compound 43 and 52 as well as those for 34a-e are found in 
Table VI. More complete listings are found in the experimental section. 
The 77se and 15N shifts for bicyclononanones 34a-e have been 
collected in Table VII. The 77se shifts of salts 34a and 34b are 
similar to each other but are several parts per million downfield from 
the salts 34c, 34d, and 34e which also show similarities. This trend is 
also seen in the 15N shifts. 
The 13c NMR spectra for 7-alkyl-3-selena-7-azabicyclo[3.3.1]nonane 
hydroperchlorate salts 36a-e were assigned by comparison with the spec-
tra of model compounds 406 and 53, 3 which are the sulfur and oxygen 
analogs of 36a. Off-resonance 13c spectra were also utilized in the 
assignments. A comparison of the shifts for the aliphatic carbons of 
these compounds is given in Table VIII with a more complete listing 
given in the experimental section. As before, the highest field reso-
nance was that of C(2,4). With the exception of the C(2,4) peak, the 
spectra of 36a and 40 were almost identical. 
The 77se and 15N shifts for the salts 36a-e are collected in Table 
IX. Once again the corresponding shifts for 36a and 36b are further 










ALIPHATIC 1.3c SHIFTS FOR SELECTED 7-ALKYL-.3-HETERA-
7-AZABICYCL0[3.3.1]NONAN-9-0NES 
0 
d, X = Se; R = 4-CH3oc6H4CH2CH2-
48 
e, X = Se; R = .3,4-(CH3o}2c6H3CH2CH2-
0(2,4) C(1 ,5) C(6,8) C(10) c ( 11) C(9) Other 
25.5 46.2 59.0 61.5 21.3.7 
24.9 46 • .3 58.8 55.9 213 • .3 
25.4 46.2 59.1 58 • .3 .33.7 213.5 
24.6 45.4 58.2 57.8 33.0 212.5 54.2 
25.4 46.2 59.1 58.6 33.2 213.8 55.7 
34.6 47.1 58.4 61.4 212.8 
73.3 49.5 57.5 61 .1 211.5 
a. Thought to exist in a chair-chair conformation.3 
a. 
TABLE VII 
SELENIUM-77 AND NITROGEN-15 SHIFTS FOR SELECTED 7-ALKYL-3-
HETERA-7-AZABICYCLO[J.3.1]NONAN-9-0NES 
0 
d, X = Se; R = 4-CH3oc6H4CH2CH2-
49 
e, X = Se; R = 3,4-(CH3o) 2C6H3CH2CH2-
GompoWld 77se (ppm) 15N (ppm) 
34a 84.68 38.31 
34b 86.28 40.31 
34c 79.51 35.44 
.34d 78.81 35.43 





ALIPHATIC 13c SHIFTS FOR SELECTED 7-ALKYL-3-HETERA-
7-AZABICYCL0[3.3.1]NONANE HYDROPERCHLORATES 
9 




e, X = Se; R = 3,4-(CH
3
o) 2c6H3cH2CH2-
Compound 0(2,4) 0(1,5) 0(6,8) 0( 10) 0(11)a C(9) Other 
36a 22.0 25.3 56.6 60.6 28.7 
36b 21.9 25-3 56.2 54.9 28.6 
J6c 21.9 25-3 56.7 58.8 29-9 28.5 
36d 21.9 25.3 56.7 58-9 28.9 28.5 55.01 
J6e 22.0 25.3 56.7 58.9 29-4 28.5 55-4, 55.5 
37 21 • 1 34-7 54-9 60.1 92.5 
·. 
40b 29.9 24.9 55.6 59-9 27.7 
53c 58.1 29-9 62.5 72.9 30.4 
a. C(11) and 0(9) may be reversed. 
b. Reference 6. 
e. Reference J. 
TABLE IX 
SELENIUM-77 AND NITROGEN-15 SHIFTS FOR SELECTED 7-ALKYL-3-HETERA-
7-AZABICYCL0[3.3.1 ]NONANE HYDROPERCP.LORATES 
J6a, X = Se; R = c6H5CH2-
9 b, X = Se; R = 2-C4H3scH2-
c, X = Se; R = c6H5cH2CH2-




e, X = Se; R = J,4-(CH
3
o) 2c6H3CH2CH2-
37, X = Se; R = c6H5cH2-; 9,9-diol 
40, X = S; R = c6H5CH2-
Compounds 77se (ppm) 15N (ppm) 
36a 96.61 51.56 
36b 89.41 58.54 
J6c 88.42 48.25 
J6d 88.64 48.10 
.36e 88.35 48.03 
37 62.39 51.88 
40a 54-16 
a. Reference 6. 
Compounds 5434 and 553 were used as model compounds in the 13c 
spectral analysis (Tables X and XI) of the 6,8-diaryl-3-selena-7-azabi-
108 cyclo[3.3.1]nonan-9-ones {34£-i). Spectral data of the isomeric ke-









ketones 34f-i. The conformations of the isomers 56 and 57 were deter-
52 
mined from spectral analysis as well as from an X-ray diffraction analysis 
which was performed on ketone 56. 108 
Similarities in the 13c shifts indicated that ketones 34£, 34g, and 
34h all had common conformations (Tables X) which were different from 
that of 341. For example, the 13c shifts for the carbon alpha to 
selenium in 34£, 34g, and 34h were 29.2, 29.3, 29.0 ppm, respectively, 
while the corresponding shift in 34i was 20.9 ppm. Comparison of the 
relative 13c shifts of the corresponding carbons in ketones 56 and 57 as 
well as those for ketones 34h and 34i seem to indicate that the nitro-
gen-containing ring in 34h resides in a boat conformation whereas the 
corresponding ring in 34i is in a chair conformation. For example, the 
13c shifts for C(2,4) and C(1,5) in ketone 56 (chair-boat; 58.8 and 55.2 













Ar NH Ar 
34i, X ~ Se; Ar = 4-ClC6H4-
55, X = 0; Ar = 2-ClC6H4-
53 
J4f, X ~ Se; Ar ~ c6H5-





34h, X ~ Se; Ar = 4-Clc6H4- 57, X = c6H5cH2N; Ar = 2-01C6H4-
54, X = S; Ar ~ C6H5-
56, X = c6H5cH2N; Ar = 2-ClC6H4-
Compound 0(2,4) C(1,5) C( 6, 8) C(9) 
34£ 29.2 53.9 64.1 206.3 
34g 29.3 54.6 59.1 212.5 
34h 29.0 53.9 63.4 213.4 
54 a 37-4 55.0 63.5 212.7 
56b 58.8 55.2 59.0 212.0 
- - - - - - - - - - - - -
34i 20.9 51.5 63.8 212.9 
55° 69.9 52.2 60.3 209.7 




for ketone 57 (chair-chair; 55.5 and 50.9, respectively). Similarly, 
the shifts for C(2,4) and C(1,5) for ketone 34h (29.0 and 53.9 ppm, 
respectively) are downfield relative to the corresponding carbons in 
ketone 34i (20.9 and 51.5 ppm, respectively). Although to a lesser 
extent, the 13c shifts for C(6,8) show a similar relationship. These 
54 
findings seem to indicate that 34h (and therefore 34f and 34g) exists in 
a chair-boat conformation with the nitrogen in the boat ring while 34i 
resides in a chair-chair conformation. 
Comparison of the 15N shifts (Table XI) of these compounds gives 
further credence to this conclusion. The 15N shift for the secondary 
nitrogen in the 7-position of 56 (58.24 ppm) is downfield from that of 
57 (54.45 ppm). A similar relationship exists between 34h and 34i. The 
15N shift for 34h (62.84 ppm) is significantly downfield from that found 
for 34i (44.24 ppm). 
Perhaps one of the strongest pieces of evidence for a chair-chair 
conformation for the ketone 34i is the drastic deshielding of selenium 
found in the 77se NMR spectrum (122.66 ppm for 34i compared to 26.67 ppm 
for 34h) indicating a hydrogen bond (Se ••• H-N) which could only be 
achieved if ketone 34i resides in a chair-chair conformation. 
Unfortunately, there are no adequate selenane systems published whose 
known structure could serve as a model for our compounds. 
Spectral data for the amines 35f-i and salts 36f-i are found in 
Tables XII and XIII and Tables XIV and XV, respectively. It is 
interesting that protonation of nitrogen four bonds removed from 
selenium causes the 77se signal to be shifted upfield one part per 
million in 36f as compared to 35f. 
TABLE XI 
SELENIUM-77 AND NITROGEN-15 SHIFTS FOR SELECTED 6,8-DIARYL-
3-SELENA-7-AZABICYCLO[J.J.1]NONAN-9-0NES 
X 
34!, X =· Se; 
Ar 
Ar = c6H5- 34i, X = Se; Ar = 4-ClC6H -- 4 
55 
34g, X = Se; Ar = 2-C 4H3S- 57, X = c6H5CH2N; Ar = 2-ClC6H4-
34h, X = Se; Ar = 4-ClC6H4-
56, X = c6a5cH2N; Ar = 2-ClC6H4-
Compound 77se (ppm) 15N (ppm) 
341' 25.38 63.28 
34g 30.60 6?.09 
34h 26.67 62.84 
5611 58.24 (38.31)b 
122.66 44.24 
54.45 (46.90) b 
a.. Reference 108. 
b. 15N shifts for the nitrogen in position J. 
a.. 
TABLE XII 





35i, X = Se; Ar = 4-Clc6H4-
56 
35f, X = Se; Ar = c6H5-
35g, X = Se; Ar = 2-C4H3S-
35h, X = Se; Ar = 4-ClC6H4-
59, X = c6H5CH2N; Ar = 2-ClC6H4-
58, X = c6H5cH2N; Ar = 2-C1C6H4-
Compound C{2,4) C( 1, 5) C{6,8) C(9) 
35f 25.1 34.5 62.0 27.2 
35g 25.0 34.6 57.1 25.8 
.35h 25.1 33.8 60.9 26.9 
58 a 58.8 36.1 56.1 24.6 
- - - - - - - - - - - - -
35i 17.7 30.4 64.0 35.0 
59 a 54·9 31.5 61.6 35.9 
Reference 108. 
TABLE XIII 
SELENIUM-77 AND NITROGEN-15 SHIFTS OF SELECTED 6,8-DIARYL-
3-SELENA-7-AZABICYCL0[3.3.1]NONANES 
X X Ar NH Ar 
35£, X = Se; Ar = c6H5- 35i, X = Se; Ar = 4-Clc6H4-
57 
35g, X = Se; Ar = 2-C4H3S- 59, X = c6H5CH2N; Ar = 2-Clc6n4-
35h, X = Se; Ar = 4-ClC6H4-
58, X = c6H5CH2N; Ar = 2-C1C6H4-
Compound 77se (ppm) 15N (ppm) 
35£ 2.38 55.68 
35g 4.05 60.10 
35h -0.79 55.37 
58a 50.48 (38.14)b 
101 .86 50.52 
53.80 (47.44)b 
a. Reference 108. 
b. 15N shift for the nitrogen in position 3. 
TABLE XIV 





36!, X = Se; Ar : c6H5-
36g, X = Se; Ar = 2-C4H3S-





- - - - - -
.36i 17.7 
2 
C( 1, 5) 0(6,8) 0(9) 
31.2 61.5 26.6 
32.5 56.1 26.2 
31 .1 60.6 26.5 
- - - - - -









J6f, X "' Se; 
J6g, X= Se; 
























A single crystal X-ray diffraction study of 4-selenanone (38, 
Tables XVI-XVIII) revealed that in the solid state the molecule assumes 
a chair conformation (Figure 7) as has been observed for six-membered 
rings such as cyclohexanone, 33 tetrahydropyran-4-one, 1 and 4-thia-





BOND DISTANCES (A) AND ANGLES ( o) FOR 1-HETE.RACYCLOHEXAN-4-0NES 
0 
scJ• 
6 X 2 
Bond CH a 2 
ob sc Sed 
X-C(2) 1.545 1.41 1.804(3) 1.92(2) 
C(6)-X 1.93(2) 
C(2)-C(3) 1.542(2) 1.53 1.527(3) 1.56(3) 
C ( 5)-C ( 6) 1. 56(3) 
C(3)-C(4) 1.503(4) 1. 51 1.527(3) 1.46( 3) 
C(4)-C(5) 1.49(2) 
C(4)-0 1.229(3) 1.222 1.223(5) 1.17(2) 
C-H 1.088(2) 1.096 1.116(6) 
X-C(2)-C(3) 110.8(0.2) 113.5 113.2(4) 112.2(11) 
C(5)-C(6)-X 111.1(13) 
C(2)-C(3)-C(4) 111.5(0.1) 11 o. 5 112.5(10) 115.8(18) 
C(4)-C(5)-C(6) 115.5(14) 
C(3)-C(4)-C(5) 115.3(0.1) 116.0 118.9(11) 118.2(16) 
C ( 6)-X-C (2) 110.8(0.2) 113.0 97.0(19) 95.0(9) 
H-C-H 106.0(0.9) 109.5 111.3(15) 
a. Electron Diffraction: reference 33. 
b. Microwave: reference 1 • 
c. Electron Diffraction: reference 103. 
d. X-ray Diffraction: reference 114. 
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TABLE XVII 
DIHEDRAL ANGLES OF SELECTED 1-HETERACYCLOHEXAN-4-0NES 
Dihedral Angles ( 0 ) CH a 2 
sb Sec 
X-C(2)-C(3)-C(4) 53.0 57.1(16) 57.0(20) 
C(4)-C(5)-C(6)-X 58.6(18) 
C(2)-C(3)-C(4)-C(5) 51.7 51.0(15) 53.1(22) 
C(3)-C(4)-C(5)-C(6) 54.4(23) 
C(6)-X-C(2)-C(3) 56.3 58.0(29) 53.5(18) 
C(5)-C(6)-X-C(2) 54.2(12) 
a. Electron diffraction: reference 33. 
b. Electron diffraction: reference 103. 
c. X-ray diffraction: reference 114. 
selenanone (38) with the 56° observed for cyclohexane indicates that the 
former ring is somewhat puckered. Comparison with the dihedral angles 
found for 4-thianone103 shows that the puckering in 38 is achieved by 
slightly greater bending of the C-Se-C and of the ring and slight flat-
tening at the carbonyl end. Tables XVI and XVII compare the bond 
distances, bond angles, and dihedral angles of 4-selenanone (38) with 
those of cyclohexanone, tetrahydropyran-4-one, and 4-thianone where data 
was available. The bond angles and distances for 4-selenanone (38) are 
comparable to others in the literature. 122 
TABLE XVIII 
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Figure 7. Perspective view of 4-selenanone (38) 
7-Benzyl-3-selen-7-azabicyclo[3.3.1]nonan-9-one (34a) crystallized 
with two molecules per asymmetric unit, both of which displayed chair-
boat (CB) conformations with the selenium-containing ring in a boat 
conformation and the nitrogen-containing ring in a chair form (Figure 
8). This is similar to the conformation observed for the 3-thia analog 
43. 6 Differences between the sulfur and selenium analogs may be inter-
preted in light of the larger covalent radius of selenium (1.16 ~as 
63 
34a 
MOLECULE A 10 
Figure 8. Perspective view of 7-benzyl-3-selena-
7-azabicyclo[J.3.1]nonan-9-one (34a) 
64 
0 88 compared to 1.02 A for sulfur) and the resulting longer bond lengths 
.(Se-C av. 1.94(1) A as compared to S-C av. 1.810(4) A). This manifests 
itself most prominently in 43a in the torsion angles [C(9)-C(1)-C(2)-
Se(3); C(9)-C(5)-C(4)-Se(3)] relating the conformation of the two ends 
of the boat. In 43, these torsion angles are small in magnitude (2.6-
3.9°) whereas in 34a, the comparable torsion angles are significantly 
greater (45.5-47.2°) indicating a flattening of the selenium end of the 
boat compared to the sulfur containing boat. This flattening also 
0 0 
manifests itself in the Se(3)-C(9) distance [2.901(13) A, 2.886(13) A] 
65 
in 34a which is larger than the S(3)-C(9) distance [2.831(4) A, 2.802(4) 
A] in 43 by an amount approximately equal to the difference in covalent 
radii. The nitrogen-containing ring in 34a displays larger [C(9)-C(5)-
C(6)-N(7); C(9)-C(1)-C(8)-N(7)] torsion angles (67.7-68.8°) as compared 
to 58.7-59.1° for 43, indicating a greater downward bend of the C(6)-
N(7)-C(8) plane of the nitrogen-containing ring in 34a. Thus, substitu-
tion of selenium for sulfur resulted in flattening of the selenium 
.containing ring and a greater deviation from planarity for the nitrogen 
containing ring. Bond lengths, bond angles, and torsion angles are 




BOND DISTANCES (A) FOR 7-BENZYL-3-SELENA-
7-AZABICYCL0[3.3.1]NONAN-9-0NE (34a) 
Molecule A Molecule B 
C(1)-C(2) 1.53(2) 1 • 51 (3) 
C ( 2 )-Se (3) 1.93(1) 1.95(2) 
Se ( 3) -C (4) 1 • 97( 1) 1. 91 ( 1) 
C(4)-C(5) 1.53(2) 1.49(2) 
C ( 5)-C ( 6) 1.53(2) 1.53(2) 
C(6)-N(7) 1. 45 ( 2) 1.44(2) 
N(7)-C(8) 1.45(2) 1. 46( 2) 
C(8)-C(1) 1.55(2) 1.57(2) 
C(1)-C(9) 1.50(2) 1.49(2) 
C(5)-C(9) 1.52(2) 1. 51 (2) 
C(9)-0(10) 1.19(2) 1. 22( 2) 
N(7)-C(11) 1.45(2) 1.48(2) 
C ( 11 ) -C ( 1 2) 1.50(2) 1. 50( 2) 
C ( 1 2 ) -C ( 1 3 ) 1.41(3) 1.35( 2) 
C ( 13) -C ( 14) 1 .37(2) 1.37(2) 
C ( 1 4) -C ( 1 5 ) 1.34(4) 1.40(3) 
C ( 1 5) -C ( 1 6) 1.36(3) 1.36(4) 
C(16)-C(17) 1.37(2) 1.35(2) 
C ( 17) -C ( 1 2) 1.37(2) 1.37(2) 
TABLE XX 
BOND ANGLES ( 0 ) FOR 7-BENZYL-3-SELENA-
7-AZABICYCL0[3.3.1]NONAN-9-0NE (34a) 
Molecule A Molecule B 
C( 1 )-C (2)-Se(3) 113.0(9) 112.1(12) 
C(2)-Se(3)-C(4) 95.3(5) 90.5(6) 
Se(3)-C(4)-C(5) 111.0(8) 114.4(9) 
C(4)-C(5)-C(6) 111.3(10) 112.2(12) 
C(5)-C(6)-N(7) 108.9(11) 112.3(11) 
C(6)-N(7)-C(8) 110.8(10) 110.1(11) 
N(7)-C(8)-C(1) 109.6(9) 110.3(10) 
C(8)-C(1)-C(2) 111.0(11) 108.6(12) 
C ( 2) -C ( 1) -C ( 9) 113.3(9) 113.4(11) 
C(4)-C(5)-C(9) 114.6(11) 112.6(11) 
C(8)-C(1)-C(9) 105. 5( 11) 106.1(11) 
C(6)-C(5)-C(9) 106. 6(9) 105.3(9) 
C ( 1 ) -C ( 9) -C ( 5) 113.0(19) 113.4(12) 
C(1)-C(9)-0(10) 123.4( 12) 123. 6( 11) 
C(5)-C(9)-0(10) 123. 5( 13) 122.8(13) 
C(6)-N(7)-C(11) 113.7(11) 113.8(10) 
C(8)-N(7)-C(11) 110.9(9) 110.7(9) 
N(7)-C(11)-C(12) 111.3(10) 111.8(10) 
C(11)-C(12)-C(13) 119.7(13) 120. 2( 13) 
C(11)-C(12)-C(17) 123. 2( 13) 118.6(13) 
C(12)-C(13)-C(14) 118.8(16) 120.2(14) 






Table XX (Continued) 
118.0(19) 
121.5(18) 
121 • 3 ( 1 5) 
117.2(13) 
119.8(16) 





TORSION ANGLES ( 0 ) FOR 7-BENZYL-3-SELENA-
7-AZABICYCL0[3.3.1]NONAN-9-0NE (34a) 
Molecule A Molecule B 
C(1)-C(2)-Se(3)-C(4) 57.9 60.0 
C(2)-Se(3)-C(4)-C(5) 55.8 58.5 
Se(3)-C(4)-C(5)-C(6) 126.2 128.2 
C(4)-C(5)-C(6)-N(7) 76.5 76.5 
C(5)-C(6)-N(7)-C(8) 74-9 73.7 
C(6)-N(7)-C(8)-C(1) 75-4 71.4 
N(7)-C(8)-C(1)-C(2) 74.6 73.9 
C(8)-C(1)-C(2)-Se(3) 125.9 130.5 
C(1)-C(9)-C(5)-C(4) 78.6 76.4 
C(5)-C(9)-C(1)-C(2) 77.1 74.1 
C(1)-C(9)-C(5)-C(6) 70.0 70.1 
C(5)-C(9)-C(1)-C(8) 68.8 70.6 
Se(3)-C(2)-C(1)-C(9) 46.3 46.5 
Se(3)-C(4)-C(5)-C(9) 45-5 47.2 
N(7)-C(8)-C(1)-C(9) 67.8 67.7 
N(7)-C(6)-C(5)-C(9) 68.2 68.8 
C(2)-C(1)-C(9)-0(10) 126.7 131 ·4 
C(4)-C(5)-C(9)-0(10) 126.3 128.0 
C(8)-C(1)-C(9)-0(10) 122.2 119.9 
C(6)-C(5)-C(9)-0(10) 122.1 119.6 
C(1)-C(8)-N(7)-C(11) 168.3 173.5 
C(5)-C(6)-N(7)-C(11) 169.1 173.6 
69 
70 
Table XXI (Continued) 
C(8)-N(7)-C(11)-C(12) 168.7 174.5 
C(6)-N(7)-C(11)-C(12) 78.8 74.9 
N(7)-C(11)-C(12)-C(13) 140.3 72.3 
N(7)-C(11)-C(12)-C(17) 68.5 134.0 
TABLE XXII 

































27.72 -1 em 
0.71069 1{ 





A single-crystal X-ray diffraction analysis was also undertaken to 
investigate the conformation of the ring system of 7-benzyl-3-selena-7-
azabicyclo[3.3.1]nonane hydroperchlorate (36a). This molecule is the 
selenium analog of the sulfur containing molecule, 7-benzyl-3-thia-7-
azabicyclo[3.3.1]nonane (40), whose crystal structure has been report-
6 ed. The two structures are isomorphous. Both are found to exist in a 
chair-chair conformation in the solid state (Figure 9) and both are 
salts in which the proton from the perchlorate has been transferred to 
the nitrogen atom in the bicyclic ring. Bond lengths, bond angles and 
torsion angles are given in Tables XXIII, XXIV, and XV for 36a. A 
packing diagram is shown in Figure 10. 
36a 40 
Figure 9. Stereo drawing of 7-benzyl-3-selena-7-azabi-
cyclo[J.J.1]nonane hydroperchlorate (36a) 
Figure 10. Stereo drawing of the packing of 7-benzyl-3-selena-7-
azabicyclo[J.3.1]nonane hydroperchlorate (36a) 
73 
74 
An intramolecular hydrogen bond between the selenium and the nitro-
gen is indicated from the interatomic distances. The distance between 
N(7) and Se(3) in 36a (Figure 9) is 3.116(5) A which is significantly 
0 
shorter than the calculated value of 3.5 A which is the theoretical van 
der Waals distance between selenium and nitrogen. 88 The geometry around 
the selenium is not ideal for hydrogen bonding, however, with the 
Se(3) ••• H(7)-N(7) angle being 113.1(2) 0 rather than the expected 180.0°. 
On the other hand, the Se(3) ••• H(7) distance of 2.450(7) A is also much 
0 
shorter than expected from the sum of the van der Waals radii of 3.2 A 
for selenium and hydrogen. The Se(3) ••• H(7)-N(7) bond may even be 
stronger than in the sulfur compound. 
0 
The C-Se bond lengths found in this structure are 1.965(7) A, and 
1.947(7) A. These are close to the range of C-Se [1.98(3) A] given by 
113 0 Sutton, and about 0.014 A longer than the comparable distances in the 
sulfur containing compound. The C-N bond lengths are slightly lengthened 
due to the protonation of the nitrogen. 
The angles between planes 1, 2, 3, 4, and 5 (Figure 11) are similar 
to the sulfur analog except for the angle between planes 1 and 2, which 
is 10 degrees larger in the selenium compound. One might expect that 
the replacement of the sulfur with selenium and the resultant increase 
in van der Waals radii could cause an increase in ring flattening ob-
served in the seleium compound. Also, the bond angles and torsion 
angles in the selenium compound are very close to those in the sulfur 
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Figure 11. View of the molecular planes of 7-benzyl-3-selena-7-




BOND DISTANCES (A) FOR 7-BENZYL-3-SELENA-7-AZABICYCL0[3.3.1]NONANE 
HYDROPERCHLORATE (36a) 
Bond Distance (A)a 












C ( 11 ) -C ( 1 2) 1.382( 1 0) 
C ( 1 2 ) -C ( 1 3) 1.400( 11) 
C( 13)-C( 14) 1.394( 1 0) 
C(14)-C(15) 1.376( 11) 
C ( 15) -C ( 16) 1.392(9) 
C ( 1 6) -C ( 11 ) 1.392(10) 
Value in parentheses are estimated standard deviations (E.S.D. 1s) 





BOND ANGLES ( 0 )a FOR 7-BENZYL-3-SELENA-7-AZABICYCL0[3.3.1]NONANE 
HYDROPERCHLORATE (36a) 
C(1)-C(2)-Se(3) 113. 5 ( 4) 
C(2)-Se(3)-C(4) 96.8(3) 




N ( 7) -C ( 8) -C ( 1) 112.3(6) 
C ( 8) -C ( 1 ) -C ( 2) 114.2(6) 












C(14)-C(15)-C(16) 119.8( 8) 
C(15)-C(16)-C(11) 118.8(7) 
C(16)-C(11)-C(12) 120.8(6) 




TORSION ANGLES ( 0 )a FOR 7-BENZYL-3-SELENA-7-AZABICYCLO-
. [3.3.1]NONANE HYDROPERCHLORATE (36a) 






















a. E.S.D. 1 s in the significant figures are given in parentheses. 
TABLE XXVI 




Linear Absorption Coeffecient 









Data Collection Range 
Radiation 
Standards 
Temperature of Date Collection 
Number of Reflections Measured 
Number of Reflections Observed 
[I>2cr(I)J 
Structure Refinement 
Refinement of Hydrogens 




c14H20NSe" ClO 4 
380.41 g/mole 








36 reflections used 
o<2e<6o 
Mo Ke~: 













A single crystal X-ray diffraction analysis of the selenium contain-
ing lidocaine derivative 39 was made. The coordination about the sele-
nium atom was found to be trigonal bipyramidal with the free electron 
pair occupying one of the positions in the basal plane (Figure 12). 
This seems to agree with previously found structures of selenium bound 
with chlorine2' 45 , 75 , 76 , 120 and with bromine9 ' 12 , 74 and with coordina-
tion number of four. Bond distances, bond angles and torsion angles are 
given Tables XXVII, XXVIII and XXIX. The deviation of the Cl-Se-Cl 
angle from the ideal value of 180° is very slight: 1.14(7) 0 • The Cl-
Se-C angles differ from 90° value by less than 2°. The C-Se-C angle was 
found to be 100.4(4) 0 which compares with 106.5 and 108° for di-E-
tolylselenium dichloride and dibromide, respectively. 76 The Se-Cl 
0 0 
distances of 2.359(2) A and 2.389(2) A agree with those found previous-
1 76,120 Y• The Se-C distances were found to be 1.972(9)! [Se(1)-C(16)] 
and 1.942(7) 1 [Se(1)-C(15)]. The latter seems somewhat short compared 
t d . t . . "l d 76 , 120 11 th 0 ht d o 1s ances 1n s1m1 ar compoun s as we as e we1g e average 
0 55 distance in non-aromatic compounds [0.98(2) A] •. The non-planarity of 
the peptide group [-NHC(O)-] is described according to Winkler and 







Figure 12. Perspective view of selenalidocaine dichloride (39) 
Figure 13. Stereoscopic view of the crystal packing of 
selenalidocaine dichloride (39) 
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The hydrogen bonding is observed between 0(5) and N(4) of the next 
molecule. 
0 
The O ••• N distance is 2.949(10) A and O ••• H distance is 
1.98(11)! and the 0-H-N angle is 165(7) 0 • There seems to be certain 
strain in the molecule caused by the tendency of the peptide group to 
align itself to allow for the best H-bonding on one hand and by the 
packing forces on the other hand (Figures 13). The angle between the 
plane of C-Se-C bonds and peptide group is 21°. The angle between the 
peptide group and the plane of six-membered ring is 60° (Table XXIX). 
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TABLE XXVII 
BOND DISTANCES (A) FOR SELENALIDOCAINE DICHLORIDE (39) 
Se(1)-Cl(2) 2.359(2) 
Se( 1}-Cl(3) 2.389(2) 
Se ( 1) -C ( 1 5) 1. 942( 7) 
Se(1)-C(16) 1.972(9) 
N(4)-C(6) 1.445( 9) 
N(4) -C ( 14) 1.342(1 0) 
0(5)-C(14) 1.216(12) 
C(6)-C(7) 1.413(9) 
C( 6) -C ( 11) 1 .400( 9) 
C ( 7) -C( 8) 1.396( 10) 
C(7)-C(13) 1.499(10) 
C(8)-C(9) 1.384(10) 
C (9 )-C ( 1 0) 1.367( 11) 
C(10)-C(11) 1.404(10) 





BOND ANGLES ( 0 ) FOR SELENALIDOCAINE DICHLORIDE (39) 
Se(1)-C(15)-C(14) 106.2(6) 







N(4)-C ( 14)-0( 5) 126.0(8) 
N(4)-C(14)-C(15) 113.5(8) 
0(5)-C(14)-C(15) 120. 5( 7) 
C(6)-N(4)-C(14) 120.9(7) 
C(6)-C(7)-C(8) 116.5(6) 
C(6)-C(7)-C(13) 122. 2( 6) 
C ( 6) -C ( 11 ) -C ( 1 0) 117.4(6) 
C ( 6) -C ( 11 ) -C ( 1 2) 121.7(7) 
C(7)-C(8)-C(9) 120.9(7) 
C(8)-C(7)-C(13) 121.2(6) 





TORSION ANGLES ( 0 ) FOR SELENALIDOCAINE DICHLORIDE (39) 
Se(1)-C(15)-C(14)-N(4) 158.1(5) 
C(6)-N(4)-C(14)-C(15) -175.5(5) 
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Number of Reflections Observed 
[ I>20'( I) 1 
Structure Refinement 
Refinement of Hydrogens 





13 • 622 < 1 o) A. 
4.?33(3} 
12.284( 8) 
113 .,36{ 4) 
727 13 
2 
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The antiarrhythmic activity of selected members of the family of 3-
selena-7-azabicyclo[3.3.1]nonanes was assessed by Dr. B. J. Scherlag of 
the Veterans Administration Medical Center in Oklahoma City using the 
24-hour infarcted dog model described in Chapter I. In these tests, the 
extent of the activity of each compound was compared to that of the 
control drug lidocaine (12). The compounds tested were the hydroper-








H + CH C H 







A series of electrograms were used in each case to monitor and 
record the results of the tests. Very brief examples of the electro-
grams taken in the assay of 36a are found in Figures 14-16. In each of 
these Figures, a series of five electrograms are shown. The uppermost 
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electrogram was taken from a standard limb lead referred to as 1-2. The 
second lead, referred to as v3 , was taken from a lead on the chest wall. 
The third originated from a lead in the His bundle. The fourth electro-
gram was taken from a composite electrode recorded from the posterior 
epicardial surface of the left ventricle in contact with a normal zone. 
The last electrogram is from a composite electrode recording from the 
anterior epicardial surface overlying the infarct zone. The tracing at 
the bottom is a recording of the arterial blood pressure. 
In the electrograms displayed in Figure 14, the first and fourth 
beats shown give a representation of isolated ectopic beats which are 
common in dogs with a 24 hour myocardial infarction. The second and 
third beats represent the normal sinus rhythm and show normal tracings 
in each of the electrograms. The last tracing in Figure 14 indicates 
that the mean blood pressure during the normal sinus rhythm was 1?0 mmHg 
in this particular dog. 
L-2: Limb electrode NZ: Normal zone electrogram 
v3: Chest wall electrode IZ: Infarct zone electrogram 
1\eg: His bundle electrogram BP: Blood pressure 






Limb electode NZ: Normal zone electrogr·am 
Chest wall electrode IZ: Infarct zone electrogram 
His bundle electrogram BP: Blood pressure 
Figure 15. Electrogram recorded after administration 
of lidocaine (12) 
L-2: Limb electrode 
v3 : Chest wall electrode 
Hb : His bundle electrogram 
eg 
NZ: Normal zone electrogram 
IZ: Infarct zone electrogram 
BP: Blood pressure 




After the fourth beat, two stimulated beats delivered from an 
electrical pacemaker induced a rapid (450 beats per minute), spontaneous, 
ventricular tachycardia (VT) due to a reentrant mechanism. If electrical 
cardioversion had not been used, this VT would probably have deteriorated 
into ventricular fibrillation and sudden death. At this VT rate, the 
heart could not efficiently pump blood which resulted in a drop in blood 
pressure to the dangerously low level of 50 mmHg. During the VT, the 
first four electrograms show each of the heart beats as unique electrical 
events. However, in the fifth electrogram (originating from the damaged 
area caused by the infarction) continuous electrical activity is seen. 
Lidocaine (12) was then administered to the dog in a dose of four 
mg/Kg and the same VT as above was reinduced. Figure 15 shows a segment 
of a series of electrograms which were recorded during the VT. The rate 
of the VT is shown to have been reduced to 375 beats per minute. Al-
though the VT was slowed, the blood pressure still fell to 50 mm Hg which 
was probably due to a depressant action of lidocaine on cardiac contrac-
tility. Continuous electrical activity was again apparent in the fifth 
electrogram which was recorded from the infarct zone. 
After a lapse of sufficient time for the action of lidocaine to 
fade (about 30 minutes), ventricular pacing induced the same VT as in 
the control state (Figure 14) indicating the dissipation of the drugs 
effects. 7-Benzyl-3-selena-7-azabicyclo[3.3.1]nonane hydroperchlorate 
(36a) was then administered in a dose of 3 mg/kg as a solution in a 
minimum of 50% ethanol. Within about two minutes, the mean blood pres-
sure increased from 170 mmHg to 200 mmHg. Ventricular tachycardia was 
then induced as before; however, the rate was greatly reduced from 450 
beats per minute found in the control to 330 beats per minute with 36a 
present. During the VT, the blood pressure fell to only 100 mmHg. In 
the electrogram taken from the infarct zone (fifth tracing), continuous 
electrical activity was no longer observed. This indicates the possi-
bility that salt 36a may act specifically on the tissue which has been 
damaged by a myocardial infarction rather than in the general manner 
observed for lidocaine (12). Results such as these indicate that 36a 
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has a more potent inhibitory effect on ventricular tachycardia than the 
commercially available, lidocaine (12). The results of similar tests on 
the salts 36c, 36f, and 37 as well as those of the selenium-containing 
lidocaine derivative 39 have been collected in Table XXXI. 
As indicated in Table XXXI, salt 36c exhibits a marked ability to 
reduce the ventricular rate at both the 3 mg/kg and the 6 mg/kg dosage. 
The ventricular tachycardia which was induced after the administration 
of 36c was not sustained but reverted back to a normal sinus rhythm. 
Salt 36c also shows a blood pressure increase at both dose levels. Salt 
36f was also found to have significant activity in the reduction of the 
rate of ventricular tachycardia. However, no significant hemodynamic 
effect was observed. Diol 37, although active, exhibited a pro-
arrhythmic effect (generation of a new arrhythmia at 390 beats per 
minute) at a dose of 6 mg/kg. The selenium-containing lidocaine mimic 
(39) showed activity, but only at the 6 mg/kg dose. There was also a 
more dramatic decrease in the blood pressure during the ventricular 
tachycardia. 
From these results as well as those obtained by Bailey and 
coworkers, 6 several structure-activity relationships are implicated. 
Bailey and coworkers showed that a carbonyl (sp2 carbon) in the 9-
position of the bicyclononanes drastically reduced the antiarrhythmic 
activity. Although the 9,9-diol 37 was shown to be somewhat active, a 
methylene (sp3 carbon) in the 9-position was necessary for optimal 
activity. It also appears that the N-alkylbicyclononanes (such as 36a 
and 36c) are more active than the 6,8-diarylbicyclononanes (such as 
36f). 
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Because of the favorable response in the biological testing of 36a, 
we are anxiously awaiting the completion of the synthesis of [75se]36a, 
now in progress. This labelled compound could potentially be very 
useful as a cardiac imaging agent by providing for a nonsurgical techni-
que for the determination of the extent and location of damage caused by 
a myocardial infarction. 
We are also interested to find how the conformation of these 
bicyclononanes influence their biological activity. The assays of the 
salts 36h (chair-boat) and 36i (chair-chair) should be instrumental in 
determining which conformation is most condusive for antiarrhythmic 
activity. 
TABLE XXXIa 
BIOLOGICAL DATA FOR SELECTED ORGANOSELENIUM COMPOUNDS 
Normal b Controlc Dosage 
Compound 
NSRd SVTe 
3 mg/kg 6 mg/kg 
BP BP SVT BP (no VT) BP (VT) SVT BP (no VT) BP (VT) 
12f 171 170 450 50 375 50 
36a 171 "170 450 50 330 230 100 
12 180 155 390 50 360 150 45 330 40 
39 180 155 390 50 390 130 40 370 35 
37 150 140 290 80 270 130 40 270 130 60 
36c 150 160 330 70 240g 125 270g 150 
36f 170 150 330 70 300 125 70 280 125 75 
37 170 160 330 70 300 125 85 310 125 70 
a. Each division represents tests performed on d. Normal sinus rhythm. 
separate dogs. e. Sustained ventricular tachycardia. 
b. Data recorded before induction of ventricular f. Administered at a 4 mg/kg dose. 
tachycardia. g. Nonsustained ventricular tachycardia. 
c. Recorded before administration of the compound. 
"' VI 
Suggestions for Future Work 
One very important aspect in the design and synthesis of bicyclo-
nonanes for the treatment of arrhythmias is that of hydrophilicity. 
Good water solubility would be an asset in the administration of these 
compounds since they must ultimately travel in the bloodstream. It was 
for this reason that the sulfur-containing salt 36b was synthesized. 
This salt {36b) contains the bioisosteric replacement of the !-benzyl 
group (as in 36a) with the !-thiophenemethyl group. The methoxy groups 
of 36d and J6e were added to the phenyl ring of salt 36c in order to 
increase the water-solubility of these salts. 
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The syntheses of the salts 36a-e utilized primary amines which were 
nearly insoluble in water. Starting amines with a greater water 
solubility should enhance the water-solubility of the final products. 
The amino acids are one type of very hydrophilic amines which could be 
used as the nitrogen donor in the double Mannich reaction in the forma-
tion of bicyclo(3.3.1]nonanes 60. These amines are also readily 
availably and fairly inexpensive. The use of amino acids may also 
eliminate the need for an acid catalyst such as acetic acid which is 






which are less expensive than either the pure ~ or pure l amino acids, 
could be used since in the Wolff-Kishner reduction of 60, epimerization 
would surely occur. Since it is unknown if the carboxylic acid function 
would survive the rather severe conditions of the Wolff-Kishner reduc-
tion, it may be protected as the tertiary butyl ester. 
~2 ( N N 




61a 61b 61c 
Another alternative in the use of water soluble amines is the use 
of amine functions which have been attached to nitrogen containing 
aromatic rings such as 6-aminomethylpurine (61a), 4-aminomethylpyrimi-
dine (61b), and 4-aminomethylimidazole (61c). These should participate 
in the double Mannich reaction in a manner similar to benzylamine but in 
contrast to benzylamine, each should be very water soluble. These 
amines (61a-c) may be synthesized from the readily available, low-cost, 
starting materials 6-methylpurine, 4-methylpyrimidine, and 4-methylimid-
azole. Chlorination of the methyl groups of these starting materials 
may be accomplished with the use of chlorine gas in the presence of 
ultraviolet light. The transformation of toluene to benzyl chloride in 
44a this manner proceeds in a yield of 92.5%. A Gabriel synthesis 
utilizing the potassium salt of phthalimide may then be used in the 
aminolysis of the alkyl chloride to give the intermediate ~-alkylphthal-
CHJ h\1 CH2Cl 
I + Cl2 I 
Ar Ar 
..,...., 
a, Ar = l~N~ 1 ) N2H4 
N ~ 2) HCl H 
b, Ar = 0 CH2NH 2 I N Ar 




imide which is then destroyed by treatment with hydrazine and hydro-
chloric acid. Aminolysis of benzyl chloride using this method yields 
benzylamine in a yield of 94%. 44b The the bicyclo[J.J.1]nonanes formed 
using these amines (61a-c) should have a much greater water solubility 
than other ~-alkylbicyclononanes (36a-e) which have been discussed. 
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Since amino acids, purine, pyrimidine, and imidazole are all common 
to the body, their presence in bicyclononanes of interest may lessen 




All reactions were performed under a nitrogen atmosphere with mag-
netic stirring unless otherwise specified. Melting points were deter-
mined with a Thomas Hoover capillary apparatus and were uncorrected. 
Infrared spectra were obtained on KBr pellets (oils-films) with a Perkin-
Elmer 681 IR spectrophotometer. The 13c NMR spectra were obtained at 
25.20 MHz on a Varian XL-100(15) NMR spectrometer equipped with a Nicolet 
TT-100 PFT accessory. Several 13c NMR spectra were also obtained at 
75.4 MHz on a Varian XL-300 NMR spectrometer. All 1H, 15N, and 77se NMR 
spectra were obtained on a Varian XL-300 NMR spectrometer at 299.99 MHz, 
30.41 MHz, and 57.22 MHz, respectively. The 1H and 13c shifts are 
reported in delta or parts per million downfield from (CH3)4si as an 
internal standard. All 15N shifts are reported in parts per million 
downfield from liquid NH3 (25°C) using 15NH4No3 (19.73 ppm) as an exter-
nal secondary standard. All 77se shifts are reported in parts per 
million downfield from (CH3)2Se (0°C) using (c6H5Se) 2 (481.0 ppm) as an 
external secondary standard. Elemental analyses were performed by 
Galbraith Laboratories, Knoxville, Tennessee. 
Residues from the reactions to be described were disposed of in 
Clorox bleach. Reaction flasks, which were frequently coated with red 
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amorphous selenium during the course of the reactions or work-up proce-
dures, were rinsed with Clorox bleach before washing to remove selenium. 
1,1-Dimethyl-4-piperidonium Iodide (41) 
A solution of freshly distilled 1-methyl-4-piperidone (15.0 g, 
0.133 mol) in 300 mL of anhydrous ether was placed in a 500-mL, round-
bottomed flask equipped with a condenser and a magnetic stirring bar. 
Iodomethane (20.0 g, 0.141 mol) was added in one portion and the resul-
ting solution was stirred for 2 h and then heated at reflux for an 
additional 20 h. During this time a dense, white solid formed which was 
suction filtered and dried under vacuum (aspirator) to give 31.0 g 
(91.4%) of 41 as a white powdery solid: mp 186-188°C (dec)(lit. 21 mp 
186-189°C); IR (KBr) cm-1 1720 (C=O); 13c NMR (DMS0-£6) ppm 35.2 [q, 
N(CH3) 2J, 51.1 [t, C(3,5)], 60.1 [t, C(2,6)], 201.3 [s, C(4)]. This 
solid was used without further purification in the synthesis of 4-
selenanone (38). However, this salt may be recrystallized from methanol 
with a molecule of methanol retained as a hemiketal (mp 196°C with 
decomposition, lit. 21 mp 189-190°C). The hemiketal may be satisfactori-
ly used in the preparation of 4-selenanone (38). 
4-Selenanone (38) 
Powdered elemental selenium (4.35 g, 55.1 mg-at.) and NaBH4 (4.0 g, 
106 mmol) were placed in a 1-L, three-necked, round-bottomed flask which 
was equipped with a condenser, a magnetic stirring bar, and a nitrogen 
inlet. The effluent gases are passed through a series of three traps; a 
blank, one containing Clorox bleach, and one containing a saturated 
solution of potassium hydroxide in 95% ethanol. Absolute ethanol (500 
mL) was added to the flask and the resulting mixture was stirred at RT 
for 30 min. Heating at reflux for an additional 2 h gave a colorless 
suspension. This resulted in the formation of the reactive species 
which was presumably NaHSe. 62 The boiling process was to complete the 
reaction and to destroy excess sodium borohydride. The salt, 41 (12.75 
g, 50.0 mmol) was then added in 2-3 g portions over 20 min (the color of 
the suspension changed to yellow almost immediately). Reflux was con-
tinued for 5 h after which time the resulting dark purple solution was 
cooled to RT. The volume of this solution was reduced to 100 mL by 
rotary evaporation. The residue was diluted with water (125 mL) and 
extracted with ether (5 X 40 mL). The combined extracts were washed 
with two 30-mL portions of a saturated sodium chloride solution and 
dried (K2co3). Rotary evaporation of the ether gave a dark yellow oil 
which was quickly transferred to a sublimation apparatus where it solid-
ified. Sublimation of this solid (50°C/0.1 mm Hg) gave 38 (5.1 g, 63%) 
as a white crystalline solid: mp 55.0-55.5°C; IR (KBr) cm-1 1700 (C=O); 
1 H NMR (CDC13) o 2.82 [t, 4 H, H(2,6), J = 6.1 Hz], 3.00 [t, 4 H, 
H(3,5), J = 6.1 Hz]; 13c NMR (CDC13 ) ppm 19.3 [C(2,6)], 43.7 [C(3,5)], 
209.3 [C(4)]; 77se NMR (CDCL3) ppm 176.6 [Se(1)]. Anal. Calcd for 
c5H80Se: C, 36.81; H, 4.94; Se, 48.44· Found: C, 36.79; H, 4.87; Se, 
48.33. 
A second sublimation may be necessary since the first sublimation 
may give a slightly yellow product. Pure 4-selenanone appears to be 
stable in air and to light but storage in capped, dark bottle in a cool 
place is recommended. Slight impurities cause its rapid decomposition. 
4-Selenanone (38) will sublime slowly even at room temperature and 
atmospheric pressure. Close work with this solid may cause minor eye 
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irritation and care should be exercised in all handling procedures. 
4-Selenanone-2,4-dinitrophenylhydrazone (42) 
Ketone 38 (0.25 g, 1.5 mmol) was added to a warm solution of 2,4-
dinitrophenylhydrazine (0.5 g, 2.5 mmol) and cone HCl (1 mL) in absolute 
ethanol. Warming was continued until the ketone had dissolved. Upon 
slow cooling, an orange solid formed which was recrystallized (absolute 
ethanol) to give orange needles of 42: mp 167.0-167.5°C; IR (KBr) cm-1 
1 3325 (N-H); H NMR (CDCLJ) o 2.80-3.20 [m, 9 H, H(2,6) and NH], 7.99 [d, 
1 H, H(6 1 ), J = 9.0 Hz], 8.33 [dd, 1 H, H(5 1 ), J = 1.5, 9.0 Hz], 9.13 
[d, 1 H, H(3 1 ), J = 1.5 Hz]; 13c NMR (CDC13) ppm 16.1 [C(2)], 18.2 
[C(6)], 30.0 [C(3)], 35.3 [C(5)], 116.2, 123.2, 129.1, 129.8, 137.7, 
77 144.9, 158.2 [Ar-C and C(4)]; Se NMR (CDC13) ppm 175.66 [Se(1)]. 
Anal. Calcd for c11H12N4o4se: C, 38.50; H, 3.52; N, 16.33; Se, 23.01. 
Found: C, 38.37; H, 3.80; N, 16.35; Se, 23.23. 
7-Benzyl-3-selena-7-azabicylo[3.3.1]nonan-9-one (34a) 
Benzylamine (0.67 g, 6.26 mmol) and glacial acetic acid (0.38 g, 
6.33 mmol) were dissolved in dry methanol (30 mL). Paraformaldehyde 
(1.5 g, 50 mmol) was added and the resulting mixture was brought to 
reflux under an atmosphere of nitrogen. 4-Selenanone (38, 1.00 g, 6.13 
mmol) was then added in one portion which quickly turned the solution 
yellow. Reflux was continued under nitrogen in the dark for 5 h. The 
resulting deep red solution was then allowe~ to cool to room temperature 
and was stirred for an additional 18 h. The methanol was evaporated 
(aspirator) and the orange residual oil was partitioned between ether 
(50 mL) and water (50 mL). The ether layer was discarded and the 
aqueous layer was made basic with KOH (85%, 1.2 g, 18.2 mmol). This 
solution was extracted with ether (5 x 40 mL). The combined extracts 
were dried (K2co3) and evaporated (aspirator) to give an oil which was 
digested on a steam bath with Skelly B (50 mL). Evaporation gave a 
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light yellow oil which solidified upon standing. This solid was recrys-
tallized (95% ethanol) to give 34a (0.78 g, 43%) as white needles: mp 
155.5-157.0°C (dec); IR (KBr) cm-1 1726 (C=O); 1H NMR (CDC13) 0 2.71 [m, 
4 H, H(2,4)], 3.08 [m, 2 H, H(1,5)], 3.20 [m, 4 H, H(6,8)], 3.57 [s, 2 
13 H, H(10)], 7.32 [m, 5 H, ArH]; C NMR (CDC13) ppm 25.5 [t, C(2,4)], 
46.2 [d, C(1,5)], 59.0 [t, C(6,8)], 61.5 [t, C(10)], 127.1 [d, C(4')], 
128.2 (d) and 128.6 (d) [C(2',3',5',6')], 138.0 [s, C(1 1 )], 213.8 [s, 




Ketone 34a (0.65 g, 2.2 mmol) was dissolved in dry benzene (250 
mL). Perchloric acid (60%, 1.0 g, 6.0 mmol) was added dropwise very 
slowly with cooling and swirling. This precipitated an orange solid 
which adhered to the side of the flask. The benzene was decanted and 
the solid was recrystallized (95% ethanol) to give the diol hydroper-
chlorate 37 (0.62 g, 68.3%) as white needles: mp 214.0-216.0°C (dec); 1H 
NMR (DMS0-£6) o 2.43 [br s, 2 H, H(2,4) ], 2.72 [br d, 2 H, H(2,4) ], ax eq 
3.22-3.50 [m, 6 H, H(6,8) , H(1,5), OH], 3.50-3.64 [m, 2 H, H(6,8) ], 
u - ~ 
4.35 [d, 2 H, H(10)], 7.40-7.70 [m, 5 H, ArH], 9.20 [br s, 1 H, H(7)]; 
13c NMR (DMSO-~) ppm 21.1 [C(2,4)], 34.7 [C(1,5)], 54.9 [C(6,8)], 60.1 
15 [C(10)], 92.5 [C(9)], 129.2, 129.7, 130.0, 130.5 [ArC]; N NMR (DMSO-~) 
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ppm 51.88 [N(7)]; 77se NMR (DMSO-~) ppm 62.39 [Se(3)J. 
7-Benzyl-3-selena-7-azabicyclo[3.3.1]nonane Hydroperchlorate (36a) 
A solution was made of 34a (2.0 g, 6.8 mmol) and hydrazine (95%, 
5.0 g, 148 mmol) in triethylene glycol (40 mL). Potassium hydroxide 
(85%, 10.0 g, 152 mmol) was added and the resulting mixture was heated 
to 140°C in an oil bath under a nitrogen atmosphere for 12 h. After 
cooling to room temperature, the solution was poured into water (200 mL) 
and the resulting suspension was extracted with ether (5 x 40 mL). The 
combined extracts were dried overnight (K2co3) and cooled to 0°C. Per-
chloric acid (60%, 2.0 g, 11.9 mmol) was added dropwise. The yellow-
orange solid which formed was filtered and recrystallized (methanol) to 
give J6a (1.94 g, 75%) as white needles: mp 161.0-162.0°C (dec); 1H NMR 
(DMS0-£6) 0 1.75 [d, 1 H, H(9), J = 13.7 Hz], 1.88 [d, 1 H, H(9), J = 
13.6 Hz], 2.41 [br s, 2 H, H(1,5)], 2.64 [d, 2 H, H(2,4) , J = 12.21 ax 
Hz], 3.19 [d, 2 H, H(2,4) , J = 12.10 Hz], 3.42 [d, 2 H, H(6,8) ], eq ax 
3.61 [d, 2 H, H(6,8) , J = 11.83 Hz], 4.32 [d, 2 H, H(10), J = 5.75 eq 
Hz]; 13c NMR (DMSO-~) ppm 22.0 [C(2,4)], 25.3 [C(1,5)], 28.7 [C(9)], 
15 56.6 [C(6,8)], 60.6 [C(10)], 128.9, 129.3, 129.8, 130.0 [ArC]; N NMR 
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(DMSO-~) ppm 51.56 [N(7)]; Se NMR (DMS0-£6) ppm 96.61 [Se(3)]. Anal. 
Calcd for c14H20c1No4se: C, 44.14; H, 5.30; N, 3.68; Cl, 9.32; Se, 
20.75. Found: C, 44-45; H, 5.38; N, 3.61; Cl, 9.52; Se, 20.67. 
7-(2-Thiophene)methyl-3-selena-7-azabicyclo[3.3.1]nonan-9-one (34b) 
A solution was made of 2-aminomethylthiophene (1.39 g, 12.3 mmol) 
and glacial acetic acid (1.10 g, 18.3 mmol) in methanol (60 mL) in a 150 
mL, three-necked, round-bottomed flask eqipped with a water-cooled 
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condenser. To this solution was added paraformaldehyde (3.0 g, 100 
mmol) and the resulting mixture was heated to reflux. Ketone 38 (2.00 
g, 12.3 mmol) was add and reflux was continued for 5 h. After allowing 
the resulting red solution to cool to room temperature, the methanol was 
evaporated (aspirator) to give a red oil. This oil was partitioned 
between water and ether (100 mL: 30 mL). The ether portion was dis-
carded and the aqueous layer was made basic by the addition of NaOH (1.5 
g, 37.5 mmol). The resulting yellow suspension was extracted with ether 
(5 x 40 mL). The combined extracts were washed with water (2 x 30 mL) 
and dried (K2co3). Evaporation of the ether gave a brown oil which was 
digested in boiling Skelly B (3 x 100 mL). Evaporation of the Skelly B 
gave 1.72 g of 34b as a colorless viscous oil (47%): IR (film) cm-1 
1 1710 (C=O); H NMR (CDC13) o 2.60-2.74 [m, 4 H, H(2,4)], 3.02-3.18 [m, 4 
H, H(1,5), H(6,8) ], 3.27 [dd, 2 H, H(6,8) , J = 11.7 Hz, 3.4 Hz], ax eq 
3.75 [s, 2 H, H(10)], 6.80-7.30 [m, 3 H, ArH]; 13c NMR (CDC13) ppm 24.8 
[C(2,4)], 46.0 [C(1,5)], 55.6 [C(10)], 58.5 [C(6,8)], 124.9 [C(4')], 
125.5 [C(2')], 126.1 [C(3')], 141.4 [C(1')], 212.9 [C(9)]; 15N NMR 
(CDC13) ppm 40.31 [N(7)]; 77se NMR (CDC13) ppm 86.28 [Se(3)]. 
7-(2-Thiophene)methyl-3-selena-7-azabicyclo[3.3.1]nonane 
Hydroperchlorate (36b) 
Ketone 34b (1.0 g, 3.33 mmol) and anhydrous hydrazine (95%, 2.0 g, 
5.94 mmol) were dissolved in triethylene glycol (40 mL) in a 60 mL 
jacketed flask which was equipped for distillation. Potassium hydroxide 
(85%, 3.0 g, 45.5 mmol) was added and the resulting mixture was heated 
with stirring to 140-145°C by boiling xylene in the jacket of the reac-
tion vessel. Heating was continued for 4 h after which time the reac-
tion mixture was cooled to room temperature and was poured into cool 
water (150 mL). The resulting suspension was extracted with ether (5 x 
40 mL) and the combined extracts were dried (K2co3). After filtration 
of the desiccant, 60% HClo4 (1.0 g, 6.0 mmol) was added dropwise very 
slowly causing an orange solid to form. The ether was decanted and the 
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solid was recrystallized twice (isopropyl alcohol, decolorizing carbon) 
to give 0.88 g of salt J6b as white needles (68%): mp 141.0-141.5°C; 1H 
NMR (DMS0-£6) o 1.74 [d, 1 H, H(9), J = 13.6 Hz], 1.86 [d, 1 H, H(9), 
J = 13.6 Hz], 2.43 [br s, 2 H, H(1,5)], 2.64 [d, 2 H, H(2,4) , J = 12.0 ax 
Hz], 3.19 [d, 2 H, H(2,4) , J = 11.3 Hz], 3.35 [m, 2 H, H(6,8) ], 3.62 eq ax 
[d, 2 H, H(6,8) , J = 12.7 Hz], 4.53 [d, 2 H, H(10), J = 5.3 Hz], 7.16 eq 
[dd, 1 H, H(3'), J = 5.1 Hz, 3.7 Hz], 7.36 [d, 1 H, H(2'), J = 3.3 Hz], 
7.75 [d, 1 H, H(4'), J = 5.1 Hz], 9.24 [br s, 1 H, H(7)]; 13c NMR (DMSO-
%) ppm 21.9 [t, C(2,4)], 25.3 [d, C(1,5)], 28.6 [t, C(9)], 54.9 [t, 
C(10)], 56.1 [t, C(6,8)], 127.2 [d, C(4')], 129.3 [d, C(2')], 130.5 [s, 
C(1 1 )], 131.8 [d, C(3')]; 15N NMR (DMS0-£6) ppm 58.54 [N(7)]; 77se NMR 
(DMS0-£6) ppm 89.41 [Se(3)]. Anal. Calcd for c12H18ClNo4sse: C, 
37.27; H, 4.69; N, 3.62; Se, 20.42. Found: C, 37.30; H, 4.76; N, 3.60; 
Se, 20.10. 
7-Phenethyl-3-selena-7-azabicyclo[3.3.1]nonan-9-one (34c) 
A 100-mL, three-necked, round-bottomed flask equipped with a con-
denser was charged with a solution of phenethylamine (1.48 g, 12.3 mmol) 
and glacial acetic acid (0.85 g, 14.2 mmol) in methanol (60 mL). Para-
formaldehyde (3.0 g, 100 mmol) was added and the resulting mixture was 
heated to reflux with magnetic stirring under an atmosphere of nitrogen. 
Ketone 38 (2.00 g, 12.3 mmol) was added and reflux was continued for 5 h 
resulting in an orange solution. The methanol was evaporated (aspira-
tor) and the resudual orange oil was mixed with water (200 mL). This 
aqueous mixture was made basic by addition of NaOH (2.0 g, 50 mmol) and 
was then extracted with ether (5 X 40 mL). The combined extracts were 
washed with saturated brine and dried (K2co3). Evaporation (aspirator) 
gave a brown residue which was digested in boiling Skelly B (150 mL). 
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Evaporation of the Skelly B gave a solid which was recrystallized (etha-
nol) to give 0.82 g (22%) of 34c as a light tan solid: mp 91-92°C; IR 
(KBr) cm-1 1710 (C=O); 1H NMR (CDC13) o 2.62-2.83 [m, 8 H, H(2,4,1,5, 
11)], 3.02-3.20 [m, 6 H, H(6,8,10)], 7.16-7.38 [m, 5 H, Ar-H]; 13c NMR 
(CDC13) ppm 25.4 [t, C(2,4)], 33.7 [t, C(11)], 46.2 [d, C(1,5)], 58.3 
[t, C(10)], 59.1 [t, C(6,8)], 125.9 [s, C(4')], 128.1 [d, C(2',6') or 
C(3',5')], 128.4 [d, C(3',5') or C(2 1 ,6 1 )], 139.7 [s, C(1')], 213.5 [s, 
C(9)]; 15N NMR (CDC13) ppm 35.44 [N(7)]; 77se NMR (CDC13) ppm 79.51 
[Se(3)]. 
7-Phenethyl-3-selena-7-azabicyclo[3.3.1]nonane Hydroperchlorate (36c) 
A 60-mL, two-necked, round-bottomed, jacketed flask was charged 
with a mixture of ketone 34c (1.3 g, 4.2 mmol), N2H4 (95%, 2.0 g, 59 
mmol), and KOH (85%, 6.0 g, 91 mmol) in triethylene glycol (40 mL). The 
flask was equipped for simple distillation under a rapid stream of 
nitrogen. The reaction mixture was heated to 140-145°C by boiling 
xylene contained in the jacket. Heating was continued under a nitrogen 
stream for 5 h. During this time, a small amount of water and hydrazine 
distilled out. The resulting clear, light brown solution was cooled in 
a water bath to room temperature and was then poured into ice-water (200 
mL). The white suspension which formed was extracted with ether (5 X 40 
mL). The combined ether extracts were washed with brine (30 mL) and 
dried (K2co3) overnight. After filtering out the desiccant, this ether 
solution was cooled to 0-5°C in an ice bath and 60% HCl04 (1.0 g, 6.0 
mmol) was added dropwise very slowly. After stirring overnight, the 
resulting orange precipitate was filtered and recrystallized (methanol, 
decolorizing carbon) to give 0.67 g (40%) of 36c as white plates: mp 
249-250oc 1 (dec.); H NMR (DMSO-~) o 1.73 [br d, 1 H, H(9), J = 14.0 
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Hz], 1.89 [br d, 1 H, H(9), J = 13.8 Hz], 2.41 [br s, 2 H, H(1,5)], 2.64 
[d, 2 H, H(2,4) , J = 12.1 Hz], 3.07 [t, 2 H, H(11), J = 7.9 Hz] 3.20 ax 
[d, 2 H, H(2,4) , eq J = 12.2 Hz], 3.33 [m, 4 H, H(10)(6,8) ], 3.86 [d, 2 ax 
H, H(6,8) , J = 12.3 Hz), 7.28-7.50 [m, 5 H, Ar-H), 8.89 [br s, 1 H, eq 
13 H(7)); C NMR (DMSO-~) ppm 21.9 [t, C(2,4)], 25.3 [d, C(1,5)], 28.5 
[t, C(9) or C(11)), 29.9 [t; C(11) or C(9)], 56.7 [y, C(6,8)), 58.8 [t, 
C(10)], 126.8 [d, C(4')], 128.5 [d, C(2 1 ,6 1 ,3',5')], 136.2 [s, C(1')); 
15N NMR (DMS0-£6) ppm 48.25 [N(7)); 77se NMR (DMS0-£6) ppm 88.42 
[Se(3)). Anal. Calcd. for c15H22ClN04se: C, 45.64; H, 5.62; N, 3.55; 
Se, 20.00. Found: C, 45.77; H, 5.80; N, 3.48; Se, 19.85. 
7-p-Methoxyphenethyl-3-selena-7-azabicyclo[3.3.1)nonan-9-one (34d) 
A 100-mL, three-necked, round-bottomed flask, equipped with a con-
denser and a magnetic stirring bar, was charged with a solution of E-
methoxyphenethylamine (0.93 g, 6.16 mmol) and glacial acetic acid (0.50 
g, 8.33 mmol) in methanol (40 mL). Paraformaldehyde (1.50 g, 50.0 mmol) 
was added and the resulting mixture was heated to reflux under an atmos-
phere of nitrogen. Ketone 38 (1.00 g, 6.13 mmol) was added in one 
portion and reflux was continued for 4 h. The methanol was evaporated 
(aspirator) from the resulting orange solution to give a very viscous 
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red oil. This oil was dissolved in water (150 mL) and KOH (85%, 1.0 g, 
15.2 mmol) was added to make the solution very basic. The resulting 
yellow suspension was extracted with ether (5 X 40 mL). The combined 
extracts were washed with water (30 mL) and dried (K2co3). Evaporation 
of the ether (aspirator) gave 0.72 g (35%) of 34d as a light yellow oil: 
IR (neat) cm-1 1723 (C=O); 1H NMR (CDC13) o 2.50-2.80 [m, 8 H, 
H(1,5,2,4,11)], 2.96-3.14 [m, 6 H, H(6,8,10)], 3.71 [s, 3 H, ocg3J, 
6.72-6.90 [m, 2 H, H(3',5')], 7.00-7.16 [m, 2 H, H(2 1 ,6 1 )]; 13c NMR 
(CDC13) ppm 24.6 [C(2,4)], 32.0 [C(11)], 45.4 [C(1,5)], 54.2 [OCH3J, 
57.8 [C(10)], 58.2 [C(6,8)], 112.8 [C(3',5')], 128.5 [C(2 1 ,6 1 )], 130.9 
[C(1 ')], 156.9 [(C(4')], 212.5 [C(9)]; 15N NMR (CDC13) ppm 35.43 [N(7)]; 
77se NMR (CDC13) 78.81 [Se(3)]. 
7-p-Methoxyphenethyl-3-selena-7-azabicyclo[3.3.1]nonane 
Hydroperchlorate (36d) 
A two-necked, 60-mL, jacketed flask equipped for simple distilla-
tion was charged with a suspension of ketone 34d (0.65 g, 1.92 mmol), 
hydrazine (95%, 1.00 g, 29.7 mmol), and potassium hydroxide (85%, 3.0 g, 
45.5 mmol) in triethylene glycol (25 mL). Under a rapid stream of 
nitrogen, the suspension was heated to 140-145°C by boiling xylene in 
the jacket of the flask. Stirring was continued at this temperature for 
3 h during which time a small amount of water and excess hydrazine was 
distilled from the reaction mixture. After cooling to room temperature, 
the resulting solution was dilluted with water (100 mL) and was 
extracted with ether (5 X 40 mL). The combined ether extracts were 
dried (K2co3) overnight and 60% perchloric acid (0.5 g, 3.0 mmol) was 
added very slowly. This precipitated an orange solid. The ether was 
110 
decanted and the solid was recrystallized (abs. ethanol) with the aid of 
decolorizing carbon to give 0.58 g (71%) of salt 36d as white needles: 
mp 208.5-209.0°C; 1H NMR (DMS0-£6) o 1.73 [br d, 1 H, H(9), J = 14Hz], 
1.90 [br d, 1 H, H(9), J =14Hz], 2.42 [br s, 2 H, H(1,5)], 2.65 [d, 2 
H, H(2,4) , J =12Hz], 3.02 [t, 2 H, H(11), J =7Hz], 3.22 [d, 2 H, ax 
H(2,4) , J =12Hz], 3.30 [m, 2 H, H(10)], 3.36 [d, 2 H, H(6,8), J = 12 
eq 
Hz], 3.76 [s, 3 H, OCH3J, 3.86 [d, 2 H, H(6,8) , J =12Hz], 6.97 [d, 2 eq 
H, H(3',5'), J =9Hz], 7.32 [d, 2 H, H(2 1 ,6 1 ), J =9Hz], 8.92 [br s, 1 
13 H, H(7)]; C NMR (DMSO-~) ppm 21.9 [t, C(2,4)], 25.3 [d, C(1,5)], 28.5 
[t, C(9) or C(11)], 28.9 [t, C(11) or C(9)], 55.0 [q, OCH3], 56.7 [t, 
C(6,8)], 58.9 [t, C(10)], 114.0 [d, C(3',5')], 127.7 [s, C(1')], 129.6 
[d, C(2 1 ,6 1 )], 158.1 [s, C(4')]; 15N NMR (DMS0-36) ppm 48.10 [N(7)]; 
77se NMR (DMS0-36) ppm 88.64 [Se(3)]. Anal. Calcd. for c16H24clN05Se: 
C, 45.24; H, 5.69; N, 3.30; Se, 18.59. Found: C, 45.42; H, 5.80; N, 
3.30; Se, 18.46. 
7-(3,4-Dimethoxy)phenethyl-3-selena-7-azabicyclo[3.3.1]nonan-9-one (34e) 
A 150 mL three-necked, round-bottomed flask was charged with a 
solution of 3,4-dimethoxyphenethylamine (2.23 g, 12.3 mmol) and glacial 
acetic acid (1.0 g, 16.6 mmol) in methanol (60 mL). Paraformaldehyde 
(3.0 g, 100 mmol) was added and the resulting mixture was heated to 
boiling. 4-Selenanone (38, 2.00g, 12.3 mmol) was added and reflux was 
continued for 4 hours. The resulting brown solution was evaporated 
(aspirator) to a brown oil. This oil was added to water (150 mL) and 
the mixture which formed was extracted with ether (4 x 50 mL). The 
combined extracts were washed with water (30 mL) and dried (K2co3). 
Evaporation (aspirator) gave a dark brown oil which was digested in 
boiling Skelly B (3 x 100 mL). Evaporation of the Skelly B gave 1.4 g 
of ketone 34e as a pale yellow viscous oil (31%): · IR (neat) em - 1 1730 
1 (C=O); H NMR (CDC13) 8 2.60-2.80 [m, 8 H, H(2,4,1,5,11)], 3.00-3.20 
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[m, 6 H, H(6,8,10)], 3.80 [s, 3 H, OCH3 J, 3.84 [s, 3 H, OCH3 J, 7.70-
7.90 [m, 3 H, ArH]; 13c NMR (CDC13) ppm 25.4 [C(2,4)], 33.2 [C(11)], 
46.2 [C(1,5)], 55.7 [both OCH3J, 58.6 [C(10)], 59.1 [C(6,8)], 111.3, 
112.0, 120.5, 132.8 [C(1 1 )], 141.2, 148.7, 213.8 [C(9)]; 15N NMR (CDCl) 
ppm 35.16 [N(7)]; 77se NMR (CDC13) ppm 77.00 [Se(3)]. 
7-(3,4-Dimethoxy)phenethyl-3-selena-7-azabicyclo[3.3.1]nonane 
Hydroperchlorate (36e) 
A 60 mL, two-necked, jacketed flask which was equpped for 
distillation, was charged with solution of ketone 34e (1.10 g, 3.00 
mmol), anhydrous hydrazine (95%, 2.00 g, 5.94 mmol), and potassium 
hydroxide (85%, 3.0 g, 45.5 mmol) in triethylene glycol (40 mL). This 
solution was heated to 140-145°C by boiling xylene in the jacket of the 
reaction flask. Heating was continued for 4 h during which time a small 
amount of water and excess hydrazine distilled out. The reaction 
mixture, which had turned brown, was cooled and poured into cool water 
(150 mL). The resulting suspension was extracted with ether (4 x 50 
mL). The combined extracts were washed with water (40 mL) and dried 
(K2co3). Perchloric acid (60%, 1.0 g, 6.0 mmol) was added to the ether 
solution dropwise very slowly. This precipitated a white solid which 
rapidly turned orange. The ether was decanted and the solid was 
recrystallized twice from absolute ethanol (decolorizing carbon) to give 
0.92 g (68%) of salt 36e as a white crystalline solid: mp 162-163°C; 1H 
NMR (DMS0-£6) 8 1.74 [d, 1 H, H(9), J =13Hz], 1.92 [d, 1 H, H(9), J = 
13Hz], 2.42 [br s, 2 H, H(1,5)], 2.65 [d, 2 H, H(2,4) , J =12Hz], ax 
3.02 [t, 2 H, H(11)], 3.22 [d, 2 H, H(2,4) , J =12Hz], 3.36 [m, 4 h, 
eq 
H(10) and H(6,8)ax]' 3.76 [s, 3 H, OCH3J, 3.80 [s, 3 H, OCH3J, 3.87 [d, 
2 H, H(6,8) , J =12Hz], 6.88-7.02 [m, 3 H, ArH], 8.88 [br s, 1 H, 
eq 
H(7)]; 13c NMR (DMSO-~) ppm 22.0 [C(2,4)], 25.3 [C(1,5)], 28.5 [C(11) 
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or C(9)], 29.4 [C(9) or C(11)], 55.4 [OCH3], 55.5 [OCH3J, 56.7 [C(6,8)], 
58.9 [ C ( 1 0) ] , 112.0, 11 2. 3, 120. 6, 1 28.3 [ C ( 1 1 ) ] , 14 7. 7 [ C ( 3 1 ) or 
C(4 1 )], 148.8 [C(3 1 ) or C(4 1 )]; 15N NMR (DMS0-£6) ppm 48.03 [N(7)]; 77se 
NMR (DMS0-£6) ppm 88.35 [Se(3)]. Anal. Calcd for c 1 ~26clN06Se: C, 
44-90; H, 5.76; N, 3.08. Found: C, 44.86; H, 5.86; N, 3.04. 
6,8-Diphenyl-3-selena-7-azabicyclo[3.3.1]nonan-9-one (34f) 
A 50-mL, two-necked, jacketed flask was charged with a solution of 
dry ammonium acetate (2.31 g, 30.0 mmol) in absolute ethanol (30 mL) 
which was warmed to 65°C by refluxing methanol in the jacket. A solu-
tion of ketone 38 (2.45 g, 15.0 mmol) and benzaldehyde (3.18 g, 30.0 
mmol) in absolute ethanol (15 mL) was added in one portion. The resul-
ting solution was stirred under nitrogen at 65°C for 45 min. After 
cooling the reaction mixture to about 30-40°C, ether (15 mL) was added 
and stirring was continued for 10 min. Cooling (5°C) overnight resulted 
in the formation of a yellow solid which was filtered and recrystallized 
(ethanol) to give 0.89 g (17%) of ketone 34f as white needles: mp 
207.0-208.5°C (dec); IR (KBr) cm-1 3320 (N-H), 1730 (C=O); 1H NMR 
(CDC13) o 1.77 [br s, 1 H, H(7)], 2.84 [br d, 4 H, H(2,4), J =8Hz], 
3.59 [m, 2 H, H(1,5)], 5.04 [m, 2 H, H(6,8)], 7.20-7.50 [m, 10 H, ArH]; 
13c NMR (CDC13) ppm 29.2 [C(2,4)], 54.0 [C(1,5)], 64.2 [C(6,8)], 144.4 
[ C ( 1 I ) ) ' 1 27 • 0 [ C ( 3 I '5 I ) Or C ( 2 I '6 1 ) ) ' 1 27 • 9 [ C ( 4 I ) ) ' 128 • 7 [ C ( 2 I '6 1 ) Or 
C(3',5)]; 15N NMR (CDC13) ppm 63.28 [N(7)]; 77se NMR (CDC13) ppm 25.38 
[Se(3)]. Anal. Calcd for c19H19NOSe: C, 64.02; H, 5.38; N, 3.93; Se, 
22.17. Found: C, 63.86; H, 5.45; N, 3.81; Se, 21.90. 
6,8-Diphenyl-3-selena-7-azabicyclo[3.3.1]nonane (35f) 
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Ketone 34f (0.89 g, 2.5 mmol) and hydrazine (95%, 3.0 g, 89 mmol) was 
dissolved in triethylene glycol (40 mL). This solution was placed in a 
60-mL, two-necked, jacketed flask which was equipped for simple distil-
lation under a rapid stream of nitrogen. Water was boiled in the jacket 
which heated the reaction mixture to about 100°C. The solution was 
stirred at this temperature for 2 h. Potassium hydroxide (85%, 1.0 g, 
15 mmol) was added and the temperature was increased to about 207° by 
boiling tetralin in the jacket. As the temperature increased, nitro-
gen was produced. After stirring at this temperature for 4 h, 3 mL of 
water and excess hydrazine had distilled out. The reaction mixture was 
cooled to 60-70°C and was then poured into ice-water (200 mL). A white 
precipitate immediately formed. After refrigerating this mixture over-
night, the solid was filtered and dried on the filter paper. This solid 
was recrystallized (ether, decolorizing carbon) to give 0.63 g (74%) of 
amine 35f as white needles: mp. 193.5-195.0°C (dec); IR (KBr) cm-1 3250 
(N-H); 1H NMR (c6o6) o 0.83 [dt, 1 H, H(9), J = 12.0, 1.5 Hz], 1.34 [m, 
1 H, H(7)], 1.78 [m, 2 H, H(1,5)], 2.00 [dd, 2 H, H(2,4) , J = 12.0, ax 
1.5 Hz], 2.33 [m, 1 H, H(9)], 2.84 [dd, 2 H, H(2,4) , J = 12.0, 2.0 eq 
13 Hz], 4.34 [d, 2 H, H(6,8), J = 2.0 Hz], 7.1-7.4 [m, 10 H, ArH]; C NMR 
(c6o6 @ 50°C) ppm 25.1 [C(2,4)], 27.2 [C(9)], 34.5 [C(1,5)], 62.0 
[C(6,8)], 126.9 [C(2') or C(3')], 127.2 [C(4')], 128.7 [C(3') or C(2 1 )], 
151.9 [C(1 1 ); 15N NMR (c6o6) ppm 55.68 [N(7)]; 77se NMR (c6o6 @ 50°C) 
ppm 2.38 [Se(3)]. Anal. Calcd for c19H21 NSe: C, 66.66; H, 6.18; N, 




A solution was made of amine 35f (0.63 g, 1.8 mmol) in benzene (100 mL) 
in a 250-mL Erlenmeyer flask. Perchloric acid (60%, 1.0 g, 6.0 mmol) 
was added dropwise very slowly with swirling. The resulting mixture was 
allowed to stand at room temperature with occasional swirling for 3 h. 
The orange solid which formed was filtered and recrystallized (methanol) 
to give 0.62 g (78%) of salt 36f as white needles: mp 288.0-289.0°C (dec, 
1 sealed tube); H NMR (DMS0-~6 ) o 1.78 [br d, 1 H, H(9), J = 13.0 Hz], 
2.36 
3.16 
[br d, 2 H, H(2,4) , J = 13.0 Hz], 2.59 [m, 3 H, H(1,5) and H(9)], ax 
[dd, 2 H, H(2,4) , J = 12.0, 2.0 Hz], 4.73 [br d, 2 H, H(6,8), J = eq 
3.0 Hz], 7.19-7.70 [m, 10 H, ArH], 8.72 [m, 1 H, H(7) ], 9.67 [m, 1 H, ax 
H(7)eq]; 13c NMR (DMSO-~) ppm 23.5 [C(2,4)], 26.6 [C(9)], 31.2 
[C(1,5)], 61.5 [C(6,8)], 128.5, 128.7, 128.6, 137.0 [C(1 1 )]; 15N NMR 
(DMS0-~6 ) ppm 57.91 [N(7)]; 77se NMR (DMSO-~) ppm 1.16 [Se(3)]. Anal. 
Calcd for c19H22clN04Se: C, 51.54; H, 5.01; N, 3.16; Se, 17.83. Found: 
C, 51.52; H, 4.94; N, 3.34; Se, 17.65. 
6,8-Di(2-thiophene)-3-selena-7-azabicyclo[3.3.1]nonan-9-one (34g) 
A solution of 2-thiophenecarboxaldehyde (1.38 g, 12.3 mmol) and dry 
ammonium acetate (0.94 g, 12.3 mmol) in absolute ethanol (20 mL) was 
heated to boiling in a 50-mL Erlenmeyer flask on a hot plate. To this 
was added a hot solution of freshly sublimed ketone 38 (1.00 g, 6.13 
mmol) in absolute ethanol (15 mL). Boiling was continued for 10 min 
with ethanol being added to keep the volume constant. During this time 
the colorless solution turned yellow. The flask was removed from the 
hot plate, was stoppered, and was allowed to stand at room temperature 
for 3 days. The resulting dark red solution was decanted from the 
yellow solid which had formed during this time. The solid was taken up 
in benzene (100 mL) and was treated with decolorizing carbon. Filtra-
tion followed by evaporation (aspirator) gave a light brown solid which 
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was recrystallized (methanol) to give 0.40 g (18%) of ketone 34g as a 
light yellow solid: mp 155-161°C (dec); IR (KBr) cm-1 3260 (N-H), 1723 
1 (C=O); H NMR (CDC13) o 2.16 [br s, 1 H, H(7)], 2.80 [m, 4 H, H(1,5) and 
H(2,4) ], 3.57 [d, 2 H, H(2,4) , J = 10.03 Hz], 5.32 [d, 2 H, H(6,8), ax eq 
13 J = 3.96 Hz], 6.90-7.40 [m, 6 H, Ar-H]; C NMR (CDC13) ppm 29.3 
[C(2,4)], 54.6 [C(1,5)], 59.1 [C(6,8)], 123.7, 124.8, 126.3 [C(2',3', 
4 1 )], 147.0 [C(1 1 )], 212.5 [C(9)]; 15N NMR (CDC13) ppm 67.09 [N(7)]; 
77se NMR (CDC13) ppm 30.60 [Se(3)]. 
The dark red mother liquor which was decanted earlier was allowed 
to evaporate. The residue was recrystallized (absolute ethanol, decol-
orizing carbon) to give a small amount of enone 47 as a yellow-orange 
solid: 1 mp 138-141°C (dec); H NMR (CDC13) o 2.19 [d, 4 H, H(2,6), J = 
6.0 Hz], 7.14 [dd, 2 H, H(11)], 7.36 [d, 2 H, H(12), J = 4.0 Hz], 7.55 
[d, 2 H, H(7), J = 6.0 Hz], 7.78 [br s, 2 H, H(10)]; 13c NMR (CDC13) ppm 
18.7 [t, C(2,6)], 131.2 [s, C(3,5)], 138.1 [s, C(8,14)], 190.4 [s, C(4)], 
127.3 (d), 128.7 (d), 129.5 (d), 133.0 (d); 77se NMR (CDC13) ppm 200.35 
[Se(3)]. Anal. Calcd. for c15H12os2se: C, 51.28; H, 3.44; S, 18.25; 
Se, 22.47. Found: C, 50.92; H, 3.65; S, 18.40; Se, 22.76. 
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6,8-Di(2-thiophene)-3-selena-7-azabicyclo[3.3.1]nonane (35g) 
Ketone 34g (1.00 g, 2.71 mmol) and anhydrous hydrazine (95%, 1.0 g, 
30 mmol) were dissolved in triethylene glycol (40 mL) which was con-
tained in a 60 mL, two-necked, jacketed flask which was equipped for 
distillation. By boiling water in the jacket, the reaction mixture.was 
heated to 100°C and stirred at this temperature for 2 h. Potassium 
hydroxide (85%, 2.0 g, 30 mmol) was added in one portion and the water 
in the jacket then replaced by xylene which when boiled, brought the 
temperature of the reaction mixture to 140-145°C. Stirring was contin-
ued at this temperature for 5 hours. After cooling to room temperature, 
the reaction mixture was poured into ice-cold water (200 mL) after which 
a precipitated immediately formed. This mixture set aside at room 
temperature overnight and then filtered. The filtrate was taken up in 
boiling benzene and treated with decolorizing carbon. The benzene was 
evaporated (aspirator) and the residue was recrystallized in 95% ethanol 
to give 0.64 g (67%) of 35g as a light tan solid: mp 183-185°C (dec); 
IR (KBr) cm-1 3270 (N-H); 1H NMR (CDC13) o 1.28 [d, 1 H, H(9), J = 13 
Hz], 1.78 [br s, 1 H, H(7)], 2.18 [br s, 2 H, H(1,5)], 2.32 [d, 2 H, 
H(2,4) , J =12Hz], 2.50 [m, 1 H, H(9)], 3.20 [dd, 2 H, H(2,4) , J = ax eq 
13Hz, 2Hz], 4.79 [d, 2 H, H(6,8), J =4Hz], 6.96 [dd, 2 H, ArH], 7.01 
[2 H, d, ArH], 7.21 [d, 2 H, ArH]; 13c NMR (CDC13) ppm 25.0 [C(2,4)], 
25.8 [C(9)], 34.6 [C(1,5)], 57.1 [C(6,8)], 122.2 [C(4')], 122.6 [C(2 1 )], 
126.1 [C(3 1 )], 150.7 [C(1 1 )]; 15N NMR (CDC13) ppm 60.10 [N(7)]; 77se NMR 
(CDC13) ppm 4.05 [Se(3)]. 
6,8-Di(2-thiophe~yl)-3-selena-7-azabicyclo[3.3.1]nonane 
Hydroperchlorate (36g) 
A solution was made of amine J5g (0.5 g, 1.4 mmol) in benzene (200 
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mL) and isopropyl alcohol (10 mL). To this solution was added 60% HCl0
4 
(0.5 g, 3.0 mmol) dropwise slowly causing a white precipitate to form. 
This precipitate quickly became yellow. The solvent was decanted and 
the solid was recrystallized twice (isopropyl alcohol, decolorizing 
carbon) to give 0.4 g (63%) of salt 36g as white needles: mp 285°0 
1 (dec); H NMR (DMSO-~) o 1.78 [d, 1 H, H(9), J =14Hz], 2.36 [d, 2 H, 
H(2,4) , J =14Hz], 2.44 [m, 1 H, H(9)], 2.66 [br s, 2 H, H(1,5)], ax 
3.19 [dd, 2 H, H(2,4) , J =12Hz, 3Hz], 5.07 [m, 2 H, H(6,8)], 7.16 eq 
[dd, 2 H, H(3')], 7.43 [d, 2 H, H(2 1 )], 7.69 [dd, 2 H, H(4 1 )], 9.36 [br 
13 . 
s, 1 H, H(7)], 9.61 [br s, 1 H, H(7)]; C NMR (DMSO-~) ppm 23.5 
[0(2,4)], 26.2 [C(9)], 32.5 [0(1,5)}, 56.1 [0(6,8)], 127.3 [C(2') or 
0(4 1 )], 127.6 [C(4') or 0(2 1 )], 129.2 [0(3 1 )], 138.9 [C(1 1 )]; 15N NMR 
{DMS0-~6) ppm 62.39 [N(?)]; 77se NMR (DMSO~) ppm 5.11 [Se(3)]. Anal. 
Oalcd for o
15
H18c1No4s2se: C, 39.61; H, 3.99; N, 3.08; S, 14.10; Se, 
17.36. Found: C, 39.81; H, 3.97; N, 3.10; S, 14.35; Se, 1?.18. 
6,8-Di(4-chlorophenyl)-3-selena-?-azabicyclo[3.3.1]nonan-9-one (34h) and 
A solution of dry ammonium acetate (0.94 g, 12.3 mmol) and E-
chlorobenzaldehyde (1.73 g, 12.3 mmol) in absolute ethanol (20 mL) was 
heated to boiling in a 50-mL Erlenmeyer flask on a hot plate. To this 
solution was added a boiling solution of freshly sublimed ketone 38 
(1.00 g, 6.13 mmol) in absoute ethanol (15 mL). The combined solutions 
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were boiled for 10 min with ethanol being added to keep the volume 
constant. During this time the colorless solution became light yellow. 
The flask was then removed from the hot plate and stoppered. The reac-
tion mixture was allowed to stand at room temperature for 3 days, during 
which time the solution turned dark redish-brown and a yellow solid 
formed. The liquid was decanted and the solid was dissolved in benzene 
(100 mL). This solution was treated with decolorizing carbon and was 
filtered. Evaporation (aspirator) of the benzene gave a light brown 
solid which was recrystallized (absolute ethanol) giving 0.33 g (13%) of 
ketone 34h as a light tan solid: mp 219-220°C (dec); IR (KBr) cm-1 3280 
1 (N-H), 1722 (C=O); H NMR (CDC13) o 1.70 [br s, 1 H, H(7)], 2.69 [m, 4 
H, H(1,5) and H(2,4) ], 3.56 [d, 2 H, H(2,4) , J = 10.20 Hz], 4.99 [d, ax eq 
13 2 H, H(6,8), J = 4.07 Hz], 7.30-7.40 [m, 8 H, Ar-H]; C NMR (CDC13) ppm 
29.0 [C(2,4)], 53.9 [C(1,5)], 63.4 [C(6,8)], 128.2 [C(2 1 ,6 1 ) or 
C ( 3 I J 5 I ) ) J 1 28 o 8 [ C ( 3 I J 5 I ) Or C ( 2 I J 6 I ) ] J 13 3 o 7 [ C ( 4 I ) ) J 142 o 5 [ C ( 1 I ) ) J 
213.4 [C(9)]; 15N NMR (CDC13) ppm 62.84 [N(7)]; 77se NMR (CDC13) ppm 
26.67 [Se(3)]. 
Addition of water (10 mL) to the original mother liquor caused the 
precipitation of a dense brown solid. After allowing this mixture to 
stand at room temperature overnight, the solid was filtered and recrys-
tallized (ethanol, decolorizing carbon) to give 0.2 g (7%) of 34i (iso-
meric with 34h) as a light tan solid: mp 168-171°C (dec); IR (KBr) cm-1 
1 3315 (N-H), 1710 (C=O); H NMR (CDC13) o 2.68-2.90 [m, 2 H, H(2,4) ], ax 
2.83 [br s, 2 H, H(1,5)], 3.06-3.18 [m, 2 H, H(2,4) ], 4.48 [br s, 2 H, eq 
13 H(6,8)], 7.30-7.60 [m, 8 H, ArH]; C NMR (CDC13) ppm 20.9 [t, C(2,4)], 
51.5 [d, C(1,5)], 63.8 [d, C(6,8)], 127.7 [d, C(2 1 ) or C(3 1 )], 128.8 [d, 
C(3 1 ) or C(2 1 )], 133.4 [s, C(4 1 )], 137.6 [s, C(1 1 )], 212.9 [s, C(9)]; 
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15N NMR (CDC13) ppm 44.24 [N(7)]; 77se NMR (CDC13) ppm 122.66 [Se(3)]. 
6,8-Di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3.1]nonane (35h) 
Ketone 34h (2.00 g, 4.71 mmol), anhydrous hydrazine (95%, 2.0 g, 60 
mmol), and triethylene glycol (35 mL) were placed in a 60-mL, two-
necked, jacketed, round-bottomed flask along with a magnetic stirring 
bar. The contents of the flask were heated to 100°C under a stream of 
nitrogen by boiling water in the jacket of the reaction flask. Stirring 
at this temperature was continued for 3 h after which time potassium 
hydroxide (85%, 5.0 g, 76 mmol) was added in one portion. The reaction 
mixture was then heated to 140-145°C by boiling xylene in the jacket. 
After 4 h at this temperature, the resulting solution was cooled (60-
70°C) and was poured into water (100 mL) which precipitated a cream-
colored solid. This solid was filtered and washed with water. 
Recrystallization (twice, absolute ethanol, decolorizing carbon) gave 
35h as a light tan solid (0.91g, 47%): mp 179-180°C (dec); IR (KBr) cm-1 
3260 (N-H); 1H NMR (CDC13) o 1.30 [d, 1 H, H(7), J =12Hz], 1.74 [br s, 
1 H, H(7)], 2.04 [br s, 2 H, (1,5)], 2.28 [br d, 2 H, H(2,4) , J = 12 ax 
Hz], 2.48 [m, 1 H, H(9)], 3.17 [dd, 2 H, H(2,4) , J =12Hz, 4Hz], eq 
13 4.43 [d, 2 H, H(6,8), J =5Hz], 7.26-7.50 [m, 8 H, ArH]; C NMR 
(CDC13) ppm 25.1 [C(2,4)], 26.9 [C(9)], 33.8 [C(1,5)], 60.9 [C(6,8)], 
127.9, 128.6, 132.6 [C(4')], 145.7 [C(1')]; 15N NMR (CDCL3) ppm 55.37 
[N(7)]; 77se NMR (CDC13) ppm -0.79 [Se(3)]. 
6,8-Di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3.1]nonane 
Hydroperchlorate (36h) 
Amine 35h (1.00 g, 2.43 mmol) was dissolved in ether (200 mL) in a 
500-mL, round-bottomed flask. Perchloric acid (60%, 1.0 g, 6.0 mmol) 
was added slowly with vigorous swirling. The resulting mixture was 
allowed to stand for 24 h with occasional swirling. The yellow-orange 
solid which formed was filtered and recrystallized (twice, absolute 
ethanol, decolorizing carbon) to give 36h as a white powder (0.46 g, 
37%): mp 272-274°C (dec); 1H NMR (DMSO-~) o 1.77 [d, 1 H, H(9), J = 
12.9 Hz], 2.36 [d, 2 H, H(2,4) , J = 10.8 Hz], 2.53 [m, 2 H, H(1,5)], ax 
3.14 [d, 2 H, H(2,4) , J = 10.5 Hz], 3.38 [br s, 1 H, H(9)], 4.76 [br eq 
s, 2 H, H(6,8)], 7.50-7.75 [m, 8 H, ArH], 8.77 [br s, 1 H, H(7)], 9.59 
[br s, 1 H, H(7)]; 13c NMR (DMSO-~) ppm 23.5 [C(2,4)], 26.5 [C(9)], 
31.1 [C(1,5)], 60.6 [C(6,8)], 128.5, 130.9, 133.8 [C(4 1 )], 136.1 [C(1 1 )]; 
15 N NMR (DMSO-~) ppm 57.67 [N(7)]; 77se NMR (DMSO-~) ppm 2.25 
[Se(3)]. Anal. Calcd. for c19H20cl3No4se: C, 44.60; H, 3.94; N, 2.47; 
Se, 15.43. Found: C, 44.53; H, 3.84; N, 2.74; Se, 14.90. 
6,8-Di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3.1]nonane (35i) 
Ketone 34i (2.00 g, 4.71 mmol), anhydrous hydrazine (95%, 2.0 g, 60 
mmol), and triethylene glycol (35 mL) were placed in a 60-mL, two-
necked, jacketed, round-bottomed flask along with a magnetic stirring 
bar. This mixture was heated to 100°C by boiling water in the jacket of 
the reaction flask. Stirring at this temperature under a stream of 
nitrogen was continued for 2 h at which time potassium hydroxide (85%, 
5.0 g, 76 mmol) was added. The temperature of the resulting mixture was 
increased to 140-145°C by boiling xylene in the jacket of the reaction 
flask. After stirring at this temperature for 3 h, the resulting solu-
tion was cooled (60-70°C) and was poured into water (100 mL). This 
precipitated a light yellow solid which was filtered and washed with 
water. This solid was recrystallized (absolute ethanol, decolorizing 
carbon) to give 35i as a white powder (1.14 g, 59%): mp 163-165°C 
(dec); IR (KBr) cm-1 3290 (N-H); 1H NMR (CDC13) o 2.04 [br s, 2 H, 
H(1,5)], 2.18 [d, 1 H, H(9), J =14Hz], 2.25 [d, 2 H, H(2,4) , J = 12 ax 
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Hz], 2.36 [d, 1 H, H(9), J =13Hz], 2.59 [br s, 1 H, H(7)], 3.04 [dd, 2 
H, H(2,4) , J =12Hz, 4Hz], 4.50 [d, 2 H, H(6,8), J =3Hz], 7.32-eq 
7.52 [m, 8 H, ArH]; 13c NMR (CDC13) ppm 17.7 [C(2,4)], 30.4 [C(1,5)], 
35.0 [C(9)], 64.0 [C(6,8)], 127.9, 128.5, 132.6 [C(4')], 141.1 [C(1 1 )]; 
15N NMR (CDC13) ppm 50.52 [N(7)]; 77se NMR (CDC13) ppm 101.86 [Se(3)]. 
6,8-Di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3.1]nonane 
Hydroperchlorate (36i) 
Amine 35i (1.00 g, 2.43 mmol) was dissolved in ether (200 mL) in a 
500-mL, round-bottomed flask. Perchloric acid (60%, 1.0 g, 6.0 mmol) 
was added slowly with swirling. The resulting mixture was allowed to 
stand at room temperature for 24 h with occasional swirling. The orange 
solid which formed was filtered and recrystallized (absolute ethanol, 
decolorizing carbon) to give 36i (0.36 g, 29%) as white needles: mp 
264-265°C (dec); 1H NMR (DMS0-£6) o 2.16 [d, 1 H, H(9), J = 12.1 Hz], 
2.29 [d, 2 H, H(2,4) , J = 12.7 Hz], 2.50 [m, 3 H, H(1,5), H(9)], 3.13 ax 
[d, 2 H, H(2,4) , J = 12.3 Hz], 5.07 [d, 2 H, H(6,8), J = 8.5 Hz], eq 
7.58-7.90 [m, 8 H, ArH], 9.18 [br s, 1 H, H(7)], 10.46 [br s, 1 H, H(7)]; 
13c NMR (DMSO-~) ppm 17.7 [C(2,4)], 29.7 [C(1,5)], 32.0 [C(9)], 63.7 
[C(6,8)], 128.6, 128.9, 133.2 [C(4')], 134.5 [C(1 1 )]; 15N NMR (DMS0-£6) 
ppm 49.57 [N(7)]; 77se NMR (DMSO-~) ppm 74.96 [Se(3)]. Anal. Calcd. 
for c19H20cl3No4se.C2H50H: C, 45.22; H, 4.70; N, 2.51; Se, 14.16. 
Found: C, 44-93; H, 4.39; N, 2.58; Se, 14.43. 
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Diethyl Diselenide (48) 
Ammonia (500 mL) was condensed into a 1-1, round-bottomed, three-
necked flask which was equipped with a gas inlet and a dry ice/acetone 
condenser. Freshly cut sodium metal (8.0 gat., 348 mmol) was added to 
the ammonia in small pieces over 30 min to give a very dark blue solu-
tion. After 30 min, selenium metal (27.7 gat., 350 mmol) was then 
added slowly in 5 g portions over 1 h. During this addition, the dark 
blue color of the sodium solution turned progressively to purple, light 
pink, light brown, and finally very dark green. This green solution was 
stirred for an additional hour. Ethyl bromide (90 g, 830 mmol) was 
added dropwise over 1 h. The ammonia was allowed to boil away overnight 
and the residue was taken up in ether (350 mL). The ether was then 
washed with water (50 mL) and dried (K2co3). Evaporation (aspirator) 
and distillation of the residue gave 36.0 g (48%) of the diselenide 48 
as an orange oil: bp 60-70°C/5 mm Hg (lit. 19 75°C/14 mm Hg); 1H NMR 
(CDC13) o 1.46 [t, 6 H, C(2), J = 7.46 Hz], 2.90 [q, 4 H, C(1), J = 7.43 
Hz]; 13c NMR (CDC13) ppm 16.4 [q, C(2)], 23.0 [t, C(1)]. 
3-Selenavaleric Acid (49) 
A solution of diethyl diselenide (48, 25.0 g, 115 mmol) in 95% 
ethanol (35 mL) was placed in a 250-mL, three-necked, round-bottomed 
flask equipped with magnetic stirring, a reflux condenser and two addi-
tion funnels, one carrying a nitrogen inlet. A solution of NaOH (5~0 g, 
217 mmol) and NaBH4 (10.0 g, 265 mmol) in wat~r (80 mL) was added 
dropwise. The resulting solution was heated to boiling and was stirred 
at reflux until the orange color disappeared (1 h). After cooling this 
colorless solution to 0°C in an ice bath, a solution of ClCH2co2H (21.8 
g, 229 mmol) and Na2co3 (12.2 g, 114 mmol) in water (75 mL) was added 
dropwise. After stirring at room temperature for 18 h, the reaction 
mixture cooled to 0°C and was acidified with cone HCl (40 mL) and was 
extracted with ether (4 X 50 mL). The combined extracts were washed 
1~ 
with water (50 mL) and dried (Na2so4). Evaporation (aspirator) of the 
ether gave a light yellow oil and a white solid. The solid was filtered 
and the oil was distilled to give acid 49 (29.2 g, 76%) as a light 
yellow oil: bp 89-94°C/1.0 mm Hg (lit13 bp 85-86°C/0.6 mm Hg); 1H NMR 
(CDC13) o 1.43 [t, 3 H, H(5), J = 7.51 Hz], 2.80 [q, 2 H, H(4), J = 7.49 
Hz], 3.19 [s, 2 H, H(2)], 11.77 [s, 1 H, C02H]; 13c NMR (CDC13) ppm 15.1 
[C(5)), 19.3 [C(4)), 21.4 [C(2)), 178.5 [C(1)); 77se NMR (CDC13) ppm 
96.29 [Se(3)). 
3-Selenavaleryl Chloride (50) 
A 25-mL, two-necked, conical flask which was equipped with magnetic 
stirring and a condenser, was charged with oxalyl chloride (7.30 g, 56.7 
mmol). Acid 49 (4.75 g, 28.3 mmol) was added cautiously with cooling. Once 
the initial, vigorous reaction had subsided, the solution was heated to 
reflux and stirred at this temperature for 4 h. The reaction flask was 
then equipped for vacuum distillation and the excess oxalyl chloride was 
distilled under aspirator vacuum. The residual oil was then distilled 
under high vacuum to give 4.0 g (76%) of acid chloride 50 as a light 
yellow oil: bp. 25-33°C/0.25 mm Hg (lit. 13 75-76°C/15 mm Hg); 1H NMR 
(CDC13) o 1.44 [t, 3 H, H(5), J =6Hz), 2.83 [q, 2 H, H(4), J =6Hz], 
13 . 
3.64 [s, 2 H, H(2)]; C NMR (CDC13) ppm 14.9 [C(5)], 19.7 [C(4)], 33.1 
[C(2)), 169.8 [C(1)]; 77se NMR (CDC13) ppm 5.06 [Se(3)]. 
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3-Selenavalero-o-xylidide (51) 
Acid chloride 50 (4.00 g, 21.6 mmol) was dissolved in anhydrous 
ether (70 mL) in a 250-mL Erlenmeyer flask. This solution was cooled to 
ooc in an ice bath and 2,6-dimethylaniline (5.30 g, 43.8 mmol) was added 
dropwise very slowly with swirling. A dense white precipitate formed 
immediately. This mixture was allowed to stand at room temperature with 
occasional stirring for 1 h. The solid 2,6-dimethylaniline 
hydrochloride was filtered and ice-water (100 mL) was cautiously. The 
layers were separated and the aqueous layer was extracted with ether (2 
x 75 mL). The combined ether portions were dried (K2co3) and evaporated 
(aspirator) to give a 4.12 g (71%) of amide 51 as white needles: mp 
93.0-94.0°C; 1H NMR (CDC13) o 1.38 [t, 3 H, H(5), J = 7.5 Hz], 2.13 [s, 
6 H, ArCH3J, 2.70 [q, 2 H, H(4), J = 7.5 Hz], 3.28 [s, 2 H, H(2)], 6.97 
[m, 3 H, ArH], 7.90 [br s, 1 H, N-H]; 13c NMR (CDC13) ppm 15.3 [C(5)], 
18.3 [ArCH3 J, 19.2 [C(4)], 25.5 [C(2)], 127.2 [C(4')], 128.1 [C(3',5')], 
133.6 [C(2',6 1 )], 135.2 [C(1 ')], 168.2 [C(1)]. Anal. Calcd for 
c12H17NOSe: C, 53.31; H, 6.34; N, 5.19; Se, 29.23. Found: C, 53.06; 
H, 6.45; N, 5.10; Se, 29.44· 
3-Selenavalero-o-xylidide Dichloride (39) 
A solution of amide 51 (0.5 g, 1.80 mmol) in anhydrous ether (100 
mL) was placed in a 250-mL Erlenmeyer flask. Chlorine gas was bubbled 
through the solution. This immediately precipitated a white solid. 
Bubbling was continued until no more solid formed. The solid was fil-
tered to give 0.48 g (78%) of dichloride 39 as a white crystalline 
solid: mp 142.0-143.0°C (dec); 1H NMR (CDC13) o 1.74 [t, 3 H, H(5)], 
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2.50 [s, 6 H, ArCH3 J, 3.98 [q, 2 H, H(4)], 4.36 [br s, 2 H, H(2)], 7.40 
[m, 3 H, ArH], 9.98 [br s, 1 H, N-H]; 13c NMR (CDC13) ppm 10.2 [C(5)], 
18.3 [ArCH3 J, 53.9 [C(4)], 62.8 [C(2)], 126.8 [C(4')], 127.7 [C(3',5')], 
133.9 (C(1 1 )], 134.9 [C(2 1 ,6 1 )], 161.9 [C(1)]; 77se NMR (CDC13) ppm 
590.06 [Se(3)]. Anal. Calcd for c12H17cl2NOSe: C, 42.22; H, 5.02; N, 
4.11; Cl, 20.79; Se, 23.15. Found: C, 42.26; H, 4.96; N, 4.06; Cl, 
20.68; Se, 22.99. 
Experimental for X-ray Data Collection for 4-Selenanone (38) 
Experimental parameters for the study of 4-selenanone (38) are 
found in Table XVIII. A single crystal of 4-selenanone (38, 0.2 x 0.2 x 
0.4 mm) was sealed in a capillary and mounted on a Syntex P3 automated 
diffractometer. Unit cell dimensions (Table XVIII) were determined by 
least squares refinement of the best angular position for fifteen inde-
pendent reflections (28>15°) during normal allignment procedures using 
0 
molybdenum radiation (A.= 0.71069 A). Data (2339 points) were collected 
at room temperature using a variable scan rate, a 8-28 scan mode and a 
scan width of 1.2° below Ka., and 1.2° above K~ to a maximum 28 value of 
116°. Backgrounds were measured at each side of the scan for a combined 
time equal to the total scan time. The intensities of three standard 
reflections were remeasured after every 97 reflections and as the inten-
sities of these reflections showed less than 8% variation, corrections 
for decomposition were deemed unnecessary. Data were corrected for 
Lorentz, polarization and background effects. After removal of redun-
dant and space group forbidden data, 812 reflections were considered 
observed [I>3.0a(I)]. The structure was solved from a Patterson synthe-
sis to locate the heavy atom. Successive least squares/ difference 
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Fourier cycles allowed location of the remainder of the non- hydrogen 
atoms. Refinement of scale factor, positional and anisotropic thermal 
108 parameters for all non-hydrogen atoms was carried out to convergence. 
Hydrogen positional parameters were determined from a difference Fourier 
synthesis. These hydrogen positional parameters and the associated 
isotropic thermal parameters were refined along with non-hydrogen para-
meters in the final cycles of refinement. The final cycle of refinement 
[function minimized L(IF I- IF 1) 2 ] led to a final agreement factor, R 
0 c 
= 8.1% [R = (LI IF I- IF II/IF I) x 100]. Anomalous dispersion correc-o c 0 
tions were made for selenium. Scattering factors were taken from Cromer 
and Mann. 30 Unit weights were used throughout. 
Experimental for X-ray Data Collection for 7-Benzyl-3-Selena-7-aza-
bicyclo[3.3.1]nonan-9-one (34a) 
A crystal of 7-benzyl-3-selena-7-azabicyclo[3.3.1]nonan-9-one (34a) 
was sealed in a capillary and mounted on a Syntex P3 automated diffrac-
tometer. Unit cell dimensions (Table XXII) were determined by least 
squares refinement of the best angular positions for fifteen independent 
reflections (26>15°) during normal allignment procedures using molybde-
num radiation (A= 0.71069 A). Data (7756 points) were collected at 
room temperature using a variable scale rate, a 6-26 scan mode and a 
scan width of 1.2° below K~ and 1.2° above Ka2 to a maximum 26 value of 
90.6°. Backgrounds were measured at each side of the scan for a com-
bined time equal to the total scan time. The intensities of three 
standard reflections were remeasured after every 97 reflections and as 
the intensities of these reflections showed less than 6% variation, 
corrections for decomposition were deemed unnecessary. Data were 
corrected for Lorentz, polarization and background effects. After re-
moval of redundent data, 2207 points were considered observed [I>3.0 cr 
(I)]. The structure was solved using MULTAN8o. 70 Refinement of scale 
factor, positional and anisotropic thermal parameters for all non-
hydrogen atoms was carried out to convergence. Hydrogen atom positions 
were determined from a difference Fourier synthesis. These positions 
were included in the final cycles of refinement but were held invari-
t 108 an • The final cycle of refinement [function minimized I( IF I-
0 
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IF0 I) x 100]. Anomalous dispersion corrections were made for selenium. 
Scattering factors were taken from Cromer and Mann. 30 Unit weights were 
used until the final cycles of refinement when a weight = 1/crF was 
introduced. 
Experimental for X-ray Data Collection for 7-Benzyl-3-Selena-7-aza-
bicyclo[3.3.1]nonane Hydroperchlorate (36a) 
Preliminary investigations indicated that the crystal system of 36a 
was orthorhombic. Observations of reflection conditions (hOO: h=2n, 
OkO: k=2n, 001: 1=2n) uniquely determined the space group P212121 • 
Unit cell dimensions were refined by a least-squares fit of the + 28 
values of 36 reflections distributed throughout reciprocal space (Table 
XXVI). Lattice parameter and intensity data were collected on an Enraf 
Nonius CAD-4 automatic X-ray diffractometer fitted with a liquid N2 low 
temperature device, using Molybdenum K radiation (A= 0.71069 A). A 8-
28 scan technique was employed using variable scan width and variable 
scan speed. Maximum scan time for a reflection was 90 seconds with two-
thirds of the time spent on the reflection; the remaining time was 
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divided equally between the high and low backgrounds. The receiving 
aperature, which had a variable width of (4.0 + 0.868) mm and a constant 
height of 5 mm, was located 173 mm from the crystal. The intensities of 
three reflections, remeasured after every 200 reflections showed no 
significant variation during the time of data collection. 
The position of the selenium atom was determined by a Patterson 
synthesis. The rest of the structure was determined by difference 
Fourier syntheses and refined by a full matrix least squares routing 
using anisotropic thermal parameters for the non-hydrogen atoms. 105 All 
of the hydrogen atoms were located from a difference Fourier map and 
were refined isotropically. Scattering factors were obtained from 
"International Tables for X-ray Crystallography 11 • 58 The refinement 
converged to a final R = (EI IFoi-IFcl I/ I Fol) of 0.0552 for 1766 observed 
reflections. An analysis of the variance after refinement of the data 
revealed no systematic variance of EwiFol -IFcl with either sine or F. 
Experimental for X-ray Data Collection for 3-Selenavalero-o-xylidide 
Dichloride (39) 
A crystal with approximate dimensions of 0.08 x 0.09 x 0.31mm was 
used for data collection. The crystal data are given in Table XXX. The 
reflections were measured on a Nonius CAD-4 automatic diffractometer 
with liquid N2 device using MoKa radiation (A = O. 71069 A). The e -41 
scan technique was used, maximum scan time per reflection was 60 s with 
2/3 of the time spent scanning the peak and the remaining 1/3 divided 
dqually between the high and low e backgrounds. 
The position of the Se atom was determined using a Patterson syn-
thesis with the y coordinate arbitrarily assigned. Positions of other 
atoms including all of the hydrogen atoms were determined by difference 
Fourier syntheses and subsequently refined with anisotropical thermal 
parameters (except the hydrogens which were kept isotropic) by full 
matrix least-squares with the SHELX program. The final difference-
Fourier map had a maximum density of 0.52 e A-3 close to the Se-atom. 
The final R factor was 0.038. The space group is polar and the centro-
symmetrically related coordinates refined to a larger R-value (0.042). 
Scattering factor for Se atom was taken from the International Tables 
for X-ray Crystallography.58 
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lH NMR SPECTRUM OF 34a 
100 80 60 
I I -. 
lLJ '--" 
~ .. 3 I I 
SF: 299.94 MHz; we: 2999.4Hz; 
Size: 12 K; PW/RF: 8 lJS/dB; TO: 0 Hz; FB: Hz; 
nc: Y,Ji; Gated Off:A or D • • DO: Hz; RF(Power): l-1/dB; 
20 
I I I 
2 l 0 111 
j I I 
T: 25 oc; NT: 16 
Lock: 2D ; Dl.D5: 0.500 s . 
NBW: liz; LB: Hz. ...... 
l_.,j ..... 
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PFT X CW Solvent: CIX::l3 SF: 25.2 MHz; wc:6ooo Hz; T: 28 oc; NT: 3924 
Size: 8 K; PW/RF: 10 J.IS/dB; T0:35101 Hz; FB: 3 K Hz; Lock: 
2D Dl,DS : 5 s. 
DC:~ N Gated Off: A D • DO: 45316 Hz; RF(Power): 7. 5 W/dB; NBW: 
Hz; LB: Hz. -> or ' 
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N 
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PLATE IV . OFF RESONANCE 
13c NMR SPECTRUM OF 34a 
l ifO 120 100 80 60 ItO 20 
PFT X CW Solvent: CDC13 SF: 
25 . 2 MHz; we: 6000 Hz; T: 28 oc; NT: 4000 
Size: 8 K· PW/RF: 10 liS/dB; TO: 35101 Hz; FB: 3 K Hz; Lock: 
2D Dl ,DS : 5 s . , 
DC : Y, N ; Gated Off: A or D; DO: 46316 Hz; RF(Power) : 7. 5 W/dB; NBW: 
Hz; LB : Hz. \JJ 
\JJ 
PLATE V. lSN NMR SPECTRUM OF 34a 






ppm g 8 7 6 s 
PFT X CW Solvent: CDClJ SF: JO • 4 06 MHz; WC:J040. 6 Hz; T: 25 °C; NT: 72 , 000 
Size: 121<; PW/RF: 40 ~s/dB; TO: - 11600 Hz; FB: Uz; Lockl 
2n ; Dl,DS: 8 . 00 s • 
DC: Y, .N.; Gated Otf:A or D; J>O: Hz; RF(Power); Hz; LB: Hz. 
160 l itO 
PLATE VI. 
120 
77se NMR SPECTRUM OF 34a 
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PFT X CW Solvent:CDC13 SF:.57 . 22 MHz ; l-JC: 28610 Hz; T: 25 oc; NT: 160 
Size: 32 K; PW/RF: 35 ~s/dB; TO: 500 Hz; FB: liz; Lock: 
2D Dl ,D5 : 25 s. 
DC: Y, N Gated Off: A or D; DO: 0 Uz; RF(Power):20 





., r· .· .) ..... . 
'1 Of · 
: I 
















H NMR SPECTRUM OF 34b 









ppm 9 8 7 6 s It 3 2 0 1" 
PFT X CW So-lvent: COOlJ SF: 299.94 MHz; WC: JOOO Hz; T· . 2.5 oc; NT: 16 
Size: 12K; PW/RF: 5 JJs/dB; TO: 0 Hz; FB: liz; Lock.: 2D ; Dl,D5: 0 s • 
DC: Y, .J!..; Gated Off:A or D ; DO: Hz; RF(Power): W/dB; NBW: Hz; LB: Hz. 
w 
-...J 
500 0 . 
2500 
10 0 0 
500 
pp~ 
PF'J' X. CW _ : 
Size: 8 K· • 
DC : y, N ; 
PLATE IX. 
12 0 
13 C NMR SPECTRUM OF 34b 
160 I '<0 100 80 GO 
8 7 
Solvent: COOl) SF: 25 . 2 MHz ; we: 6000 Hz; 
PW/RF: 10 ~s/dB; TO: 35101 Hz; FB: )K Hz; 
Gated Off:A or D ; DO: 45Jt6 liz; RF(Power): 7·5 l..J/dB; 
20 
T: 28 OC; NT: )000 
Lock: 2D ;Dl , D5 : 5 s • 









Size : 10 K; 
DC : Y, N_; 
PLATE X. 
12 0 
lSN NMR SPECTRUM OF 34b 
140 100 80 60 
8 7 6 5 
Solvent: COC13 
SF: J0 , 406 MHz; we: J04o . 6Hz ; 
PW/RF: 40 .0 ~s/dB; TO: -11600 Hz: FB: Hz; 
Gated Off:A or D ; DO: Hz; RF(Power): ll/dB; 
ItO 
T: 25 °C; NT: 5600 
Lock: 2D ; Dl,D5: 8 s . 












100 160 1 40 



































)2 K; PW/RF: .35 JJS/dB; TO: 500 Hz; FB: Hz; 


































PLATE XII . IR SPECTRUM OF 34c 
s 6 7 a 



















ppm ~ 8 I 
PFT X CW Solvent: 
Size: 12 K; ·pw/RF: 5 
DC: N . Gated Off: , 
PLATE XIII. 1u NMR SPECTRUM OF 34c 
1110 12 0 100 80 so ItO 20 









7 ~ 5 
.. 3 2. ) o 18 
I I I I _j I I 
CDClJ SF: 299.94 MHz; WC:)OOO Hz; T: 25 oc; NT: 12 
J.IS/dB; so: 0 Hz; FB: Hz; Lock: 2D Delay: 0.500 s. 













PFT X CW 











C NMR SPECTRUM OF 34c 
litO 12 0 100 80 60 




r 6 -~ It 3 I I I 
COClJ SF: 2_5 .2 MHz; WC: 6000 Hz; 
tJs/dB; SO: 3_5101 Hz; FB: JK Hz; 
Offset: 4_'5)16 Hz ; RF: 7·5 W/dB; 
ItO 20 
' I I 
- il ! - ~- ..... ~ o lH I 
T: 28 oc; NT : 1)98 
Lock: 2D Delay : 5 8 • 







ppm g a 
PFT X CW Solvent: 
Size: 8 K; ·pw/RF: 




OFF RESONANCE C NMR SPECTRUM QF 34c 
12D 100 80 60 
7 
CDCl) SF: 25.2 MHz; we: 6000 Hz; T: 
7.5 }Js/dB; SO: 35101 Hz; FB: )K Hz; Lock: 
Offset: 45316 Hz; RF: 7•5W/dB; NBW: 
ItO 20 
28 OC; NT: )000 






































JJs/ dB I 
!! Gated Off:A or D ; DO: 
12 0 10 0 80 
I J 
































; Dl , D5 : 8 






























Se NMR SPECTRUM OF 34c. 


























































.. . :1 ·I ,., -.-






' I : ; I :.;:; I 
~i 
I ' . ! 
.4". 1 ·10 ; I 
"'L I 
n' I 
f- . ' 





0.:!. : . ·-
4000 
PLATE XIX. lH NMR SPECTRUM OF 34d 
5000 
• 














PFT X C,-1 Sol vent: C I:X::lJ SF: 299 • 94 MHz; WC: JOOO 
Size: 12 K; Pl-1/RF: .5 }.Is/dB; TO: 0 Hz; FB: 
DC: Y, !! ; Gated Off:A or D ; DO: Hz; RF(Power): 
60 20 
Hz; T: 25 oC; NT: 12 
liz; Lock: 
2
D ; Dl,DS: 0 






















DC: ...L. N ; 











C NMR SPECTRUM OF 34d 
100 80 60 






L \J \.u._ 
5 14 3 
I I I 
SF: 25.2 MHz; WC: 6000 Hz; T: 28 
PW/RF: 14 JJS/dB; TO: 35101 Hz; FB: JK Hz; Lock: 
Gated Off:A or D ; DO: 45)16 Hz; Rio' (Power) : 7 ·~/dB; NBW: 
20 
I I I 
_, "-J \.. .l 
2 1 G IH 
I I I 
oc; NT: 8600 
20 ; Dl,D5: 6 s. 
Hz; LB: Hz, ..... .,.... 
-D 
5000 
' 250 0 . 
1000 
ppm 
PFT X CW 
Si.ze: 12 K; 
DC: Y, JL_; 
15 
N NMR SPECTRUM OF 34d 
1 ~0 
PLATE XXI. 
120 100 80 60 
7 
Solvent: CDC1.3 SF: J0.406 Mlfz; we: )040. CHz; 
P'W/RF: 40 JJS/dB; TO: -11600 Hz; FB: Hz; 
Gated Off:A or D • 
' DO: Hz; RF(Power); W/dB; 
20 
T: 2.5 oc; NT: 10000 
Lock; 2D ; Dl,D5: 8 s • 












160 litO 12 0 





PFT ~ CW 
Size: 32 












PW/RF: 35 lJs/dB; 






100 80 60 







57.22 Mllz; we: 28610 Hz; 
.500 liz; FB: lb:; 
































180 )60 l lfO 120 





ppm • 9 
a 7 6 
I I I I 
PFT X Cl.J Solvent: COC13 
SF: 
Size: 12K; PW/RF: 5 )..Is/dB; TO: 
DC: Y ,.....tL; Gated Off:A or D ; DO: 
100 80 GO 
I I I I 
~ 1 W\..... ' -
5 .. 3 2 
I I I I 
299.94 MHz; 'WC: 3000 Hz; T• . 25 
0 Hz; FB: Hz; Lock; 










1 o 111 
~- I I 
oc; NT: 16 
2D ; Dl,DS: 0 s. 
Hz; LB: Hz, ..... 
"' \.rJ 
PLATE XXV. 
13c NMR SPECTRUM OF 34e 
ppm 190 160 1-.o 120 100 eo &o loO 20 
I I ' I T ' I I I I I 5000 
I 
250 0 0 
I 




J ~ ..,...., - .J 
ppm 9 8 
7 6 5 lj 3 2 1 o 111 
I . I I I I I I I I I I 
PFT X CW Solvent: COClJ SF: 25.2 MHz; we: 6000 Hz; T· 28 oc; NT: 6000 . 
Size: 8 K; PW/RF: 14 llS/dB; T0:35101 Hz~ FD: )K Hz; Lock: 2D ;Dl,D5: 6 s • 
oc:x., N Gated Off:A or D ; DO: 45316 Hz; RF(Power): ? • 5u/dR; NBW: Hz; LB: Hz, ..... 
"" .p.. 
15 















PFT X CW 




























60 loD 20 
T I 









SF: J0.406 MHz; we: 3 040 , 6 Hz ; T: 25 oc; NT: 
TO: -11600 Hz; Fn: Hz; 
2 
Locks D ;Dl,D5: 






























Size: 32 K; PW/RF: 35 
























































PLATE XXVIII. IR SPECTRUM OF 34£ 
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PFT ! CW 
Size: 12 K; 




PLATE XXIX . 
12'0 
1 
SF: 299 .94 
Pt~/RF: 5 }Js/dB~ TO: 0 
Gated Off:A or D ; DO: Hz; 
H NMR SPECTRUM 'OF 34f 
100 80 60 40 20 
MHz; we: 3000 Hz• . J T• • 25 •c; NT: 24 
Hz; FB: Hz; Locka 2D ; Dl 1D5: 0 s • 






13c NMR SPECTRUM OF 34f 
100 eo 60 20 








PFT X CW Sal vent: coc13 SF: 
25 . 2 MHz; we: 6000 Hz; T: 28 oc; NT: 928 
Size: 8 K; PH/RF: 10 }.Is/dB; TO: 35101 Hz; FB: 3K 
Hz; Lock: 2D ;Dl,D5: 5 s • 
DC: y, N ; Gated Off:A or D • DO: 45316 Hz; RF(Power): 7 • 5 · H/dB; NBW: Hz; LB: 
Hz. 
' IJl ~ 
PLATE XXXI. 
15
N NMR SPECTRUM OF 34f 








ppm 9 8 7 6 
PFTX CW Solvent: CDClJ ; sr:J0.4o6 MHz; 'WC: 3040. 6Hz; T· . 25 oc; N'f: 15800 
Stze: 12K; PW/RF: 40 JlS/dB; TO: -11600 Hz; FB: liz; 
2 
Lock: D ;ol.o5: 8 s • 
DC:_!, N ; Gated Off:A or D ; DO: 0 Hz; RF (Power) : 0 1l/dB; NBW: Hz; LB: liz. 
PLATE XXXII. 
77 Se NMR SPECTRUM OF 34f 








ppm 9 B 7 6 5 
PFt.X CW Solvent: CIX.!l) SF: 57.22 MHz; we: 28610 Hz; T• 2.5 . 
2 
Size: )2 K; Pl~/RF: 35 lJS/dB; TO: 500 Hz; FB: Hz; Lock: D 
°C; NT: 1000 
; Dl.D5: 15 s • 




:: rf Of 
. ·I. . 
,I ; .. 
• i ,, 
~ : .. 
:: 
::1 no 
PLATE XXXIV. lH NMR SPECTRUM OF 34g 
ppm 180 160 
I I 
litO 120 100 80 60 20 




ppm 8 7 6 5 
PFT X CW Solvent: CDC13 SF: 
299.94 MHz; WC: 3000 Hz; T• 25 oc; NT: 16 . 
Size: 12 l<: PW/RFc 5 tJB/d.8; TO: 0 Hz; FD: Hz; Lock; 2D ;Dl,D5:0 s • 




13c NMR SPECTRUM OF 34q 
ppm 
f 







PFT X CW Solvent: CDClJ SF: 25.2 MHz; HC: 6000 Hz; T: 28 oc; NT: 1740 
Size: 8 K; PW/RF: 10 }.Is/dB; TO: 35101 Hz; FB: Uz; Lock: 2D ; Dl,D5: 5 s . 





N NMR SPECTRUM OF 34q 








ppm II 5 .. 
PFTX cw Solvent: CDClJ SF: )0.40p MHz; we: J04o. 6Hz; T: 25 •c; NT: 6200 
Size: 12 K; PW/RF: 40 ps/dB; TO: -11600 HJ; FDl Hz; Luck I 2D ; Dl,D.S: 8 s . 





Se NMR SPECTRUM OF 34g 







PFT X cw Solvent: CDClJ SF.: 57.22 MH~; WC::I 28610 H:oo:; T: 25 "C; NT; 176 
Size: 32 I<; PW/RFI 35 lJS/dB; TO: 500 Ill; FB: lhq Locka 
2D ; Dl,D5: 18 s. 








.... ( r; 
..:"! 
(/) 







I I I 
I i 
6(. ' I I ! 
I 




'i : J 40 
j i ! i 
i : I 
I i 
1i( ~ 









PFTx_ CW _ ; 
Size: 12 l<i 
oc: Y., tt• 
H iD lifO 
8 7 
PLATE XXXIX . 
120 
6 
l H NMR S PECTRUM OF 34h 
IDO eo 60 
0 
s 
Solvent : CDClJ SF: 299. 94 Mllz; WC: JOOO Hz; T: 25 
PW/RF r 5 )Js/dB; TO: 0 Hz; FB: Hz; Lock: 
Gated Off;A o~ D ; DO: Hz; RF(Power): U/dB; NBW: 
ItO 20 
Cl 
oc; NT: 16 
2D ; Dl, DS : 0 s . 




PLATE XL. C NMR SPECTRUM OF 34h 
500 I) 





PFTX cw Solvent: CDClJ SF: 25.2 MHz; l<IC: 6000 Hz; T: 28 oc; NT: 1000 
35101 
2 5 Size: 8 K; Pl<1/RF: 10 J..ls/dB; TO: Hz; FB: Hz; Lock: D ;Dl.D5: s . 
DC: _L. N ; Gated Off: A or D ; DO: 45316 Hz; RF(Power): 7 • 5 U/dB; NBW: Hz; LB: Uz. 
PLATE XLI. lSN NMR SPECTRUM OF 34h 
160 ) '10 120 100 8() 611 20 






ppm 8 7 6 5 
PFT X CW Solvent: CDClJ SF: 30.406 MHz; WC:J040. 6 Hz; T• 25 oc; NT: 6000 . 
She: 12K; JlW/RF: 40 lJS/dB; TO: -1160Glz; FB: Hz; Lock: 
2D ;Dl,D5:8 s. 
nc: Y, J!_; Gated Off:A or D ; 1)0: Hz; RF(Power): 1-1/dB; NBW: Hz; LB: Hz. 
77 
PLATE XLII. Se NMR SPECTRUM OF 34h 




250 0 0 . 
1000 
50 0 
ppm 8 7 
PFTX cw Solvent: CDClJ SF: 57.22 MHz; WC:28610 Hz; T: 25 oc; NT: 100 
Size: )2 K; PW/RF: 35 j.ls/dB; ro: .sao Hz; FB: liz; Lock: 2D ; Dl,D5: 18 s • 




H NMR SPECTRUM OF 34i 
160 1110 120 100 eo Go 2D 
500 0 





ppm 9 8 7 
PFTX cw Solvent: CI.Xa3 SF: 
299.94 MHz; WC:)OOO Hz; T: 25 "C; NT: 8 
Size: 12 K; Pl~/RF: 5 }.Is/dB; TO: 0 Hz; FB: Hz; Lock: 
2o ;Dl,D5: 0 s • 
DC: Y, N • Gated Off:A or D ; DO: Hz; RF(Power): l-1/dB; NBW: Hz; LB: Hz. -. ---' -.J w 
PLATE XLV. 
13c NMR SPECTRUM OF 34i 








ppm 9 8 7 6 5 
3 2 
PFT X C'W SF: 25 . 2 MHz ; we: 6000 Hz; T: 28 ac; NT: 1000 
Size: 8 K; PH/RJ:.' : 10 lJs/dB; TO:J5101 Hz; FB: liz; Lock: 2D ;Dl,D5: 5 9 • 
RF(Power): 7·5U/dB; NB'W: liz; LB : Hz . ..... 
-..J 






PF;r ~ Ct-1 
Size : 8 K; 








Gated Off : A or D ; DO: 
OFF RESONANCE 
13c NMR SPECTRUM OF 34i 
120 100 60 60 40 20 
0 
SF: 25 . 2 HHz; WC: 6000 Hz; T: 28 OC; NT: 1.000 
TO: J51 01 Hz; FB: Hz; Lock: 
2D ; Dl, DS: 5 s • 













DC: Y ,.Ji_ ; 
PLATE XLVII . 
15
N NMR SPECTRUM OF 34! 
160 I .. 0 120 100 80 60 
Cl 
a 7 6 5 
Solvent; CDCl) SF: )0 . 406 MHz; WC: 3040 Hz; 
PW/RF : 40 lJS/dB; TO: -11600 Hz; FB: Hz; 
GateQ Off:A or D ; DO: -11600 Hz; RF(Power) : 20 U/dB; 
20 
T: 25 OC; NT: 11500 
Lock: 2:n ;Dl,D5: 8 s . 




PLATE XLVIII. Se NMR SPECTRUM OF 34i 
160 1110 120 100 80 60 ItO 20 
500 0 
I 





PFT X CI.J Solvent: CDClJ SF: 57.22 MHz; wc:286to Hz; T: 25 DC; NT:60 
Size: 32 K; PW/RF: 35 lJS/dB; TO: 500 Hz; FB: Hz; Lock: 2D ;Dl,D5:20 s . 








































1n NMR SPECTRUM OF 35f 
100 80 60 
5 3 
C6D6 SF: 299 . 94 Nllz ; WC: 3000 Hz; 
J..IS/dB; TO: 0 Hz; FB : Hz; 
or D • , DO: Hz; RF(Powe r ): tv/dB; 
40 20 
2 
T· 50 OC; NT : 200 
Lock~ 2D ; Dl , D5: 0 . 5 s • 










PFT X CW Solvent: 
Size: 20 K; ·p\,Y/RF: 12 








13c NMR SPECTRUM OF 35f 
100 BO 60 
5 .. 
75 .4J MHz; we: 1.508.5 Hz; 
}Js/dB; SO: 1000 Hz; FB: Hz; 
Offset: 0 Hz; RF: 20 W/dB; 
T: .50 oc; NT:240 
Lock: 2D Delay: 4 s • 









Si ze : 12 K: 
DC: Y. N 
160 1 ~0 
8 7 
Sal vent: C6D6 




N NMR SPECTRUM OF 35£ 
100 80 60 
s 
SF: J0 .406 MHz ; we: J040 . 6 Hz; 
PW/ RF: l~O ).Is/dB; TO: - 11600 Hz ; FB: Hz; 
Gated Off:A or D ; DO: Hz; RF(Power) : 11/dB; 
40 20 
T: 50 oc; NT: 1)600 
Lock: 2D ; Dl , D5 : 8 s . 










PFT)l CW _ ; 
Si ze ; 32 K; 
DC : y 
PLATE LIII . 
77 
Se NMR SPECTRUM OF 35f 
1 .. 0 120 1 00 80 60 
8 7 6 5 
Sol vent : c6n6 SF: 57 ~ 22 MHz ; t~C: 50000 Hz ; 
·pw/RF : 35 ~s/dB; SO : 500 Hz~ FB: Hz ; 
Gated Off : Offset: 0 Hz ; RF : 20 W/dB; 
2 0 
T : 50 OC; NT : 200 
Lock• 2D Delay : 25 s • 












PFT X CW 
Size : 12 
g 
K; 
vc: y' .lL ; 
I ~o 
8 7 




H NMR SPECTRUM OF 35g-
100 80 60 
5 
Solvent: crxa3 
SF: 299 . 94 MHz; WC: .3000 Hz; 
PW/RF : 7 ~s/dB; TO: 0 Hz; FB: Hz; 
Gated Off:A or D • • DO: Hz; RF(Power): W/dB; 
20 
T: 22 OC; NT: 16 
Lock: 2D ;Dl,D5 : 0 s • 
NBW: liz; LH: Hz. ..... 
00 
.f:-. 
PLATE LVI . 
13 
C NMR SPECTRUM OF 35q 
1 ~0 120 10 0 80 6 0 ItO 20 
soo 0 
' 





ppm 9 8 7 5 
PFT X cw Solvent: CDClJ SF: 25 . 2 MHz ; we: 5000 Hz; T· 28 oc ; NT : 2648 
Size : 8 K; PW/RF: 10 )..Is/dB; TO: 35101 Hz: FB: Hz; Lock: 2o ; Dl,D5 : 5 s . 












12 K j 
N . - , 
PI.ATE LVII. 
1 5 
N NMR SPECTRUM OF 35q 
1 11 0 120 100 80 60 
8 7 6 s .. 
Solvent: CDClJ SF: )0 . 406 MHz : WC:)040.6Hz; 
PH/RF: 40 lJS/dB; TO: -11600 Hz; FB: Hz; 
Gated Off: A or D • • DO: Hz ; RF(Power): U/dB; 
20 
T• . 2.5 oc; NT: 9600 
2 
Lock: D ; D1,D5: 8 s • 
NBW: Hz ; LB: Hz. ...... 
00 
<1' 
PLATE LVIII. 77se NMR SPECTRUM OF 35g 







ppm 9 8 7 6 
PFTX C\-1 Solvent: CDClJ SF: 57 • 22 J.ffiz; we: 28610 Hz; T: 25 oc; NT: 200 
Size: )2 K; PW/RF: JS lJS/dB; TO: soo Hz: FB: Hz; Lock: 2D ;Dl,D5: 15 s. 
DC: .J, N ; Gated Off:A or D ; DO: 0 liz; RF(Power): 20 l-1/dB; NBW: Hz; LB: Hz. 
(X) __, 






H NMR SPECTRUM OF 35h 
J60 IJtO 12. 0 10 0 80 60 2 0 
5000 
• 
250 0 . 
1 00 0 
soo Cl 
pplll !I 7 6 s 
PFTX cw Solvent: CDC13 SF: 299. 94 MHz; wc:3000 Hz; T· . 2.5 OC; NT: 8 
Size: 1 2 K; PW/RF: 5 IJS/dB; TO: 0 Hz; FB: Hz; 
2 
Lock~ D ; Dl,D5: 0 s. 










PFT X CW 
Size: 16 K; 






C NMR SPECTRUM OF 35b 
100 80 &D 
5 4 3 
Sal vent: CDC13 SF: 75.4 MHz; WC:15085 Hz; 
PW/RF: 12 )Js/dB; TO: 1000 Uz; FB: ltz; 
Gated Off:A or D ; DO: o·. Hz; RF(Power): 20 U/dB; 
Cl 
2 
T· . 25 oc; NT: 80 
Lock: 2D ;Dl,D5: 4 s. 




N NMR SPECTRUM OF 35h 




' 100 0 
Cl 
ppm 9 8 1 6 s 
PFT X CW Solvent: coca
3 
SF: )0.406 MHz; we: J04o. 6Hz; T: 25 oc; NT: 6000 
Size: 12 K; PW/RF: 40 J,~s/dB; TO: -11600 Hz; FB: Hz; Lock: 2[) ;Dl,D5: 8 s • 
DC: Y, N Gated Off:A or D ; DO: Hz; RF(Power): ll/dB; NBW: Hz; LB: nz. ..... 
-.C) ..... 
77 
PLATE LXIII. Se NMR SPECTRUM OF 35h 







ppm 9 8 7 6 s 4 
PFTX cw Solvent; CDClJ SF: 57.22 MHz; t.JC: 28610 Hz; T: 25 oc; NT: 40 
Size: J2 J<; PU/RF: 3.5 lJS/dB; TO: 500 Hz; FB: Hz; Lock I ?o ;Dl,D5: 1.5 s • 
DC: ~ N ; Gated Off: A or D • ' DO: 0 Hz; RF(Power): 
20 U/dB; NBW: Hz; LB: Hz. ..... 
..0 
1\) 
















PLATE LXV. 1u NMR SPECTRUM OF lSi 






ppm 9 8 1 
PFT X CW Solvent: CDClJ ; SF: 299.94 Mlfz; WC: JOOO Hz; T: 25 oc; NT~ 
Size: 12 K; PII/RF: 5 lJS/dB; TO: 0 Hz; FB: Hz; Lock: 2D ; Dl,t>5: 0 s. 
nc: Y,J!._; Gated Off:A or D ; DO: Hz; RF(Power): U/dB; NBW: liz; LB: Hz. ~ 
....0 .p... 
PLATE LXVI. 
13c NMR SPECTRUM OF lSi 
l60 100 80 60 20 
5GO 0 
I 
250 0 . 
1000 . 
SOD 
ppm 9 8 '1 6 5 
PFT X CW Solvent: CDC13 
SF: 75.4 MHz; we: 15085 Hz; T: 25 oc; NT: 21}0 
Size: 16 K; Plol/RF: 12 lJS/dB; TO: 1500 Hz~ FB: Hz; Locks 2D ;Dl,D5: 4 s • 




PFT X CW 
Size: 12 K; 
DC: Y, N ; 
l GO 1~0 
Cl 
a 7 




N NMR SPECTRUM OF 35i 
100 80 60 
Salvent: CDClJ SF: )0.406 Mllz; wc:3040 . 6 Hz; 
P\1/RF: 40 )Js/dB; T0:-11 600 liz; FB: Hz; 
Gated Off:A or D ; DO: Hz; RF(Power); IJ/dB; 
20 
T• . 25 oc; NT: 6000 
Lock~ 2D ;Dl,D5: 8 s . 
NBW: liz; LB: Hz. 
PLATE LXVIII. 
77 
Se NMR SPECTRUM OF 35i 
)60 litO 120 100 ao 60 211 
5000 
I 




ppm 9 8 7 3 2 
PFT Y CW Solvent: CDClJ SF: 57.22 Mllz; we: 28610 Hz; T: 25 oc; NT: 200 
Size: )2 K; PI~/RF: J5 JJs/dB; TO: 0 Hz; FB: liz; Locks 2D ; Dl,D5: 15 s . 
nc:y,N; Gated Off:A or D ; DO: 0 liz; RF{Power): 20 W/dB; NBW: Hz; LB: Hz. ~ 
'-'> 
-..1 











' ,, 1.' 
• • 





I , II ,. 
A"'', "" Se----H...-N~ 
jl 
litllirrlliHfliillliliilil!iiWi!lliHHillifilhi 





CM' 2500 2C 
CHART NO. 199-1042 




I [IIDll1' lllii!J- Ul llll1llli1 ltiti~ 










PLATE LXX. 1H NMR SPECTRUM OF 36a 
ppm ) 80 )60 120 100 80 GO 20 
I r T I I I I I I I I 
5 0 00 
I 
2 50 0 
~'"' 000 soo J~--H~t•L{) 
I ! 
L Vl ''--\. ~ ~ ..... J ..)II 
1 . 
ppm ' 8 7 6 5 It 3 2 ) o l H I I . I J I I I I I I 
PFT X CW Solven t : DMSO- d6 
. SF: 299 . 94 MHz; WC : JOOO Hz ; T: 28 oc; NT : 24 • 
Size : 12K; Pl.f/RF: 5 lJS/dB; TO: 1500 Hz; FB: Hz; Lock: 2D ; Dl,DS : 0 s • 
De : Y, Ji_ ; Gated Off:A or D ; DO: Hz ; RF (Power) : U/dB; NBW: Hz ; LB: Hz . 
"' "' 
PLATE LXXI. 
13c NMR SPECTRUM OF 36a 
PFT X CW Solvent: DMSO-d6 SF: 
2_5 . 2 MHz ; wc:6ooo n.Z; T: 28 oc; NT: 4000 
Size: 8 K; PW/RF: 10 lJS/dB; TO: 35201 Hz; FB: Hz; Lock: 2D Dl,D5 : .5 s. 




PLATE LXXII. lSN NMR SPECTRUM OF 36a 






ppm 9 8 7 6 5 
PFT X CW So-lvent: DMSO-d6 . SF: 30.401 MHz; we: J040. 4tz; T: 25 oc; NT: 13400 • 
Size: 12 K; PW/RF: 40 lJs/dB; TO: -11600 Hz; FB: Hz; Lock~ 2D ;Dl,DS: 8.00 s. 
nc: y, ..M ; Gated Off:A or D ; DO: Hz; Rl-~(Power); U/dB; NBW: Hz; LB: Hz. 1\) 
0 ...... 
PLATE LXXIII. 
77se NMR SPECTRUM OF 36a 
PFTX cw Solvent: IlVISO-d6 SF:57 • 22 MHz; WC: 50 . ooonz; T:25 OC; NT: 80 
Size: 32 K; PW/RF: 35 lJS/dB; TO : 500 Hz; FB: Hz; Lock: 
2D Dl,D5 : 20 . 0 s. 
DC:_!, N . GatE!d Off: A D • DO: 0 Hz; RF(Power) : 20 W/dB; NBW: Hz; I.B : Hz. 
1\) 
or 0 • ' 
1\) 
PLATE LXXIV. IR SPECTRUM OF 36b 
2-!:) 3 MICRONS 4 5 6 7 8 9 1 0 12 14 16 20 25 
.. : .
1
. , • . .~ 1 ,. •.. 1• 1 •. ~,·, ., ••.• 1, .......... ~~=-·-~ .,~>;,· I.Ll'-';';l..":'·····' 1 
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' DO 0 
SGO 
ppm 
100 160 litO 
I I I 
A'"' 
Se •.•• H-N~ 
s 
L..J'"" 
~ 8 1 






1u NMR SPECTRUM OF 36b 
100 80 60 
I I I 
.AJ \) '-._.) 
5 .. 3 
• I . I 
PFT X CW Solvent: dmso-d6 ; SF: 299.94 MHz; WC: JOOO Hz; 
Size: t2 K; Pllf/RF: .5 lJs/dB; TO: 1500 Hz; FD: Hz; 
oc:Y,.lL; Gated Off;A or D ; DO: Hz; RF (Pot~er) : U/dB; 
ItO 20 
' I I 
J J -.-
2 1 o lH 
I I I I 
T: 25 oc; NT: 8 
Locks 2D ;Dl,D5:0 s. 
NBW: Hz; LB: Hz. 1\) 
0 .,__ 
PLATE LXXVI. 
13c NMR SPECTRUM OF 36b 










PFT K_ CW Solvent: DKSO-d6 ; 
Size: 8 K; PW/RF: 10 l-IS/dB; 
DC: y, N ; Ga t e d Off:A o r D ; DO: 
120 to o 80 60 
SF: 25.2 MHz; WC: ,5000 Hz ; 
TO: 35201 Hz; FB: Hz ; 
4)316 Hz; RF(Power) ; 7.) ~>1/dB ; 
20 
T: 28 oc; NT: 1000 
Lock: 2D ; Dl, D5: .5 s • 











Sa •••• H ... N~ 
s 
9 a 
PLATE LXXVII • 
... o 
7 
PFT X CW Solvent: DMSO-d6 
Size: 8 K; PW/RF: 10 J,.ls/dB; 
OFF RESONANCE 13c NMR SPECTRUM OF 36b 
120 lOO 
6 
SF: 25.2 MHz; wc:5000 Hz; T: 28 
TO: 35201 liz; FB: Uz; Locks 
DC: L N Gated Off: A or D ; DO: L~6)t6 Hz; RF (Pm.re r) : 7.5 U/dB; NBW: 
20 
oc; NT: 2000 
. 2D ;Dl,D5: 5 s • 





N NMR SPECTRUM OF 36b 




Se •••• H-N~ 
s 
ppm 7 
PFT X CW Solvent: DMSO-d6 ; SF: )0.406 MHz; WC: J040. 6Hz; T: 25 
Size: 12 K; PW/RF: 40 lJS/dB; TO: -11600 Hz; FB: Hz; Lock: 
2n 
DC: Y, _E ; Gated Off:A or D ; DO: Hz; RF(Power): I~/dB; NBW: 
20 









' 250 0 











9 a 7 
cw Solvent: DMSO-d6 . • 
32 K; P1.J/RF: 3.5 )..ls/dB; 
N ; Gated Off:A or D ; DO: 0 
120 100 80 60 
6 5 
SF: 57.22 MHz; we: 28610 liz; 
TO: 500 Hz; FB: Hz; 
Hz; RF(Power): 20 l-1/dB; 
ljQ 20 
T: 25 OC; NT: 104 
Lock: 2D ; Dl,D5: 20 s. 
NBW: Hz; LB: Hz. l\) 
0 
()J 









J i I 
I j • I 
·I· T-·~· 
i I: :I. ! 
.. I I: I 
: I 1 4q I 
i I I. ; 
A 
1 ·1'1:t 
. : Cl04- : I I' . : I 
~'ll I I ?0 . . , I 
Se----H~N~ i r:~: II :II ullll 
o .. i.: '. l _lt~L:LL! J 1 ! 
4000 3000 




























PLATE LXXXI. H NMR SPECTRUM OF 36c 
litO 120 )00 eo 60 





I . 5 I It I 3 I 
Solvent: DMSO-d6 SF: 299. 94r-mz; WC: JOOO Hz; 
Ptol/RF ~ 8 ~s/dB; TO: 1500 Hz; FB: Hz; 























PLATE LXXXII. C NMR SPECTRUM OF 36c 
litO 120 100 20 
500 D 
' 250 0 
' 
)000 
soo A, .. , ....... ~•'-0 
ppm 9 8 7 6 5 .. 
PFT Xcw Solvent: DMSO-d6 SF: 25.2 MHz; WC: 5000 Hz; T• . 28 oc; NT: 6t68 
Size: 8 K; PW/RF: 10 lJs/dB; TO: 3.5101 Hz; Fn: 3K Hz; 
2 
J.ock: D ;Dl,D5: 5 s • 






PFT X Ct-1 
Size: 8 




PLATE LXXXIII . OFF RESONANCE C NMR SPECTRUM OF 36c 
JSO 1 40 120 100 80 so 40 
Solvent: DMSO-d6 SF: 25 . 2 MHz; WC: 5000 Hz; T: 28 
P\-1/RF : 10 }.ls/dB; TO: 35201 Hz; FB : JK Hz ; 2 Lock: D 
Ga t ed Off : A or D • • DO: 46)16 Hz ; RF(Power): ?.5 \/I dB; NBW: 
20 
oc; NT: 1600 
; Dl , DS : 5 s • 
Hz; LB: Hz. rv 
rv 
PLATE LXXXIV. lSN NMR SPECTRUM OF 36c 






PFTX Cl-1 Solvent:DMSO-d6 SF: 30.406 MHz; wc:J04o. 6 Hz; T:25 oc; NT: 6000 
Size: 12 K; Pli'/RF: 40 )JS/dB; TO: -11600 Hz; FB: liz; Lock: 2:0 ; Dl,D5: 8 s • 
DC: Y, H._ ; Gated Off;A or P ; DO: llz; RF(Power); W/dB; NBW: H2; LB: Hz. l\) ...... 
\.l) 
5000 




PFT X CW 
Size : 32 




PLATE LXXXV. Se NMR SPECTRUM OF 36c 
1 ~0 12 0 100 80 60 
8 7 6 s 
Solvent: Dl\1SO-d6 ; SF: 5? . 22 MHz ; WC : 28 610 Hz ; 
PH/Rt-• : 35 lJS/dB; TO: 500 Hz ; FB: Hz; 
Gated Off:A or p ; DO: 0 H~ ; RF(Power): 20 U/dB; 
'10 2 0 
T• . 25 oc; NT: 108 
Lock: 2D ; Dl,D5 : 15 s • 












PLATE LXXXVII . l H NMR SPECTRUM OF 36d 





1 6 s 
cw Sol vent: DMS) - d6 ; SF: 299 . 94 MHz ; WC: JOOO Hz ; 
12K; PW/RF: .5 ).Is/dB; TO: 1500 Hz; FB: Hz; 
N • _, Gated Off:A or D • ' DO: Hz; RF(Power) : U/dB; 
20 
T: 2.5 ac ; NT : 16 
2 0 Lock: D ; Dl , D5: s . 












PLATE LXXXVIII. C NMR SPECTRUM OF 36d 
160 I '+0 120 100 80 60 
8 7 6 s . .. 
Solvent: DMSO-d6 ; SF: 25 . 2 MHz ; l.JC : 5000 Hz ; 
P\-1/RF: 14 IJS/dB; TO: 35101 Hz ; FB: 3K Hz; 
Gated Off : A or D • 
' DO: 
45316 Hz ; RF(Power) : 7 . 5 \.,I dB ; 
'+0 20 
2 
T: 28 oc; NT: 6000 
Lock: 2D ; Dl , DS : 6 s . 








PFT X CW 
Size: 8 K· ,
DC: f, N ; 
PLATE LXXXIX. OFF RESONANCE 
13c NMR SPECTRUM OF 36d 
160 1 ~0 120 100 60 60 
6 7 6 5 . 
Solvent: DMSO-d6 ; SF: 25 . 2 MHz; WC: 5000 Hz; T: 28 
Pl-1/RF : 14 lJs/dB; TO: 35101 Hz; FB : )K Hz; Lock: 
Gated Off:A or D . , DO: 46)16 Hz; RF(Power): ?.5 H/dB; NBW : 
20 
oc; NT: )000 
2D ; Dl ,DS: 6 s . 
liz; LB: Hz. 1\) 
(X) 
sooo 
25 0 0 . 
10 0 0 
ppm 




DC: Y, ~ i 
15 
PLATE XC. N NMR SPECTRUM OF 36d 
160 I 110 120 100 80 60 
a 7 6 5 
Solvent: DMSO-d6 ; SF: )0 . 406 MHz; we: J040 . 6nz ; 
P1"/RF I 40 lJS/dB; TOI -11600 Hz; FB: H~j 
Gatod Off: A or p ; DO: llz~ RF(Power) : \Uc:t8; 
20 
T: 25 oc; NT: 7200 
LockJ 2D ; Dl,D5 : 8 s • 




Se NMR SPECTRUM OF 36d 
t .. o 120 100 80 60 20 
5000 




PFTX cw Solvent: Dl\180- d6 SF: .57. 22 MHz; 'WC: 28610Hz; T: 25 oc; NT: 48 
Size: 32K; Pl.f/RF: 3.5 )Js/dB; TO: .500 Hz; 
2 25 FB: Hz; Lock; D ; Dl,D.5: s • 
DC: _x, N ; Gated Off:A or p ; DO: 0 Hz; RF(Power); 20 l-1/dB; NBW: Hz; LB: Hz. 1\) 
1\) 
0 
PLATE XCII. IR SPECTRm.l or• 36e 
6 7 8 9 10 12 6 20 2 ,. .I 50 
'TT" f1 II' ''I' 100 ! .~, J ' I" 
; 
1 1 I ! II 
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PLATE XCIII. 
1u NMR SPECTRUM OF 36e 
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PFT X CW Solvent: Dr1ISO-d6 . SF: 299.94 MHz; WC: JOOO Hz; T: 25 oc; NT: 16 , 
Size: 12 K; P1v/RF: 7 }.Is/dB; TO: 1500 Hz; FB: Hz; Lock~ 2D ; Dl,D5: 0 s. 





C NMR SPECTRUM OF 36e 






PFT X CW Solvent: DMSO-d6 ; SF: 25.2 MHz; we: 5000 Hz; T: 28 
oc; NT: 3)96 
Size: 8 K; PI-1/RF: 10 }.Is/dB; TO: 35101 Hz; FB: 3K Uz; Lock; 2D ;Dl,D5: 5 s. 











lSN NMR SPECTRUM OF 36e 
100 80 60 
5 
PFT X CW Solvent: DIV!SO-d6 ; SF: )0.406MHz; \.JC: )040.6Iz; T: 2.5 
Size: 12 K; PW/RF: 40 Jjs/dB; T0:-11600 Hz; FB: liz; Lock: 
2n 
DC: Y, JL; Gated Off:A or D ; DO: Hz; RF(Power): U/dB; NBW: 
20 
oC; NT: 21721 
;Dl,D5: 8 s . 












PFT _! C\o/ 
Size: J2 K; 
DC:_L N ; 
77 
PLATE XCVI. Se NMR SPECTRUM OF 36e 
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PLATE XCVII. IR SPECTRUM OF 36f 
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PFT X CW 
Size: 12 K; 





1u NMR SPECTRUM OF 36f 
100 60 60 
s 
Solvent: DMSO-d6 ; SF: 
299.94 MHz; WC: 3000 Hz; 
PW/RF: 5 J.Is/dB; TO: 1500 Hz; FB: Hz; 
Gated Off:A or D ; DO: Hz; RF(Power): l.J/dB; 
20 
T: 25 oc; NT: 16 
l..ock: 2D ;Dl,D5: o.s s • 










PFT X CW 
Size : 8 




PLATE. XCix. ·. C · NMR SPECTRUM OF 36£ 




8 7 6 s 
Solvent: DMSO-d6 
. SF: 2.5 . 2 MHz ; WC: 5000 Hz; 
' 
Pl-1/RF: 10 }Js/dB; TO: 3.5201 Hz; FB: Hz; 
Gated Off:A or D ; no: 4.5316 Hz; RF(Power) : 7.5 U/dB; 
110 20 
T: 28 oc; NT: 5.510 
Lock: 2D ; Dl,D5: .5 s . 









PF1' X CW 
Size: 12 K; 








lSN NMR SPECTRUM OF 36f 
100 eo 60 
5 
30 .406MHz; WC: 3040. 6tz; 
P1>1/RF: 40 llS/dB; TO: -11600 Hz; FB: Hz; 
Gated Off:A or D ; DO: Hz; RF(Power): U/dB; 
ItO 20 
T: 25 gc; NT: 1.5800 
2 Lock: D ; Dl.D5: 8 s. 








PFT _K CW 
Size: 32 K; 




se NMR SPECTRUM OF 36£ 




e 7 6 s 
Solvent: DMSO-d6 . SF:)7.22 Mllz; WC:50000 Hz; ' 
PU/RF: 35 llS/dB; TO: 500 liz; FB: Hz; 
Gated Off:A or D ; DO: 0 Hz; RF(Power): 20 H/dB; 
211 
T: 25 oc; NT: 112 
Lock: 2D ; Dl,D5: 1.5 s. 
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PLATE CIII. 
1 
H NMR SPECTRUM OF 36g 







ppm 9 e 1 6 s .. 
PFT K C\.J Solvent: DMSO-d~ SF: 299.94 MHz; WC: 3000 Hz; T: 25 oc; NT: 16 
Size: 1_2K; PW/RF: 5 }.Is/dB; TO: 1500 H~; FO: Hz; Locka 2n ;01,05: 0 s • 





C NMR SPECTRUM OF 36q 







ppm 9 8 7 6 s 
PFT X cw Solvent: DMSO-d6 ; SF: 75.4 MHz; WC: 15085 Hz; T· . 25 oc; N'£: 1240 
Size: 16 K; PW/RF: 12 ).Is/dB; TO: 1500 Hz: FB: Hz; Lock: 2D ;Dl,D5: 4 s • 
DC: x_, N ; c;a ted Off: A or J) t DO: 0 Hz; RF(Power): 20 \1/dB; NBW: liz; LB: Hz. 
N 
\JJ w 
PLATE CV. lSN NMR SPECTRUM OF 36q 








PFTX cw Solvent: DMSO-d6 . SF: JO .406 MHz; we: 3040. Az; T: 25 oc; NT: 6000 • 
Size1: 12K; PW/RF: 40 JlS/dB; TO: -11600 Hz; FB: liz; Lock; 2n ; Dl,D5: 8 s • 





Se NMR SPECTRUM OF 36g 
160 litO 120 100 80 60 
500 D 
' 250 0 
' 1000 
50 0 
ppm 9 8 7 6 5 .. 
PFTX cw Solvent: DMSO-d6; SF: 57.22 MHz; WC: 28610 Hz; T: 25 oc; Nl': 40 
Size: 321<: PW/RF: 35 )Js/dB; TO: 500 Hz; FB: Hz; Locks 2D ;Dl,D5: 25 s. 
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PLATE CVII. I R SPECTRUM OF 36h 
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PLATE CVIII. 
1 
HNMR SPECTRUM OF 36b 
180 160 litO 120 100 80 60 ItO 20 
sooo 
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ppm 9 8 7 6 s .. 
PFT X CW Solvent: DMSO-d6 SF: 299.94 MHz; WC:)OOO Hz; T· . 25 oc; NT: 1)60 
Size: 12 K; Pl~/RF: 70 ).Is/dB; TO: 1500 Hz; FB: liz; Lock: 20 ;Dl,D5: 0 s. 
DC: .X, JL; Gated Off:A or D ; DO: Hz; RF(Power): U/dB; NB\-1: Hz; LB: Hz. 1\) 
w 
-..J 
PLATE CIX. 13 C NMR SPECTRUM OF 36h 










9 8 7 
PFT X CW Solvent: DMSO-d6 SF: 75.4 MHz; we: 15000 Hz; T: 25 oc; N'J': 80 
Size: 1tf<; PlJ/RF: 12 IJS/dB; TO: 1500 Hz; FB: Uz; Lock: 
2D 
;Dl,D5: 4 s. 




PFT X Cl-1 
Size: 12 K; 
DC :,..L N 
PLATE CX. 
120 
lSN NMR SPECTRUM OF 36h 
litO 100 eo 60 
Cl 
8 
Solvent: DMSO-d6 SF:J0.406 MHz; WC: 3040.6 Hz; 
Pl-1/RF: 40 lJS/dB; TO: -11.600 Hz; FB: Hz; 
Gated Off:A or D ; DO: 0 Hz; RF(Power): 0 U/dB; 
ItO 211 
T· . 2.5 oc; NT: 6000 
Lock: 2D ; Dl,D5: 8 s . 




Se NMR SPECTRUM OF 36b 
l60 1'10 120 100 60 60 20 
5000 




ppm 6 5 
PFT 1 Cl-1 SGlvent: Dl\IISO-d6 SF: 
57.22 Mllz; we: 2861 Otz; T• . 25 oc; NT: 160 
Size: 32 JC; PlJ/RF: 35 }.Is/dB; TO: 500 Hz; FB: Hz; Lock: 2D ; Dl,D5: 15 s . 
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PLATE CXII. IR SPECTRUM OF 36i 
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PFT X CW 
Size: 12 K; 
DC: Y, JL; 
1 
PLATE CXIII. H NMR SPECTRUM OF 36i 
litO 120 IDD 
Cl 
6 7 6 5 
Solvent: DMSO-d6; SF: 299.94t-mz~ WC: )000 Hz; 
Pl~/RF: 5 J,Js/dB; TO: 1500 Hz; FB: liz; 
Gated Off:A or D i DO: Hz; RF(Power): W/dB; 
20 
T· . 25 oc; NT: 8 
Lock: 2D ; Dl,D5: 0 s. 




13c NMR SPECTRUM OF 36! 







ppm 9 e 
PFTX cw Solvent: DMSO-d6 ; SF: 7,5.4 MHz; we: 1.5085 Hz; T: 2.5' . "C; NT: 240 
16K; 12 }.IS/dB; 
2 4 Size: Pt~/RF: TO: 1.500 Hz; FD: Hz; Locks D ; Dl,D5: s. 




N NMR SPECTRUM OF 36i 
160 litO 120 lDO 60 60 20 
500 It 





ppm 8 7 
PFTX cw Solvent: DloJISO-d6 ; SF: 30.406 MHz; UC: J040.6Uz; T· . 25 oc; NT: 6000 
Size: 12 K; Pl-1/RF: 40 ~s/dB; TO: -11600 Hz; FB: liz; 
2 
Lock; D ;Dl,D5: 8 s. 
nc: Y, N ; Gated Off:A or D ; DO: Hz; RF(Power): 11/dB; NBW: Hz; LB: Hz. 
180 
500 0 







Size: )2 I<; 











PW/RF: 35 lJS/dB; TO: 500 
Gated Off:A or D ; DO: 0 Hz; 
Se NMR SPECTRUM OF 36i 
100 80 60 40 20 
5 .. 2 
MHz; we: 28610 Hz; T• . 25 oc; NT: 200 
liz; FB: liz; LockJ 2D ;Dl,D5: 15 B • 
RF(Power): 20 W/dB; NBW: Hz; LB: Hz. 1\) .,_.. 
Vo 
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PFT X CW Solvent: DMSO-d6 SF:· 299. 94MHz; we: 3000 Hz; T: 2.5 
oc; NT:l~ 
Size: 12 K; PW/RF: 5 J.IS/dB; so:1.500 Hz; FB: Hz; Lock: 2D Delay: 0.5 s. 










PFT' CW X • - -, 
She: 8 K 







Pl~/RF r 5 "lois/dB; TO: 35201 
Gated OfftA or D ; DO: 45316 H;q 
C NMR SPECTRUM OF 37 
BO 60 20 
5 3 
Mltz; WC: ·SOOO Hz; T: 28 •c; NTI 800 
Hz; rn: 3K Hz; Locka 2D ; Dl,DS: 10 s • 




N NMR SPECTRUM OF 37 
160 1110 120 100 eo 60 20 
5000 




ppm 7 6 5 . 
PFTX cw Solvent: DMSO-d6 : SF: )0.406 Mllz; we: )040. t!lz; T: 25 oc; NT: 15800 
Size: 12 K; PW/RF: 40 lJs/dB; TO: -11600 Hz; FD: Hz; Lock; 2D iDl,DS: 8 s. 
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PFT X CW Sol vent: DMSO-d6 ; SF: 57 . 22 MHz ; we: 28610 nz; T: 25 
ac; NT : 88 
Size: 32 I< ; PH/RF : 35 J.ls/dB; TO : 500 Hz ; FB: Hz; Lock: 
2D Dl,D5 : 25 s. 





3 MICROMETERS 4 
~ 1l 
~ 40 IIHHIH-!+IHHh·+IHI'"Illtff+H+ 
111 
'I 
~LATE CXXII. IR SPECrRUM OF 38 
6 7 8 9 10 12 14 16 20 25 50 
600 
PLATE CXXIII. lH NMR SPECTRUM OF 38 
ppm !80 160 litO 120 100 80 60 
PFTX cw Solvent: C:C.ClJ SF: ·299.94 MHz; WC: JOOO nz; T:25 oc; NT:4 
Size: 12K; PW/RF: 5.1 )Js/dB; SO: 200 Hz; FB: Hz; Lock: 2D Delay: 0.500 s. 
DC: N Gated Off: Offset: Hz; RF: W/dB; NBW: Hz; LB: 1\l Vt 
1\l 
PLATE CXXIV. 13c NMR SPECTRUM OF 38 
ppm 180 uo 1 .. 0 120 100 80 60 20 0 
PFTX cw Solvent: DMSO-d6 SF: 24.2 MHz; we: 6ooo Hz; T: 28 
oc; NT: 4000 
Size: 8 K; PW/RF: tO )Js/dB; SO:J.5101 Hz; FB: Hz; Lock: 2n Delay: 5 s. 
DC: y Gated Off: Offset: 4.5316 Hz; RF:7.5 W/dB; NBW: Hz; LB: 1\) \Jt 
w 
pnX cw Solvent: CIX;lJ SF : 57 . 22 MHz ; we : 500 nz; T: 2.5 oc; NT: ,32 
Size: 32 K· , PW/RF: J5, 0 JIS/dB; SO : .500 Hz ; FB : Hz; Lock: 2D Delay : 25 . 0 s. 
DC : y Gated Off: Offset: 0 Hz; RF : 20 W/dB; NBW: Hz ; LB : 1\J Vl 
.t--
PLATE CXXV!. 
1H NMR SPECTRUM OF 39 
ppm 180 160 l itO 120 100 80 60 20 
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PFT .X CW _ ; Solvent: DlVlSO-d6 SF: 299 . 94 Mltz; we: 3000 Hz; T: 25 
oc ; NT: 20 
12 K; PW/RF: 5 j.ls/dB; 1)00 
2 
Size: TO: Hz; FB: Hz; Lock: D Dl,DS 0 . ) s. 
nc: Y, .N . Gated Off: A 0[' D ; DO: Hz; RF (Power): W/dB; NBW: Hz; LB: Hz. l\.) , "' "' 
PLATE CXXVI II. 
77
Se NMR SPECTRUM OF ·39 
ppm 1111 160 l 'lt 120 10 0 80 6 0 '1 0 21 
PFT X cw- ; Sol vent: DMSO-d6 
. SF: 57 . 22 MHz; WC :17166 Hz; T : 25 oc; NT: .. 40 • 
Size: 32 K; PW/RF : 35 JlS/dB; SO: 500 Hz; FB: Hz; Lock: 2D Delay: 15 s. 
DC : y Gat ed Off: Offset : 0 Hz; RF: 20 W/dB; NBW: Hz; LB: N \.1'1 
-J 
?·!) MICRONS '-
00 I~: : : ·r ; 





if 40 ! 
0 
6 20 ·r 
i N+ -I I 
(CH3)2 
I 0 . 
4000 3000 
PLATE CXXI X. IR SPECTRUM OF 41 
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WAVENUMBER (CM-') 
PLATE CXXX. 1H NMR SPECTRUM OF 41 
1110 120 100 80 6D 20 
500 0 








----------------------------------~~~----------------'L--J ~A-·-J -~-----A ______________ __; 
ppm 9 8 7 6 s lj 3 2 
PFT X CW Solvent: IJI.ISO-d6 ; SF: 299.94 MHz; WC: 3000 Hz; T:25 oc; NT: 4 
Size: 12 K; ·pw/RF: 3 • 0 J.IS/dB; SO: 100 Hz; FB: Hz; Lock: 2D Delay: o.soo s. 





13c NMR SPECTRUM OF 41 
160 1 '10 120 100 80 60 20 -,--








ppm 9 8 7 6 5 .. 3 2 
PFT X CW Solvent: D.MSO-d6 SF: 2.5.2 MHz; wc:sooo Hz; T· . 28 oc; NT:1J70 
Size: 8 K; ·pw/RF: 10 !.Is/dB; SO: 35201 Hz; FB: JK Hz; 2 Lock; D Delay: 5 s • 







PFT X cw 
Size : 8 
DC : y 
180 
K; 
PLATE CXXXII . OFF RESONANCE 
13c NMR SPECTRUM OF 41 
160 1 4 0 120 100 80 60 40 
Solvent : DMSO- d6 SF:25 ~ 2 MHz ; WC : 5000 Hz; T: 28 
·pw/RF : 10 )Js/dB ; SO : 35201 Hz; FB:J K Hz; Lock: 
2o 
Gated Off : Offset: 46) 16 Hz ; RF : 7 . 5 W/dB; NBW: 
20 
oc; NT:2000 
Delay : 5 s . 






H NMR SPECTRUM OF 42 
160 }110 120 100 80 60 20 






ppm 9 a 7 6 5 
PFT X CW Solvent:CDClJ SF: 2~9.94 MHz; UC: 500 Hz; T: 25 OC; NT: 8 
Size: 12 K; "P\~/RF: 90 J.ls/dB; SO: 0 Hz; FB: Hz; Lock; 20 Delay: 0 s. 





C NMR SPECTRUM OF 42 
ppm 180 160 litO 12.0 100 80 60 
PFTX cw - ; Solvent: CDC13 SF:25. 2 1-1Hz; wc:5000 Hz; T:28 oc; NT:5000 
Size: 18 K; PW/RF: 10 IJS/dB; SO: 35101 Hz; FB: 3 Hz; Lock: 2D Delay: 5 s. 















PFT X CW 
















Solvent: CDC!!.) SF: 57 • 22 
·pw/RF: 35 )Js/dB; SO: 500 
Gated Off! Offset: 0 
77 
















WC: 50,000 Hz; 
FB: Hz; 


















-rl+r ·' ···, 


















PFT X CW 
Size: 12K; 







H NMR SPECTRUM OF 47. 
1 ItO 120 100 80 60 ItO 20 
1 6 
CDClJ SF: 299.94 MHz; wc:JOOO Hz; T: 25 OC; N'f: 12 
~s/dB; SO: 0 Hz; FB: Hz; Lock: 2D Delay: 0.5 s. 





13c NMR SPECTRUM OF 47 







PFT X cw Solvent: CDClJ SF:25~2 MHz; WC: .5000 Hz; T: 28 
oc; NT: 5000 
Size: 8 K; ·pw/RF: 10 ).JS/dB; SO: 35101 Hz~ FB: Hz; Lock: 
2D Delay: 5 s • 








PFT :J. C'-1 





13c NMR SPECTRUM OF 47 
120 10 0 80 60 .. 0 
Solvent: COC 1
3 
SF: 25 .2 MHz; WC: 5000 Hz; T: 28 
"PW/RF: 10 llS/dB; SO: 35101 Hz; FB : Hz; Lock: 
Gated Off: Offset: 46)16 Hz ; RF: 7. 5 W/dB; NBW: 
20 
DC; NT : 8400 






77se NMR SPECTRUM OF 47 
litO 120 100 80 60 
5000 
' 250 0 
' lOOD s . 
500 
ppm 9 4 
PFT X CW Solvent: COOlJ SF: 57.22 z.nlz; we: 28610 Hz; T: 25 oc; NT: 120 
Size: 32 K; -PW/RF: 35 lJS/dB; SO: 500 Hz; FB: Hz; Lock: 2D Delay: 20 s . 




PLATE CXLII. iu NMR SPECTRUM OF 48 
ppm teo tso Ho 120 1o o eo 60 too 20 o 
13c 
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PFT X CW Solvent: CDCl) SF: 299 • 94 MHz; we : 3000 Hz; T: 25 ac; NT : 8 
Size : 12 K; PW/RF: .5 IJS/dB; TO : 0 Hz; FB: Hz; Lock: 20 Dl, D5 : o.s s. 




13c NMR SPECTRUM OF 48 
PFT X. CW Solvent: CDClJ SF : 25 . 2 MHz; tole: 5000 nz; T: 28 oc ; NT: 1000 
Size: 8 K; PW/RF: 14 lJS/dB; TO:J5101 Hz; FB: Hz; Lock: 2D Dl,D5 : 5 s. 
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PLATE CXLIV. OFF RESONANCE 
1 3c NMR SPECTRUM OF 48 
PFT Y CW Solvent: CDClJ ; SF : 25 . 2 MHz ; WC : 3000 Hz; T: 28 oc; NT: 2000 
Size: 8 K· • PW/RF: 14 IJS/dB; TO : 35101 Hz ; FB: Hz; 
Lock: 2D Dl, D5 : 5 s . 
nc: x. N ; Gated Off: A or D • DO: 46316 Hz; RF(Power): 7 • o/dB; NBW: Hz; J.B: Hz. 
N , -J 'v.> 
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PFT Y, CW Sol vent: CDCl J SF : 299 . 94 Mllz ; we: JOOO nz; T : 25 oc; NT: 4 
Si z e : 12 K; PW/RF:_5 ).ls/dB; SO : 0 Hz; FB : Hz; Lock: 2D Delay : , 0_5 





PLATE CXLVI. lJC NMR SPECTRUM OF 49 
ppm 180 160 lifO 120 
I I I I I 
00 0 . 5 





ppm g 8 7 6 I . I . I I 
PFT 1 CW Solvent: CDCl J SF: 
Size: 16 K; P1v/RF: 12 )Js/dB; TO: 
DC: y, N ; Gated Off:A or D ; DO: 0 
100 80 61) 
I I -. 
5 .. 1 
I I I 
25.2 MHz; we: .sooo Hz; 
1.500 Hz; FB: Uz; 
Hz; RF(Power); 20 W/dB; 
40 20 
' I ' 
11 
2 I ~ lH 
I I 
T: 28 DC; NT: 40 
Locka 2D ~ Dl,D5: 4 s. 




77 Se NMR SPECTRUM OF 49 
ppm 180 160 litO 120 100 80 60 ItO 20 
PFT X CW Solvent: CDC 13 SF: '37.22 MHz; we: 1.7166 
Hz; T: 25 oc; NT : 20 
Size: 32 K; PW/RF: 35 ~s/dB; SO: 500 Hz; FB: Hz; Lock: 2D De l ay: 20 s. 














PFT X CW 
Size: 12K; 
DC: ,!, N i 
PLATE CXLVIII. 
1 
H NMR SPECTRUM OF 50 
l&D I II D 120 100 BO 60 
I I I I I I 
CH3cu2SeCH2COC1 
J j 
8 7 ~ ~ It 3 . I I . I I 
Solvent: CDClJ SF: 299.94 MUz; t.JC:JOOO Hz; 
PW/RF: .5 lJS/dB; TO: 0 Hz; Fn: Hz; 
Gated Off:A or D i DO: 0 Hz; RF(Power); 20 ll/dH' 
ItO 20 
I I f 
2 I 0 1" 
t . I I 
T: 25 OC; NT: 16 
Lock: 2D ;Dl,D5: 0 s. 


















PLATE CXLIX . 
120 
SF: 25 . 2 
14 IJS/dB ; TO: 35101 
13 
C NMR SPECTRUM OF 50 
100 eo 60 
MHz; WC : 5000 Hz ; 
Hz; FB: Hz; 
Gated Off:A or D . • DO: 45316 Hz; RF(Power): 7 • .lt/dB; 
40 20 
T: 28 OC ; NT: 750 
Lock: 2D ; Dl,D5: 5 s . 







' 1000 . 
soo 
ppm 9 
PFT K cw 
Size :)2 K; 






77 Se NMR SPECTRUM OF 50 
100 80 60 
SF: 57.22 MHz; l.JC: 28610 Hz; 
PW/RFs J5 )Js/dB; TO: 500 Hz; FB: Hz; 
Gated Off:A or 0 ; J)O: 0 lhq RF(Power): 20 lJ/dB; 
20 
T:2.5 oc; NT: ,56 
Lock; 2D ; Dl,D5: 25 s. 
NBW: Hz; LB: liz. N ..., 
"' 
ppm uo 1so 1110 120 uo eo 6o .. o 20 o 13c 
PLATE CLI. 
1H NMR SPECTRUM OF 51 
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PFTX_ cw Solvent: CIXa3 SF:299o 94 MHz; WC: )000 Hz; T: 25 
oc; NT: 40 
Size: 8 K; PW/RF: 10 jlS/dB; TO: 0 Hz; FB: Hz; Lock: 2D Dl,D5 : 0.5 s. 
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PLATE CLII . lJC NMR SPECTRUM OF 51 
PFT X CW Solvent: CDClJ SF : 75e4 MHz ; we :· 15000 Hz; T: 28 
oc; NT: 280 
"Si ze : 20 K; Pi-1/RF: 12 )Js/dB; TO: 1000 Hz; FB: Hz; Lock: 
2D Dl,D5 : 5 s. 
DC: Y, N ; Gated Off: A or D; DO: 0 Hz ; RF (Power) : 20 







PFT X CW 
Size: J2 K; 
DC: ¥., N ; 
PLATE CLIII. 
120 
77se NMR SPECTRUM OF 51 
J 110 100 80 
B 7 6 5 
Solvent: CDClJ SF: 57.22 MHz; WC:28610 Hz; 
PW/RF: J5 ).Is/dB; TO: 500 Hz; FB: Hz; 
Gated Off:A or D ; DO: 0 Hz; RF (Pot~er): 20 t-1/dB; 
20 
T· . 25 oc; NT: 80 
Lock: 2D ;Dl,D5: 15 s. 
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